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P001
Acute cholecystitis complicated by benign obstructive jaundice - a challenge for
the surgeon
S Tadjer1, St Pernishki1, R Boiadjiev1,V Marinov1 and Z Krastev2
1Emergency Medicine Institute Pirogov, Emergency Surgery, Sofia, Bulgaria
2University Hospital Sveti Ivan Rilski, Gastroenterology, Sofia, Bulgaria
We aimed, on the base of a new classification of the acute cholecystitis (AC),
complicated by benign obstructive jaundice, to work out in detail it’s genesis.
For a period of 14 years at the Emergency surgery department, 2132 patients
suffering AC were operated on. 18 % of them were complicated by benign
obstructive jaundice. 36 % were male, and 64 % were female. We found out
choledocholithiasis (ChL) in 17 %, ChL with purulent cholangitis and cholan-
giohepatitis in 37 %, stenosis of the papilla of Vater with purulent cholangitis and
cholangiohepatitis in 5 %, stenosis of the papilla of Vater alone in 11 %,ChL with
stenosis of the papilla of Vater in 16 %, ChL, stenosis of the papilla with puru-
lent cholangitis and cholangiohepatitis in 9 %, pericholedochal adenopathy in 14
%, and infiltration of the hepatoduodenal junction in 16 %.The sum of the inves-
tigated predicators of the ChL and the obstructive jaundice presented positive
predictive value of 98.5%.We created a consequative system for treatment of
ChL.We performed selective ERCP and EPST up to 15 mm. It was done on 77
patients. In 69 of them it was performed successfully preoperatively, in 3 pre-
operatively unsuccessfully, and in 5 postoperatively successfully. External
drainage was performed on 163 patients, choledochoduodenostomy on 222.
P002
Temporary antegrade stenting with primary closure of common bile duct in the
treatment of choledocholithiasis
IY Park1,YK You, KH Lee, S Lee, DG Kim, EK Kim and SN Kim
1Catholic University of Korea, Surgery, Pucheon-City, Korea
Common bile duct exploration with stone removal and placement of drainage
tubes in the hepatobiliary duct is generally accepted as the gold standard
treatment for choledocholithiasis patients.After placement of the T-tube, many
complications may develop, including bile leakage.We undertook primary com-
mon bile duct closure with temporary antegrade stenting after common duct
exploration in cholodocholithiasis patients. Between February 1999 and
October 2000, 34 patients underwent primary common bile duct closure with
antegrade stenting.The study population included 18 men and 16 women with
a median age of 57 years (range 28 to 79 years). Laparoscopic choledochoto-
my was performed in 8 patients and open choledochotomy in 26 patients. Duct
clearance was confirmed and the antegrade stent was inserted using a chole-
dochoscope. Mean postoperative hospital stay of laparoscopic choledochoto-
my patients was 6 ± 1.8 days and 10 ± 4.1 days for open choledochotomy
patients. Antegrade stents disappeared into the abdomen within 24.8 ± 13.9
days postoperatively. Treatment-related morbidity was seen in 2 cases (5.9%),
proximal migration of the stent was seen in 1 case, and distal migration and bile
leakage in 1 case.The proximally migrated stent was successfully treated with
endoscopy. In conclusion, primary common bile duct closure with temporary
antegrade stenting after common bile duct exploration is a safe, effective alter-
native to routine T-tube drainage in choledocholithiasis patients.
P003
Gallstones accompanying with colorectal cancer
K Yoshida1, M Ohtake1, H Matsuki2,T Aiba3,T Tsubono3 and Y Tamiya4
1Nippon Dental University, Surgery, Niigata, Japan
2Tashiro Shokakika Hospital, Surgery, Niigata, Japan
3Niigata Saiseikai 2nd Hospital, Surgery, Niigata, Japan
4Prefectural Yoshida Hospital, Surgery,Yoshida, Japan
BACKGROUND:Although risk of colorectal cancer (CRC) after cholecystec-
tomy was intensively discussed, relationship between CRC and cholelithiasis
itself is still unclear. PURPOSE:To know whether is there any characteristics in
gallstones accompanying with CRC, composition of stones of such cases was
studied. METHODS: Clinical records of 454 patients with CRC operated upon
in the 4 hospitals which authors belonged to were reviewed. Infrared analysis
was employed to determine composition of stones when macroscopic judge-
ment was inconclusive . X-square test and Student’s t-test were employed for
statistical evaluation. RESULTS: 32 patients were diagnosed to have gallstone
concomitantly with CRC (7%). Kinds of stones removed and examined were
black pigment in 14 cases, cholesterol in 8 and brown pigment in 3. Percentage
of black pigment stone among patients with CRC was significantly higher than
that in whole series of cholelithiasis treated during the same period (14/25 vs
132/551;P<0,01) . Among patients with black pigment gallstones, those with
CRC showed higher cholesterol saturation index of the gallbladder bile than
those without CRC (1,145 vs 0,82;P<0,01) . CSI in patients with black pigment
stone and CRC was comparable to that in cholesterol stone cases (1,14).
CONCLUSION: Black pigment stone was most frequently accompanied with
CRC. High fat diet may be the common background for both CRC and accom-
panying gallstones. The reason why black pigment stone was predominant
seemed an interesting subject for farther study. Actual incidence and clinical
importance of cholelithiasis in patients with CRC should also be investigated.
P004
The predictive factors for the conversion of laparoscopic colecystectomy to
open surgery
A Cotarlet, I Ivan and M Cotirlet
Department of Surgery, Hospital Moinesti
From the introduction of the laparoscopic surgery in our clinic, more and more
of the cholecystectomies, reaching over 85% are done by this technique . Still
considered a failure by some surgeons and patients the conversion to open
cholecystectomy is sometimes required. Based upon the accumulation of our
experience , the paper tries to analyze the situations in which, during or after
laparoscopic cholecystectomy, intra operative conversions (deliberate or of
necessity) were necessary. Retrospective study of the laparoscopic cholecys-
tectomies between Jan1996-Dec2000 in our clinic. We had registered 1022
cases (801 women, 221men, middle age 46,5).We have made an analysis of the
demographic factors, the antecedents (obesity, previous abdominal surgery) the
clinical findings (acute cholecystite, pauci-simptomatic or asimptomatic)
echografic findings, intraoperative findings (anatomic variants, sclero atrofic
cholecystite, incidents, accidents), the experience and degree of surgeon.
39/1022 cases (3,8%) needed conversion.We present a global view of the num-
ber of these cases and also an (in detail) analysis of the causes that imposed
such decisions and of the solutions adopted. Preoperative predictors of con-
version were the shrunken gallbladder, acute cholecystitis, a long history of bil-
liary suffering, the presence of anatomic (billiary or vascular) variants and acci-
dents during the intervention.The predictors may be useful in selecting the ini-
tial cases for beginners, in warning the patients about the necessity of an open
cholecystectomy and for establishing a scale of comparison between series.
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P005
Microprobe analysis of gallstones - what’s the new
S Tadjer1, Z Krastev2, St Pernishki1, R Boiadjiev1, M Tadjer1 and V Marinov1
1Emergency Medicine Institute Pirogov, Emergency Surgery, Sofia, Bulgaria
2University Hospital Sveti Ivan Rilski, Gastroenterology, Sofia, Bulgaria
We aimed to investigate the compound of the gallstones using the microprobe
analysis. It was performed by a scanning electronic microscope JEOL supertube
(Japan) and an X-ray microanalysis ORTEX 2000 (USA).We investigated 48 gall-
stones received after cholecystectomy.After the initial observation, which gave
us information about the structure of the gallstones we investigated their core
and their coats.We found crystal structures of cholesterol monohydrate, spin-
like crystals (multiplication 220) and granules (multiplication 3200).The multi-
plication possibilities were 300000.The microprobe analysis permits investiga-
tion of the very point of the gallstone (1014m spot). It is the very exact method
for discovering elements and oxides. In the pure cholesterol gallstones the
chlorine oxide is up to 25.81w%.The calcium oxide (respectively the calcium)
is up to 36.9w%. Si is slightly increased, but in some samples Ti, Zn and Cu are
very increased. In a sample the silver is 90.76w%, and it is not an artefact.The
Mg is in much more higher concentration in two samples.The Cu is a chemical
element from the D-element group.The discovering of Zn and Cu in the cen-
tral part, or the matrix if the gallstones, which contain less Ca creates the
hypotesis of Cupreous and Zinc bilirubinate.We divide the gallstones into two
groups: mineral-cholesterol and pigment ones, which are black and brown.
P006
Anatomofunctional study of the gallbladder of chagasic patients
E Crema,A Silva and R Lenza
Faculdade de Medicina do Triãngulo Mineiro, Digestive System Surgery,
Uberaba, Brasil
Many authors agree on the finding of high incidence of cholelythiasis in Chagas’
Disease patients. The most likely explanation for this fact is based on the
parassympathetic denervation in the digestive tuve caused by Chagas’ Disease.
In order to analyse the occurence of this alteration, a scintiscan study and neu-
ronal counts of the gallbladder both in Chagasic and non-Chagasic patients, pre-
senting with colelythiasis. In order to evaluate the motor function, 80 patients
underwent liver and bile duct scintiscans preoperatively.They were distributed
in two groups: Chagasic - 40 patients, 29 female, 11 male, mean age 55.6 years
(33-78); and Non-Chagasic - 40 patients, 34 female, 6 male.The comparison of
the last appearance of gallbladder (LA) at the scintiscan evidenced that in the
Chagasic Group, the length of time was greater (68.24 min) in comparison to
Non-Chagasic (50.91), this difference being statistically significant (p=0.001).
For the neuronal counts in the gall bladder, 32 patients divided in two groups:
Chagasic - 17 patients, 12 (70.5%) female and 5 (29.5%) male, mean age 57.64
(41-68); and Non-Chagasic -15patients, 12 (80%) female and 3 (20%) male.
Significant reductio of neuron numbers in the gall bladder of Chagsics (60.2) in
comparison to Non-Chagasic (177.1) was observed (p=003). Based on these
results, we concluded that:1.The gall bladder emptying shown at the scintiscan
is slower in Chagasic than in Non-Chagasic which denotes compromise of its
motor function; 2. It was noted expressive reduction of neuron numbers int he
gall bladder wall in Chagasics when compared to Non-Chagasics.
P007
Choledocholithiases: a diagnostic and therapeutic approach
JA Pascoalinho1, C Maia Santos2, E Filipe3 and J Palla Garcia4
1Hospital Curry Cabral, Surgery, Lisbon, Portugal
PATIENTS, METHODS AND GOALS: The authors present a retrospective
analysis based on 75 cases of choledocholithiases treated on a department of
surgery, between July 1998 and November 2000.The aim of this study was to
discuss the diagnostic and therapeutic methodology based on expressed
results. RESULTS: Population: middle aged > 65,6; 71% men, 29% women.
Clinical presentation: Pancreatitis > 51%; jaundice > 42%; biliary colic > 31%;
cholangitis 12%; atypical pain + cholesthasis 5%; non-symptomatic cholestasis
1%.Associations with acute cholecystitis were excluded. Imagiology:Ultrasound
> Diagnosis of gallstones; diagnosis of bile duct stones imaging accuracy; CT >
specific indications; ERCP > diagnostic and therapeutic method used on 97% of
the patients â†’ evaluation for success rates and morbimortality. Therapeutic
approach: ERCP + laparoscopic cholecistectomy > 31 cases (41%); results.ERCP
+ classic cholecistectomy > 17 cases (23 %); indications, results. ERCP alone >
26 cases (35 % of total sample); explanations and results. Laparotomy alone >
1 case (1 %). CONCLUSIONS: In a significant majority of cases, the diagnostic
and therapeutic approach of this patients included ERCP, a method that proves
a success rate higher than 86% with a low percentage of morbimortality 2%.
The major problem was still to obtain adequate response for ERCP perform-
ance. Laparoscopic surgery is proving more and more to be the standard
approach for etiological treatment (cholecystectomy) of this patients. It was
possible to treat this quite old population with a rate of morbimortality around
9%, which, we believe, is an encouraging result.
P008
Mirizzi Syndrome in the laparoscopic era
R Bracco1, J Grondona2 and L Trinchero1
1Clinica Privada Pueyrredon, HPB Unit, Department of Surgery, Mar del Plata,
Argentina
2Centro Medico Martinez y Omar,HPB Unit,Department of Surgery, San Isidro,
Bs As,Argentina
AIM:The Mirizzi syndrome (MS) is observed in elderly patients who have suf-
fered gallbladder disease for a long time. In the laparoscopic era, it became
more difficult to treat leading to high risk of Common Bile Duct (CBD) injury.
STATEMENT OF FINDINGS: Between 1991 and 2000, 2020 laparoscopic
cholecystectomies were carried out.Ten cases (0,5%) were MS: 3 with MS type
I, caused by the calculus compression from the gallbladder on the CBD, and 7
with MS type II, resulting from stone penetration into the extrahepatic biliary
tree with an installed fistulous defect. The 10 patients were initially operated
with laparoscopic approach.The 3 MS type I cases were solved by laparoscopy
and 2 out of 7 MS type II cases received a plastic reparation of the fistula tract
as well. The remaining 4 MS type II cases were converted into open surgery
after an Intra-Operative Cholangiogram (IOC) showed the absence of filling of
the proximal bile duct, and a T-tube was placed to fix the wall defect of the
CBD.The postoperative course of all patients was uneventful .All of them have
undergone follow-up, and only one case developed a stricture 4 months later,
which was solved by an endoscopic procedure. KEY CONCLUSIONS: 1)
Mirizzi type II syndrome is difficult to solve by laparoscopy.The conversion into
open surgery depends on the complexity of each case and the experience of
the surgeon. 2) The IOC has a determining role recognizing and avoiding a bile
duct injury.
P009
Up-dated methods of detoxification and immunocorrection in surgical treat-
ment of patients with obstructive jaundice
VI Mamchich, NP Subbota,AB Kebkalo,VI Palamarchuck,AI Tarahonich and AN
Syvack
Kiyv Medical Academy for Post-Graduate Education, Ukraine
The Thesis is devoted to the research of peculiarities of using laparoscopic
methods, biohemosorption in the treatment of patients with mechanical jaun-
dice of benign genesis complicated by acute hepatic insufficiency (AHI). The
influence of cryoconserved xenohepatocytes has been studied separately and
in combination with the fragments of the spleen for biochemical, immunologi-
cal values and rats¢ span of life following five- and seven- day experimental
mechanical jaundice. 273 animals were used in the experiment.The effects of
the treatment of 79 patients were demonstrated. Grade II AHI was detected in
62 patients (79,1%) and Grade III AHI - in 17 patients (20,9%).These patients
underwent preoperative laparoscopic decompression of biliary tract, surgical
treatment, postoperative extracorporal inclusion of cryoconserved xenohepa-
tocytes separately and in combination with cryoconserved xenospleen frag-
ments. On the basis of the obtained results an efficient treatment tactics for
patients with mechanical jaundice of benign genesis complicated by AHI has
been developed. The use of laparoscopic methods and biohemosorption
allowed to reduce the number of complications and lethal outcome by 17,8%
in surgical treatment.
P010
The prevalence of asymptomatic gallstones in a Turkish population
M Ungan1, K Karayalcin2, N Aras2 and YR Laleli3
1Middle East Technical University Medical Centre, Family Medicine, Ankara,
Turkey
2Ankara University Medical Faculty, General Surgery, HPB Unit,Ankara,Turkey
3Duzen Laboratorries, Biochemistry and Nucleer Medicine,Ankara,Turkey
Cholelithiasis is a major public health issue in numerous countries because of
its high prevalence. Gallstones are much less prevalent in Turkey than in west-
ern countries, and few studies have investigated the risk factors of gallstones in
this country.The aim of this study was to search for the prevalence and risk
factors of cholelithiasis in an asymptomatic population of 1486 subjects under-
going a physical check-up. Their demographic characteristics and biochemica l
parameters were researched and compared. Overall 6.16 % of all study subjects
exhibited evidence of gallbladder disease.A regression model was used in the
multivariate analyzes to detect the relative risk of gallbladder disease. Age
(adjusted odds ratio: 1.112; p<0.003) , obesity (adjusted odds ratio: 1,284;
p<0.001), positive family history (adjusted odds ratio: 5.16; p<0.001) was signif-
icant risk factors. Neither sex nor parity proved to be risk factors.The results
show that the prevalence of gallstones in Turkey rank in the lower third of the
prevalence range reported for European sonographic studies to date and pos-
itive family history, age and increased BMI correlated positively with the preva-
lence of gallbladder disease.
P011
Acute cholangitis - risk factors and autcome
V Tasev, R Gaydarski and V Popov
Medical University, Department of General and Liver Surgery, Sofia, Bulgaria
INTRODUCTION Acute cholangitis is a clinical syndrome characterized by
fever, jaundice, abdominal pain that develops as a result of stasis and infection
in the biliary tract.The mainstays of therapy are antibiotics and biliary drainage.
The aim of this study is to delineate our actual policy on treatment and deter-
minate risk factors. PATIENTS AND METHODS Between 1995-1999, 66
patients with established acute cholangitis were treated in our Department.
There were 29/43,9%/male and 37/56,1%/female, aged 22 to 84 years.The acute
cholangitis was complication of primary benign disease with 41/62,1%/ of the
patients and followed primary malignant disease with 25/37,9%/of them.
Diagnosis was established with clinical manifestation, laboratory tests, US,
ERCP and bacteriology investigations- blood and bile cultures.The management
includes antibiotics therapy and biliary decompresion. RESULTS: The classic
triad of Charcot - occurs in 73% of patients. Routine laboratory tests typically
reveal an elevated white blood cell count with neutrophyl predominance and a
cholestatic pattern of liver function tests. Bacteriology- echerichia coli is the
major gram negative bacterium isolated in 37 %.The most common gram pos-
itive bacteria is enterococcus species- 15%.Mortality was 15/22,7%/ . CON-
CLUSION: We recommend ultrasonography as the first immaging study in
patients suspected of having cholangitis to look for CBD dilatation and pres-
ence of stones. US should be followed by ERCP, both to confirm the diagnosis
and to intervene therapeutically with sphincterotomy, stone extraction or
stend insertion. Emergency surgery has largely been replaced by nonoperative
biliary drainage.Risk factors which we determinated were: the patient age; asso-
ciated diseases; presurgical duration of cholangitis; hepatic and hepato-renal
insullitiency ; hyperbilirubinemia and notable leukocytosis.
P012
Endothelin-3 causes potent contraction of human gallbladder in-vitro, via
endothelin-B and endothelin-A receptors
BO Al-Jiffry, J Toouli and GTP Saccone
Flinders University of South Australia, General and Digestive Surgery,Adelaide,
Australia
BACKGROUND: Guinea pig and possum gallbladder muscle strip contractility
are mainly stimulated by endothelin-3 (ET-3) acting on endothelin-B receptors
(ETB). The effect of ET-3 on gallbladder contractility in human is unknown.
Aims:To characterise the effect of ET-3 on human gallbladder muscle strip con-
traction and to pharmacologically identify the receptor(s) mediating the
response. METHODS: Muscle strips prepared from chronically inflamed human
gallbladders with gallstones were exposed to cumulative concentrations of ET-
3 (10-11-10-7M) . Some muscle strips were pre-treated with 10-6M tetrodotox-
in (TTX) to block nerves, the ET receptor antagonists BQ-123 (ETA), BQ-788
(ETB)(alone or together), or the mixed antagonist tezosentan (all at 10-6M).
Maximal changes in tone were measured and expressed as a % of the tone
induced by carbachol (10-4M), added at the end of the experiment. ANOVA
was used for statistical analysis. Results: ET-3 induced a slow developing, con-
centration-dependent increase in all gallbladder muscle strips (P<0.05) and at
10-7M represented 44.2 ± 4.5% of the carbachol induced tone. The ET-3
response was TTX-insensitive . Whilst BQ-123 shifted the concentration
response curve to the right, BQ-788 produced a greater shift, with the combi-
nation of both antagonists producing a cumulative reduction in the ET-3
induced contraction (P<0.01). Tezosentan pre-treatment further antagonized
the ET-3 induced contraction to 12.0 ± 4.9% of the carbachol induced response
(P<0.001). Conclusions: ET-3 produces potent contraction of human gallblad-
der acting directly on the smooth muscle. It’s action acting mainly on ETB
receptors with partial mediation by ETA receptors.
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Etiology of obstructive jaundice in our operative material
D Stankovic1, M Miladinovic2,A Kitanovic3, M Smiljkovic4 and V Stankovic5
Health Centre Krusevac, Department of Oncology Surgery, Krusevac,
Yugoslavia
In our surgical department during the period 1990-2000 , 12350 patients were
operated.Analysing our operative protocols, 1248 (10,10%)surgeries on biliary
tract were done.171 of them (13,70%) were operated because of mechanical
obstruction of bile ducts with different etiology.At 125 patients (77,64%) the
cause of obstructive jaundice is biliary genesis and at 46 (22,36%)extrabiliary.
According to our analysis benign illness toward malignant is 6:1, namely 138
patients (86,25%) had benign obstruction and 23 (13,75%) had malignant. In fur-
ther analysis were found that in benign obstruction is the biggest participation
of cholelythiasis in more than a half of the cases-87 (63,04%); 34 patients
(24,64%) had cholelythiasis associated with inflamation on hepaticocholedochus ;
than 21 patients (15,21%)had cholelythiasis with inflamation and pancreatitis;12
patients (8,69%)with chronical pancreatitis and 7 patients (5,07%)other illness.
Perceive the given facts, cholelythiasis was directly or indirectly involved in
obstruction in cases of 142 (88,19%)patients which showed us that cholelythi-
asis is illness which is in most cases complicated by obstructive jaundice. In eti-
ology of malignant illness in cases of 23 patients (13,75%) the participation of
malignant tumour of pancreas is more than a half-13 of them (56,52%) , than
malignant tumour of gallbladder 5 (21,74%), malignant tumour of hepaticoc-
holedohus 3 (13,04%), papile Vateri 1 (4,35%) and primary liver cancer 1
(4,35%).
P014
Clinical analysis of congenital bile duct dilatation in different ages group
Y Yun1,Wang Liang1, Q Ribin2 and W Huizhen2
1Second Clinical Hospital China Medical University, Department of Surgery,
Shenyang, China
2Second Clinical Hospital, China Medical University, Department of Pediatrics
Surgery, Shenyang, China
OBJECTIVE: To analyze the diagnosis and treatment of congenital bile duct
dilatation in different ages group. Methods: From Jan 1998 to Dec 1998, 192
cases with congenital bile duct dilatation were divided into two groups: non-
adult group (1~14 years), adult group (more than 15years).The etiology, clini-
cal manifestation, diagnosis and treatment were analyzed. Results: Non-adult
group had 159 cases, 76 cases accepted ERCPI /MRCP and choledochography,
62 cases 58% showed anomalous junction of pancreaticobiliary ductal sys-
temï?Œ 96 cases accepted hepaticojejunostomy 57 cases accepted hepatico-
duodenostomy, 6 cases accepted external drainage. Mortality rate was 0.6%.
Adult group had 33cases, accuracy rate of B-ultrasound was 78.78% 6 cases had
accepted operations previously, 2 cases (6.06%) had malignant change, 31cases
accepted hepaticojejunostomy 2 cases accepted radical operation of hilar
cholangiocarcinoma and pancreatoduodenectomy due to malignant change of
cyst. Mortality rate was 3%. CONCLUSION: Etiology of congenital bile duct
dilatation was not clear, anomalous junction of pancreaticobiliary ductal system
was main cause in non-adult group, congenital abnormity and recurrent infec-
tion were main cause of adult group.B-ultrasound was the first choice of exam-
ination and MRCP was a method with unique superiority.Adult group had com-
plexity in long course of disease, complex etiology, more complications and
sometimes more operation experiences. Early diagnosis, early treatment, selec-
tion of proper operation, early management of complications and enhancement
of postoperative follow-up are keys to improve prognosis.
P015
Ileus caused by migration of fragment of metalic self expanding stent
J Pechan, D Pinák, J Durdík, M Hubka and A Vavreka
2nd Department of Surgery of Medical Faculty, Comenius University, Bratislava,
Slovak republic
Description of a rare complication after self-expanding metalic stent implanta-
tion into the biliary tract of a 76 year old patient - 6 months after endoscopi-
cal pertubation of stenosis of hepaticojejunal-anastomosis by metalic self-
expanding stent, was admited and operated for ileus caused by bezoar obstruc-
tion in terminal ileum.This bezoar grew around the destructed part of the stent
through its small intestine passage (radiological scans and photodocumentation
is enclosed).Authors are describing this rare complication in discussion.
P016
Hemobilia And Jaundice Due To Acalculous Cholecystitis - A Case Report
T Nursal1, S Yildirim1,T Noyan1,T Yildirim2 and G Moray1
1Baskent University Adana Practice and Research Centre, General Surgery,
Adana,Turkey
2Baskent University Adana Practice and Research Centre, Radiology, Adana,
Turkey
INTRODUCTION: The etiology of hemobilia is largely attributed to trauma,
followed by infection and gallstones. Although gallstone disease is relatively a
common etiological factor, acalculous cholecystitis is a rare cause. CASE
REPORT: A 65 year old man complained of abdominal pain and jaundice .
Bilirubin, alkaline phosphatase and gamma-glutamyl transpeptidase levels were
increased. Ultrasonography, computed tomography and magnetic resonance
revealed gallbladder wall thickening , a small polipoid lesion on the gallbladder
wall and hemorhage into the lumen.Active bleeding was observed on ERCP.At
operation the gallbladder was noted to be inflamed and hydropic. Following
cholecystectomy, gallbladder was opened and an open vessel mouth in the base
of small ulcer was observed. No gallstones and mucosal abnormalities were
present. Although pancreas and periampullary area were normal by palpation,
common bile duct was dilated. Choledochoduodenostomy was done after
cleansing of the common bile duct of blood clots. Histopathological examina-
tion revealed cholecytitis with mucosal erosions.The postoperative period was
uneventful . DISCUSSION: Although hemobilia due to gallstone disease is
responsible about 15% of the cases, acalculous cholecystitis is an extremely
rare factor. Our patient is the fourth case in the English literature, in whom
hemobilia was clearly attributable to acalculous cholecystitis. In acalculous
cholecystitis it is postulated that mucosal necrosis and subsequent ulceration
into one or multiple vessels cause hemobilia. Although traumatic-iatrogenic
causes are the most frequent factors of hemobilia, rare conditions such as acal-
culous cholecystitis should be kept in mind in this difficult to diagnosis entity.
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P017
Porcelain gallbladder or gangrenous cholecystitis in patients with neuroen-
docrine tumours treated by somatostatin
G Montalto1, F Cetta1, M Zuckermann1, A Cariati1, M Gori1, P Rossi2, MA
Centra3 and L Forzini3
1University of Siena, Institute of Surgical Clinics, Siena, Italy
2University of Siena, Institute of Pathology, Siena, Italy
3University of Siena, Institute of Radiology, Siena, Italy
Somatostatin (SST) decreases gallbladder (GB) motility and facilitates gallstone
(GS) formation. During the prospective study of 2200 patients with GS, who
had systematic stone and bile analysis, 3 patients with unusual complications of
GS after long-term treatment by SST-like drugs have been observed.The first
patient, a 49-year-old male, underwent emergency operation for intestinal
occlusion due to small bowel adhesion to a porcelain GB. The patient had
appendicectomy and ileal resection for carcinoid of the appendix 13 years
before. Somatostatin was addes as a part of the therapeutic regimen during the
last 7 years.There was only another patient younger than 50 in a series of 15
patients with porcelain GB observed during the same study. The other 2
patients, both males, aged 53, with previous unknown GS, had gangrenous
cholecystitis, with concomitant liver abscesses and peritonitis, within 2 and 3
days after onset of symptoms. Both required wedge liver resection of segment
IV and V.The former patient had emergency gastrectomy 5 years before; the lat-
ter had a gastric perforation (gastrinoma of unknown origin) with liver metas-
tases 7 years before. Both had long-term treatment with SST-like drugs, as a
part of the therapeutic regimen. Unusual (porcelain GB in a 49-year-old man)
or unusually severe complications (gangrenous cholecystitis with liver abscess
and peritonitis) of GS can be found in patients with long-term treatment with
SST-like drugs. If these findings will be confirmed, prophylactic cholecystectomy
should be advised in patients with presumed long-term treatment by SST-like
drugs.
P018
Surgical technique and rationale for removal of a long cystic remnant after
cholecystectomy in patients with previous heart surgery and severe biliopan-
creatic symptoms
F Cetta1, G Forzini2, M Pieraccini2, M Zuckermann1 and G Montalto1
1University of Siena, Institute of Surgical Clinics, Siena, Italy
2University of Siena, Institute of Radiology, Siena, Italy
During cholecystectomy the cystic duct is ligated at a variable distance from the
common duct (CD).Therefore, long cystic remnants (LCR, >1.5cm), can occur
either as a result of the surgical technique or of anatomic variability, which also
includes arterial variations. During the prospective study of 2200 patients who
underwent surgery for gallstones, 366 had CD stones. 113 patients had post-
cholecystectomy stones. Nineteen of them had a LCR. Gallstones in the LCR
were cholesterol (n=2), mixed (n=4) brown (n=2) and black pigment (n=11).
Nine patients had surgery before 1995, 10 patients during the last 5 years,
mainly because of recurrent pancreatitis. In the latter group, gallstones were
black (irregular, often spicular, with high calcium carbonate content) in 9
patients (5M, 4F) with previous heart surgery, whereas they were mixed cho-
lesterol in a 54-year-old female without previous heart surgery. In all patients
there was complete remission of symptoms 6 to 60 months after surgery. Even
if there was considerable variability in the length of the LCR and the confluence
between cystic duct and CD, multiple arterial branches (up to 6) had to be sep-
arately ligated (in 2 cases close to the papilla within the pancreatic tissue), in
order to remove completely the LCR. A complete removal is mandatory
because even a small remnant could act as a mini gallbladder, where bile stasis
occurs, in these patients who are prone to form gallstones both for anatomic
predisposition (tortuous and dilated cystic duct) and increased hemolysis.
P019
Surgical treatment of patients with hilar cholangiocarcinoma
VM Kopchak,AI Dronov,AV Duvalko and IV Khomyak
Department of Pancreatic and Bile Duct Surgery, Institute of Surgery and
Transplantology, Kiev, Ukraine 
In the period of 1992-2000 years 72 patients with hilar cholangiocarcinoma
underwent surgical treatment in the Institute of Surgery and Transplantology. It
makes 26.6% of all patients with extrahepatic bile duct’s tumours. Radical sur-
gical operations were performed in 23 patients (32%). In cases of hilar tumours
T1-2N0M0 (19 patients) surgical treatment included resection of bile ducts
bifurcation with the dissection not less then 1.5 cm proximally as to the
tumour, followed by the formation of biliodigestive anastomoses. In 13 patients
the bihepaticojejunoanastomoses were performed. In 6 cases anastomoses
were formed with 4-7 segmental bile ducts. In 4 patients the en bloc tumour
resection with right or left hepatical lobectomy was performed, depending on
the primary affection of the lobal bile duct right (1 case) or left (3 cases). In 49
patients that didn’t undergo radical surgical manipulations different palliative
interventions were performed.We preferred the low-invasive methods of bile
decompression and endoscopic bile stent placement.The postoperative mor-
tality was 12.4%.
P020
Results of Surgical Treatment of Gallbladder Cancer
A Frena, G La Guardia and F Martin
Ospedale Regionale, Chirurgia Generale 2, Bolzano, Italy
AIMS: primary carcinoma of gallbladder (GC) is a progressive lethal disease
(incidence of 2%). The survival of the patients depends strictly on depth of
tumour invasion.We evaluated the results of our surgical series according to
pTNM classification and stage. METHODS: a retrospective analysis of a fifteen-
years experience was performed.Of 72 patients with GC observed at our insti-
tution between 1983 and 1999, a curative operation was carried-out in 25
patients (34,7%). Most common presenting symptom was pain (78,6%) in 13
patients with Stage I-II and jaundice (41,7%) in 12 patients with Stage III-IV. Of
25 patients, 15 underwent cholecystectomy and 10 had an extended operation
(6 cholecystectomy plus liver segmentectomy IV or IV-V; 2 cases of Whipple-
procedure; 1 case of Whipple-procedure and liver segmentectomy IV; 1 case of
cholecystectomy and bile-duct resection). RESULTS: Kaplan-Meyer’s survival-
time is 81,8% after 1 year, 63,6% after 2 years, and 18,1% after 5 years for Stage
I-II patients; 27,2%, 0, and 0 for Stage III-IV patients respectively. Moreover, one-
, two-, and five-years survival rates were 69,2%, 53,8%, and 15,2% in the patients
treated by cholecystectomy; 30,0%, 0, and 0 in the patients who underwent an
extended surgical approach. CONCLUSIONS: the Stage I-II patients represent
a minority of cases of GC: they have a localized disease and surgical treatment
provides the opportunity of a good survival.The Stage III-IV patients aren’t cur-
able: the survival rates demonstrated that surgery is only a good palliation.
Extended operations for advanced stages are associated with a poor prognosis.
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Role of interventional radiology in hepatopancreatobiliary cancer complicated
by obstructive jaundice
A Granov1,A Polikarpov2, P Tarazov2,A Kozlov2 and V Polysalov1
1Research Institute of Roentgenology, Surgery, St.Petersburg, Russia
2Research Institute of Roentgenology, Angio/Interventional, St.Petersburg,
Russia
AIM: To increase effectiveness of interventional radiological treatment in
hepatopancreatobiliary cancer complicated by obstructive jaundice.
METHODS: We treated 71 pts with malignant jaundice in the past 10 years.
Patients were divided into three groups according to treatment: A, external
transhepatic biliary drainage (ETBD) plus symptomatic therapy ( n= 18 ); B,
external-internal (EI)TBD or biliary stenting ( BS) with symptomatic therapy
(n= 38); C, E-ITBD or BS plus transcatheter regional chemotherapy ( n= 15
)that included hepatic artery infusion with 5 FU and/or doxorubicin or
chemoembolization (doxorubicin+Lipiodol+Gelfoam. These procedures were
performed after serum bilirubin decrease < 50 mg/dL. RESULTS: Major compli-
cations such as cholangitis, bile leakage, malfunction of drainage catheter and
hemobilia occurred in 18 pts (25 %) and were equal in all groups. Mean serum
bilirubin 1mo after biliary drainage decrease from 203.9 mg/dL to 110.8 mg/dL
in group A, from 205.6 to 64.6 mg/dL in groups B and C (p< 0.001). Mean sur-
vival (M + SD) calculated for pts who died was 2.1+ 0.5 mo for group A
(pb,c<0.01) , 7.9+ 6.7 mo for group B, and 16.6+ 14.8 mo for group C ( NS  with
B). The actuarial 1-yr survival was 10%, 25%, and 45%, respectively.
CONCLUSION: E-ITBD or BS are safe and effective palliative procedures for
patients with malignant obstructive jaundice . Regional chemotherapy after
PTBD permits to achieve the two-fold increase of survival in patients with
hepatopancreatobiliary cancer.
P022
Comparision of the different methods in the treatment of proximal bile duct
cancer
A Chzhao,V Vishnevsky, R Ikramov and T Tarasyuk
Institute of Surgery n.a.Vishnevsky,Abdominal Surgery, Moscow, Russia
METHODS: Different kinds of palliative surgical procedure were done in 70
(54,3%) of 129 pts. with proximal dile duct cancer (Klatskin tumour). Radical
resection and palliative resection, including liver resection was performed in 59
(45,7%) of pts. TREATMENT:Tumour recanalization and stanting ere performed
in 24 pts, bilioenteric anastomoses in 22, PTC- in 21, endoprothesis- in 3 pts.
30% of pts. hat underwent palliative procedure had stage III tumour, 70%- stage
IY. 15(25,4%) of 59 pts. underwent tumour resection had stage II tumour,
32(54,2%)- stage III, 12(23%)- stage IY. Bile duct resection was done in
35(59,3%)pts , in 24 cases bile duct resection combined with liver resection (11-
segment IYA, 6-right hepatectomy, 7-left hepatectomy). In 4 cases after pallia-
tive resection of the tumour, local radiotherapy with iridium was performed
RESULTS: Postoperative mortality after palliative non-resecting surgical proce-
dure was 25,7%, after radical and palliative resections including liver resection
13,6%.Actuarial survival in the first group in 1, 2 and 3 years was 62,5%, 37,5%,
and - 0%, in the second group 1, 2,3,4 and 5 year survival was 97,6%, 86,8%,
55,6%, 15,6% and 15%. CONCLUSION: Palliative as well as radical resection,
including partial hepatectomy in patients with Klatskin tumour approved in the
view of quality of life and long term survival.
P023
Transduodenal excision of ampullary tumours
A Bohra1, L McKie2 and T Diamond3
Mater Hospital, Surgery, Belfast, United Kingdom
BACKGROUND: True ampullary tumours are rare, have a high incidence of
malignancy and a varied presentation.Accurate preoperative diagnosis is diffi-
cult and pancreaticoduodenectomy causes significant morbidity and mortality.
This study illustrates the procedure of transduodenal excision and evaluates
the results of investigations and the impact of the histopathological findings on
the overall survival following this procedure. METHOD:This is a retrospective
study of 15 patients treated with transduodenal excision. Demographics, symp-
toms, histopathology and outcomes were analysed. Survival analysis was done
by the method of Kaplan-Meier. RESULTS:The median age was 68 years (range
54-78).Twelve (80%) patients were males. Jaundice (n=10) and pain (n=7) were
the commonest presentations. Endoscopic biopsy was accurate in 41% cases
while CT scan demonstrated a mass in 50%. Definitive histology revealed 4 ade-
nomas, 2 carcinomas-in-situ and 9 adenocarcinomas. Resection margins were
clear in 14 cases.There was no operative mortality.There were 2 postopera-
tive complications - 1 wound infection and 1 subphrenic abscess. Mean dura-
tion of follow-up was 28 months (range 4-66 months). Four patients died dur-
ing follow-up, all due to local recurrence.The procedure appears curative for
adenomas and in-situ carcinomas. Overall 3-year acturial survival is 63% while
that for moderately differentiated carcinoma is 50%. The longest survival for
poorly differentiated carcinoma is 10 months. CONCLUSION:Transduodenal
excision is a safe procedure with low morbidity and good survival. Preoperative
investigations are inadequate. Outcome depends on tumour differentiation
after adequate resection. A multicentric , controlled study would help further
evaluation.
P024
Cancer of extrahepatic gall ducts and gall bladder
CM Cernisevski Mihajlo, MM Morisan Marinko and JM Janic Mladen
General Hospital Pancevo, Surgery, Pancevo, Greece
Cancer of the extrahepatic gall ducts and gall bladder is a frecvent malignant
disease and it is on the fifth place of the digestive tract malignant diseases.The
objective of this paper is to present our experience in the surgical treatment
of these patients in the 1995 - 2000 period; 42 patients were surgically treated
in our ward. Of this number, 26 patients underwent surgical operation on their
gall bladders, 14 gall ducts and 2 Ca papillae. In the case of about 50% patients,
the preoperative diagnoses were valid.The surgical procedures, we used, were
dependent on cancer localization, invasiveness and presence of metastases.
Unfortunatly, we had to perform explorative laparotomia with most patients
due to the advamed malignant process. In the case of 10 patients with Ca of
gall bladder - cholecystectomy was performed, whereas with 2 patients chole-
cystectomy + segment resection of the liver was performed. In the 4 cases of
patients with Klatzin tumours hepatico-jejunostomia Roux-y was performed. In
the case of 2 patients with Ca papillae, a classic pancreatoduodenectomia (s.
Whipple) was performed. CONCLUSION: Cancers of gall bladder and
extrarhepatic gall ducts are tumours with considerable malignant potentials.
The prognosis is bed. A radical operation is offten infiseable and with the
patients treated surgically, the recurrence of the disease occurs very quickly.
Somewhat better results can be expected in the case of those patients where
macroscopic examination (intraoperative) reveals no malignant changes, but
only a postoperative PH examination reveals malignancy.
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Proximal extrahepatic biliary tumours: palliative management
L Sanz, CA Laso, M García, E Azcano,V Ovejero, LA Miyar, JJ González and E
Martínez
Hospital Central, University of Oviedo, Surgery B, Oviedo, Spain
INTRODUCTION:Neoplasms of the upper third of the extrahepatic bile ducts
are frequently unresectable. We reviewed our experience in the palliation of
malignant obstructive jaundice (MOJ) secondary to these neoplasms. PATIENTS
AND METHODS: Between January 1989 and December 1998 we treated 136
patients with MOJ unsuitable for curative treatment. 32 of them (23.5%) had
proximal biliary tumours. Median age was 68.1 years (SD=10.3) and 22 were
men. Jaundice was the clinical presentation in all except two patients.The cause
of palliation was: unresectability 18 patients, poor general condition 11 patients
and metastatic spread 3 patients. RESULTS:We performed 4 surgical bypasses
and 4 surgical external drainages. Radiologic internal-external drainage was
used in 17 cases and endoprosthesis in 7. Morbidity after procedure occured
in 15 patients and 9 patients died through the follow-up, the majority of them
due to progression of hepatorenal failure.Median survival time was 4.5 months,
with no significant differences between surgical and radiologic method. CON-
CLUSIONS:The palliation of MOJ due to proximal extrahepatic biliary tumours
has a high morbimortality and a poor long-term survival rate.
P026
Surgical treatment of cystic dilatation of the biliary tree
G Nuzzo1, C Cavicchioni , G Clemente and F Cadeddu
Agostino Gemelli Medical School, Surgical Sciences, Rome, Italy
Patients with congenital cystic dilatation of intra- and extra-hepatic bile ducts
can develop cholangitis, chirrosis, portal hypertension, lithiasis, pancreatitis and
carcinoma between 20 and 100 times more frequently than general population.
An anomalous junction of the pancreaticobiliary duct was found in 90% of
patients.The reflux of pancreatic juice into the bile ducts can produce a chron-
ic inflammation and may play a role in carcinogenesis. In the last years hepatic
resections have been performed increasingly for treatment of these conditions,
rather than internal biliary drainage.This retrospective clinical study analyzes
the incidence of carcinoma and the results of treatment in a series of 16
patients with congenital cystic biliary dilatation observed at our Department
between Jan 1992 and Dec 2000. Patients were classified according to Todani
classification: type I= 1 pt; type IV = 4 pts; type V: 11 pts. Thirteen patients
underwent radical resection:six hepatectomies and seven sectoriectomies
were performed. Two patients underwent palliative treatment by hepatico-
jejunostomy and one patient was treated by endoscopic drainage and ESWL.A
cholangiocarcinoma was diagnosed intraoperatively in three cases (18.7%).
Morbidity related to the treatment was 25%.There was not postoperative mor-
tality. Considering the high incidence of malignancy in these patients, surgical
treatment is recommended. In fact, both early detection and radical excision
are essential for successful treatment of these anomalies.
P027
The in vitro properties of four photosensitizers in photodynamic therapy for
cholangiocarcinoma
F van Duijnhoven1, J Rovers1, M Bordui1,A Suijdendorp1, J Schuitmaker2 and OT
Terpstra1
1Leiden University Medical Centre, Surgery, Leiden,The Netherlands
2PhotoBioChem, Leiden,The Netherlands
Photodynamic therapy (PDT) is a treatment modality in which a combination of
drug and light is used to induce tissue damage.A promising development is the
use of PDT for palliative treatment of cholangiocarcinoma.The goal of this study
is to evaluate which photosensitizer is most potent in photodynamic therapy for
cholangiocarcinoma.Cellular localisation, uptake and cytotoxicity of four photo-
sensitizers were assessed in an in vitro human cholangiocarcinoma cell line (CC-
LP-1). These sensitizers were Photofrin, meta-tetra(hydroxyphenyl)chlorin
(mTHPC), meta-tetra(hydroxyphenyl)bacteriochlori n (mTHPBC) and the pre-
cursor of endogenous photosensitizer protoporphyrin IX (PpIX), aminolae-
vulinic acid (ALA).To study the intracellular localisation of these drugs,CC-LP-1
cells were incubated with the sensitizer as well as with three cellular markers.
Photofrin and PpIX were located within the endoplasmatic reticulum and lyso-
somes whereas with mTHPC, a diffuse cytoplasmic distribution was seen.
Uptake experiments showed that for all sensitizers, intracellular photosensitizer
concentration increased up to a certain point after incubation (range: 8-24
hours), when a plateau phase was reached. Cytotoxicity was assessed by illumi-
nating cells with a broadband light source (> 600 nm wavelength).This experi-
ment showed incubation withALA to be minimally cytotoxic,with 50% cell death
at an incubation concentration of 214 µg/ml medium with a 20 J/cm2 light dose.
With the same light dose, IC50 for Photofrin, mTHPC and mTHPBC was 2.8
Âµg/ml, 0.08 µg/ml and 0.11 µg/ml medium respectively.We therefore conclude
from our in vitro experiments that mTHPC and mTHPBC are the most potent
sensitizers in PDT for cholangiocarcinoma.
P028
Nonoperative therapy of anastomotic stoma stenosis after cholangio-jejunos-
tomy
J Liu1, G Miao2 and Y Yu1
1The Second Affiliated Hospital,China Medical University, Surgery Department,
Shenyang, China
2The third people’s hospital of Anshan City, Surgery Department,Anshan, China
The anastomotic stoma stenosis after cholangio-jejunostomy often leads to bil-
iary obstruction, cholangitis, gallstone, cholestatic cirrhosis, and may cause
death in severe cases.There are difficulties, heavy trauma in re-operation and
restenosis may occur.The methods of choledochofiberoscope and X-ray were
used in 33 cases since 1994, and got good results.METHODS: Passed the chole-
dochofiberoscope through subcutaneous blindloop (8 cases) and T tube sinus
(13 cases).The stenosis was expanded in ballon catheter then stones superior
the stenosis were taken out. Cicatrical stenosis should be supported for 3-
6months in rigid plastic tube. Metal stents could be used in malignant stenosis
by choledochofiberoscope.12 cases suffered from PTCD. Metal stents were put
through malignant stenosis without bile duct stones by choledochofiberro-
scope and X-rays. If stones or cicatical stenosis existed, first expanded sinus,
then took stones out using percutaneous transhepatic choledochoscopy
(PTCS), put in metal stand for malignant stenosis or rigid plastic tube for ciatri-
cal stenosis by choledochoscope and X-ray. RESULTS: There were 24 benign
stenosis in 33 cases. 19 cases accepted expansion and 5 cases accepted rigid
plastic tube supporting.All stenosis were successfully relieved. Restenosis hap-
pened in 2 cases after 8-36 months. In 9 malignant stenosis,8 cases with
obstruction were relieved by metal stent supporting. 3 cases died for hemobil-
ia or metastasis after 4-18 month.Choledochofiberoscope was used in 15 cases
with bile duct stones and all succeeded. CONCLUSION:The method of chole-
dochofiberoscope and X-ray has fewer traumas and side effects. It has definite
therapeutic effectiveness.
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Minimally invasive management of bile leak after laparoscopic cholecystectomy
G Tzovaras1, P Peyser2, L Kow2,T Wilson2, R Padbury2 and J Toouli2
1University of Thessaly Medical School, Dept of Surgery, Larissa, Greece
2Flinders Medical Centre, Dept of Gastrointestinal Surgery,Adelaide,Australia
OBJECTIVE:The introduction of laparoscopic cholecystectomy has dramatical-
ly changed the approach to gallstone disease over the last decade.However, the
laparoscopic operation has been associated with a higher incidence of bile leak
compared to open cholecystectomy. Similar to other groups, we applied mini-
mal access techniques to treat patients presenting with symptomatic bile leaks.
We report the outcome of this approach in a consecutive series of patients.
MATERIAL/METHODS: Between 1990 and 1998 twenty-one consecutive
patients (7 men, 14 women, median age: 62 years, range: 29-92 years) were
treated for symptomatic bile leak after laparoscopic cholecystectomy. Median
interval from operation to presentation was 5 days (0-22 days). RESULTS:
Endoscopic treatment by ERCP was attempted in 20 of the 21 patients (95%);
one referred patient, found on ERCP to have complete transection of the right
hepatic duct, underwent open reconstruction. In 19 of the remaining patients
(95%) minimally invasive techniques which included endoscopic sphincteroto-
my and/or stenting often in combination with percutaneous drainage under
US/CT guidance of localized collections (n:6) or laparoscopy with lavage and
drain placement for diffuse collections (n:4), were successful in treating bile
leak. CONCLUSION:This series is complementary to previous reports, which
confirm the safety and efficacy of minimally invasive procedures in the manage-
ment of symptomatic bile leak following minor biliary injuries associated with
laparoscopic cholecystectomy. Endoscopic treatment by means of ERCP is the
cornerstone of the management, supplemented by either interventional radio-
logical or laparoscopic procedures.
P030
Malignant obstructive jaundice: patient outcome after non-surgical palliative
therapy
G Nuzzo1, G Clemente, F Cadeddu and F Ardito
1Agostino Gemelli Medical School, Rome, Italy
A retrospective study on patients submitted to non-surgical treatment for
malignant obstructive jaundice (MOJ) was made to assess clinical outcomes.
Clinical records of patients treated at our Dept between Jan 1992 and Dec
1999 were rewieved. Recurrence of jaundice and number of Hospital readmis-
sions were also considered to evaluate the quality of residual life.There were
94 pts. (53 m and 41 f, mean age 66.5 yrs).Tumour site was hepatic hilus in 45
pts., pancreatic head in 33 pts., distal CBD in 6 pts.,Vater’s ampulla in 3 pts. and
metastatic lymphnodes in 7 pts. Patients with gallbladder cancer were not con-
sidered. Endoscopic insertion of endoprostheses was the preferred modality of
palliation (86 out of 94 pts. = 91.5%). Morbidity related to the procedure was
33% and cholangitis was the most common complication. Mortality was 14%.
Fourty-one pts. out of 85 survivors developed recurrent jaundice and cholan-
gitis due to the blockage of endoprosthesis. Seventy-one readmissions for stent
change were required.The mean survival was 6.7 months. Most patients with
MOJ are unsuitable for curative resection and candidates to palliative treat-
ment. In the last years non-surgical methods of biliary decompression have
been used increasingly instead of surgical biliary bypass. Otherwise, a high inci-
dence of complications and Hospital readmissions were found after biliary
stenting in this series. So, considering that the goal of palliative therapy is also
to improve the quality of residual life, biliary stenting might be reserved to high-
risk patients or when a short survival is expected.
P031
Reinterpretation of radiological images of patients with the suspicion of a
hepatic, pancreatic or a biliary malignancy
EHBM Tilleman 1, OM Delden2, SKA Phoa2, EAJ Rauws 3, JS Laméris2 and DJ
Gouma1
Departments of Surgery1, Radiology2 and Gastroentrology3 of the Academic
Medical Centre
Patients referred to a centre with the suspicion of a hepatic, pancreatic or bil-
iary (HPB) malignancy generally arrive with radiological investigations per-
formed elsewhere. Occasionally marked differences between the initial report
and a renewed interpretation of these earlier investigations resulted in a change
in tumour staging with therapeutic consequences for the patient.This study was
performed to determine the clinical importance of reinterpretation earlier
investigations and to determine the additional value of subsequent investiga-
tions in a single centre.The referral diagnosis, the radiological investigations and
reports from 78 patients with a suspicion of a HPB malignancy who were
referred to the AMC were included.A blinded reinterpretation panel existing
of two HPB- radiologists, one gastroenterologist and one surgeon scored the
technical quality of the investigations and made a reinterpretation report.
Furthermore the additional value of the radiological investigations in the AMC
was measured.As best available golden standard in decreasing order of validity
pathology, surgery and/or follow up was used.The quality of ultrasound and CT
was sufficient for reinterpretation in respectively 52% and 70%. The reinter-
pretation reports of the ultrasounds were compared to the initial reports and
graded as “agreement” in 83%, as “minor disagreement”, (no therapeutic con-
sequences) in 8% and as “major disagreement” (change in therapy) in 8%.The
reinterpretation reports of the CT were graded as “agreement” in 70%, as
“minor disagreement” in 19% and as “major disagreement”12%.A second ultra-
sound in the AMC (n=55) showed no additional findings compared with the sit-
uation at referral in 11%, minor additional findings (no therapeutic conse-
quences) in 49% and major additional findings (change in therapy) in 35%. For
CT (n=47) no additional value was found in 21%, minor additional findings in
47%, and major additional findings in 32%. CONCLUSION: Reinterpretation of
ultrasound and CT from elsewhere resulted in a change in therapy for 7
patients (9%).An additional ultrasound and CT in the AMC resulted in a change
in treatment strategy for another 24 patients (30%).
P032
Surgical treatment for advanced hepatocellular carcinoma
XP Geng
Department of Surgery, Affiliated Hospital of Anhui Medical University, Hefei,
230022, P. R. China
OBJECTIVE:To investigate the problem of surgical treatment for patients with
advanced hepatocellular carcinoma (HCC). METHODS & RESULTS: Clinical
data from 242 patients with advanced HCC who underwent hepatectomy was
retrospectively analyzed. Lobectomy and segmentectomy were performed for
140 cases, nonregular resection for 101 cases and liver transplantation for 1
case. First hilar occlusion and total blood occlusion were adopted for 173 and
54 patients with clamping time of 6-28 and 4-25 minutes respectively. Total
blood occlusion was applied especially for the patient with HCC that located
in the centre of the liver to decrease blood loss and prevent air embolization.
The forceps clamping technique was used for performing the resection. The
postoperative complications were occurred in 36 patients (15%) with 3% mor-
tality. CONCLUSION: The technique of resection with forceps is ease and safe
in clinic. Postoperative intensive care is requested to protect the liver function.
P033
Laparoscopic surgery in hydatid disease of the liver
E Altinli, K Saribeyoglu, S Pekmezca, C Uras, H Tasci and T Akcal
University of Istanbul Cerrahpasa Medical Faculty, General Surgery, Istanbul,
Turkey
In this study we report the characteristics and outcome of the patients who
were laparoscopically managed in our clinic , details of the technique and dis-
cussed the role that laparoscopy might have in this field. Between January 1998
and April 2000, eleven patients (5 men and 6 women) with a mean age of 39
years (range, 23 to 63 years), suffering from hydatid disease of the liver consid-
ered for laparoscopic surgery in our department.Ten patients had single cysts
and one patient had two.The average diameter of the cysts was 6.7 cm. (range,
4 to 12 cm.).There were no evidence or suspicion of biliary rupture upon clin-
ical findings and radiological studies. All the patients underwent laparoscopic
surgical interventions by using locking trocar for the evacuation of cysts con-
tent. In all patients laparoscopic cystotomy, partial cystectomy and omento-
plasty were performed.There was no conversion to laparotomy and the pro-
cedures were accomplished uneventfull y. In one case, with a single cyst in the
right lobe, a bile leakage was observed. In the clinical course, the biliary drainage
gradually tapered off and ceased spontaneously on the postoperative day 9,
without any further intervention. Except this case, there were no early or late
complications. The average hospital stay was five days (range 2-11 days). No
radiological recurrence was observed in an average lenght of follow-up of 16
months (range 6-34 months). Laparoscopy is quite feasible and safe to perform
in hydatid disease of the liver.
P034
Pyogenic liver abscess: effectiveness of a conservative approach
JA Alvarez1, JJ González2, RF Baldonedo1, L Sanz2, CA Laso2, E Azcano2, G
Carreño3 and JI Rodríguez4
1Hospital San Agustín, Surgery,Avilés, Spain
2Hospital Central, University of Oviedo, Surgery, Oviedo, Spain
3Hospital de Cabueñes, Surgery, Gijón, Spain
4Hospital de Jarrio, Surgery, Coaña, Spain
INTRODUCTION:The advent of newer diagnostic imaging has shown conser-
vative methods to be effective modalities of treatment. AIM:To audit our clini-
cal experience with a conservative management (nonsurgical 
treatment) of patients with pyogenic liver abscess.PATIENTS AND METHODS:
From 1985 to 1997, 133 cases with pyogenic liver abscess were treated in our
units. Of these, 25 (18.8%) were treated with antibiotics alone, and 63 (47.4%)
were managed percutaneously. In these patients, we evaluated the clinical char-
acteristics, methods of treatment and outcome in relation to the incidence of
complicated clinical course (CCC), complicated-related clinical course
(CRCC), and hospital mortality. RESULTS: In the antibiotic group, the average
duration of therapy was 22 ± 10 days. Of the 63 patients subjected to percu-
taneous drainage, 51 were treated by catheter drainage and 12 by needle aspi-
ration. CCC, CRCC and mortality rates in patients treated with antibiotics
alone were 28%, 20% and 20%, respectively, while the rates found in those
drained percutaneously were 30%, 19% and 13%. In the last therapeutic group,
a CCC, a CRCC and mortality were seen in 33%, 17% and 17% of the patients
treated by needle aspiration, and in 29%, 20% and 12% of the cases treated by
catheter drainage. Among these results there were no significant differences.
CONCLUSIONS:Antibiotic therapy alone in carefully selected cases and per-
cutaneous drainage with antibiotics are safe and effective nonsurgical approach-
es for treatment of pyogenic liver abscess.
P035
Prevention of incisional hernia after liver surgery by a butterfly mesh
G Mangiante, L Marchori, N Nicoli, S Carluccio*, R Asheminia ,A Casaril and G
Colucci
Department of Surgery and Gastroenterology, University of Verona, Italy
INTRODUCTION:To perform liver resection surgery we adopted a “Mercedes
star” incision: but with this approach, the incidence of incisional hernias is evi-
dent at the central areas at a very high rate: on postoperative period it is
caused especially in cirrhotic patients by an increase of abdominal pressure, due
to fluids retention or by onset of respiratory disease, and less by wound infec-
tions. METHOD: Nowadays, the central cross area is covered during closure of
the wound by two sheets of polypropylene mesh (Surgipromesh®, Tyco
Healthcare) conformed as a butterfly swings and fixed to the anterior and pos-
terior fascial layers by polypropylene mattress stitches.With this method the
edges of the wall are not strictly tight performing a “free tension “ closure of
the abdominal wall, that is extremely important on our opinion to prevent
complications due to increase of abdominal pressure on postoperative period.
RESULTS: From 1998 till now 30 over 219 resections have been closed with
this method: of these 189 patients 75 (39.7%) had incisional hernias at the cen-
tral point, while 25(13.2%) were the incisional hernias at the lateral point if the
scars. On the last 30 patients on a median follow-up of 27 months (range 2-36
months) neither incisional hernias has been observed nor late infections of
wound nor persistent pain of the scar.These results account for a total of 745
months free of hernias onset.Anyway, on these cases we had 25 cases of later-
al hernias onset (13.2%).CONCLUSION:The method is easy, quick to perform,
and safe. So far butterfly mesh method prevents of incisional hernia, and avoid-
ing a major increase of abdominal pressure preserves from respiratory compli-
cations after liver surgery especially in cirrhotic patients.
P036
Non - operative treatment of liver injuries
E Yettimis, N Varsamidakis, E Costopanagiotou,V Polymeropoulos, S Metrou S,
C Katis, E Lahanas and E Kalokerinos
Athens General Hospital, 1st Surgical Department,Athens, Greece
Liver injuries are very common in traumatiology and very often are accompa-
nied by other organ injuries.The extensive diagnostic use of the Ultrasound and
the Computer Tomography Scan examinations helped to treat some of these
patients without any operation.We present our experience of the last 4 years
to this kind of treatment. During this period we treated 33 patients with liver
injury (22 men and 11 women).The diagnosis was confirmed with CT or US in
16 cases or with abdominal paracentesis or emergency laparotomy in the oth-
ers. 9 patients (27,3%) with liver injury diagnosed and estimated with CT Scan
were not operated.They underwent an intensive follow-up with daily CT Scan
to estimate the changes of the liver injury and the perihepatic fluid collection.
They had also vital signs observations and blood examinations every hour the
first 48 hours after the injury. The other patients were operated in order to
stop the intraperitoneal bleeding. 3 pts died all from the operated group. Many
complications were also seen in the operated patients (morbidity 28%) and this
was due to the multiple organ injury. Conclusion:The liver injuries can be man-
aged without operations in certain patients and under continuous medical and
radiological observation with CT scan to daily estimate the bleeding and peri-
hepatic fluid collection.
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P037
Ischemic preconditioning is significantly more effective in preventing reperfu-
sion injury after warm liver ischemia in rats than methylprednisolone
M Glanemann1, AK Nüssler1, R Kuntze1, F Lippek2, L Liu1, E Tüzüner1, JM
Langrehr1, H Dietl2 and P Neuhaus1
1Charité, Humboldt University of Berlin, Dept. of General-, Visceral- and
Transplantation Surgery, Berlin, Germany
2Charité, Humboldt University of Berlin, Dept. of Pathology, Berlin, Germany
INTRODUCTION: Methylprednisolone (MP) was shown to prevent reperfu-
sion injury after liver ischemia and therefore, introduced in clinical surgery.
Recently, ischemic preconditioning (I/P) has been demonstrated to confer a
state of protection against subsequent sustained ischemia in several organs.We
have compared both regimes on the extent of reperfusion injury after warm
liver ischemia in rats. MATERIALS/METHODS: Hepatic ischemia was induced
by clamping the hepatoduodenal ligament in male Wistar rats (200-250g) using
ketamine/xylazine anaesthesia. All animals underwent 45 min of hepatic
ischemia. Group 1 was defined as ischemic control group.AST,ALT, and GLDH
levels were measured before, immediately, and 3, 6, and 24 hrs after liver
ischemia. Group 2 received MP (30mg/kgIV) before ischemia, whereas group 3
underwent I/P (5/30 min). Heme oxygenase-1 (HO-1) levels, as well as histo-
logic examinations were analysed. The Ethics Committee of the Charité
approved the study. RESULTS: I/P revealed a statistically significantly (p<0.01)
reduction of reperfusion injury measured by AST,ALT, and GLDH levels within
24 hrs after ischemia when compared to the ischemic control group. In com-
parison to MP-treated rats, reperfusion injury was significantly (p<0.001)
reduced at 3 and 6 hrs after ischemia in the I/P-treated rats. HO-1 was pres-
ent in both groups after 6 h. DISCUSSION: I/P presents as strong mechanism
of protection against reperfusion injury after warm liver ischemia. In compari-
son to MP treatment, which is clinically established, I/P-treated rats revealed sig-
nificantly lower liver enzyme levels at 3 and 6 hrs after ischemia, which was
probably caused by reactive hyperperfusion .
P038
Different adhesive materials for final hemostasis on the raw liver surface (part
II: laboratory)
A Severtsev, E Ivanova and I Repin
Medical Centre for Russian Government, Moscow, Russia
Now there are many different adhesive materials used for the control of
haemostasis on the raw liver surface during resections of this organ.The vol-
ume of such kind of material inserted in the field of operation was registered,
but nobody investigated the influence of that material on the general condition
of body.The aim of this study was to investigate the influence of inserted adhe-
sive materials during laboratory tests for patients with liver resection and to
compare different materials.We compared: 2 different collagen fleeces (Russian
production - 11 patients and TissuFleece E,Austria - 10 patients), Spongostan -
6 patients, Surgicel - 7 patients, Gelfoum - 7 patients, fibrin glue (Tissucol - 26
patients) and TachoComb - 18 patients. We calculated blood count tests (5
positions), biochemical tests (11 positions) and coagulation (4 positions). We
performed tests before surgery, during the 0-, 1-, 3- and 5th postoperative days.
We didn’t use adhesive materials in 27 control group patients. There was a
group of patients where we used a combination of different materials. Results
were very difficult for interpretation, and all patterns were changed to some
kinds of trends.All curves and trends were statistically different from control.
Finally the combination of curves and trends showed that the line of best and
worst materials according to their influence to inner status of operated
patients. CONCLUSIONS: 1) it is possible that local adhesive materials could
influence homeostatic parameters of operated patients; 2) TachoComb and
Tissucol had the best effect; 3) Surgicel, Gelfoum, Spongostan, Russian collagen
fleece had the worst effect; 4) TissuFleece E had a very unpredictable influence,
so it could be used for some selected cases.
P039
The role of cellular apoptosis and proliferation in experimental liver fibrosis
E Papalambros1, E Felekouras1,A Tsamandas2,A Salakou2,T Kourelis2,T Tsiganis1,
C Scopa2, D Bonikos2, E Bastounis1 and G Michalopoulos3
1University of Athens Medical School, First Department of Surgery, Athens,
Greece
2University of Patras Medical School, Department of pathology, Patras, Greece
3University of Pittsburgh Medical Centre, Department of Pathology, Pittsburgh,
United States
AIM:This study assesses the role of cell-apoptosis and proliferation in progress
of experimental liver fibrosis and failure. DESIGN:The study included 90 male
Wistar rats divided in 2-groups: A (n=60)-CCl4 injection (intraperitoneally-
2ml/Kg/BW-twice-weekly), and B (n=30)-controls. Rats were sacrificed at 4, 8,
12 weeks. Pathologic examination of liver tissue included H&E, Massons-
trichrome, immunohistochemistry for Ki67 (cell-proliferation), TUNEL-stain
(cell-apoptosis), double stain (TUNEL/Ki67) to detect Ki67 (+) cells that enter
apoptosis. Rates for fibrosis, cell-proliferation and apoptosis (apoptosis index-
AI) were calculated following computerized analysis. RESULTS: Progressive liver
fibrosis and failure developed in rats of group-A. Sections from group-A showed
portal/pericentral fibrosis- (4w), bridging fibrosis- (8w) and regenerative (cir-
rhotic) nodules- (12w). Furthermore, a progressive increase in AI and %Ki67 (+)
cells was recorded. At 12w, the increase of AI compared to controls was
25.8±4.5(M±SEM) fold for hepatocytes (p<0.0001) and 11.32±2.46fold for por-
tal tracts (PT) (p=0.006).The increase for Ki67 (+) cells was 61.2±11.10 fold
(p<0.05) for hepatocytes and 15.00±4.44fold (p<0.05) for PT. Also, Ki67
(+)/TUNEL (+) cells were present; implying that Ki67 (+) cells undergo apop-
tosis. Positive correlations were observed between: TUNEL (+) or Ki67 (+)
cells and degree of fibrosis (p<0.001 respectively), TUNEL (+) cells and SGPT
values (p<0.05). CONCLUSIONS:This study shows a time-dependent increase
in cell-apoptosis and proliferation during progress of liver fibrosis and failure.
Apoptosis is implicated in the pathogenesis of liver fibrosis and progress of liver
failure and potentially outweighs proliferation by a factor of 2-8 fold, at the
same time period.
P040
The potential role of hepatocytic apoptosis during hepatic injury and regener-
ation following simultaneous allyl-alcohol and carbon tetrachloride administra-
tion
E Felekouras1, A Tsamandas2, F Sigala1, S Salakou2, T Kourelis2, T Tsiganis1, K
Chatzikostantinou1, C Scopa2, E Papalambros1 and G Michalopoulos3
1University of Athens Medical School, First Department of Surgery, Athens,
Greece
2University of Patras Medical School, Department of Pathology, Patra, Greece
3University of Pittsburgh Medical School, Department of Pathology, Pittsburgh,
United States
AIM: Allyl-alcohol (AA) and carbon tetrachloride (CCl4) cause periportal and
pericentral necrosis respectively. This study investigates whether liver injury
after simultaneous AA+CCl4 institution is the result of hepatocyte necrosis, or
combined hepatocyte necrosis and apoptosis. DESIGN: The study comprised
120 Wistar rats that received simultaneously AA (ip-0.05ml/kg) and CCl4
(peros-1.9ml/kg) and were sacrificed at certain intervals, after. Pathologic exam-
ination of liver tissue included H&E, immunohistochemistry for cytokeratin-
AE1, hepatocyte-paraffin-antigen (HEPPAR), phagocyte-marker (CD68) and ±-
SMA and TUNEL method (apoptotic cells). Parenchymal necrosis and apoptot-
ic body numbers (apoptosis index-AI) were expressed following morphomet-
ric analysis. RESULTS: Sections showed combined periportal and pericentral
necrosis; which was developed at 2hr and the peak was at 48hr. Liver regen-
eration originated from zone-2, extended to zones 1 and 3, and accomplished
at 153hrs, was mediated mainly by proliferation of non-necrotic cells that were
positive either to AE1 (biliary-phenotype) , or to HEPPAR (hepatocytic-pheno-
type).AI reached the peak in necrotic areas at 6hrs (range 0.6-0.9) and in non-
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necrotic areas at 48hrs (range 0.3-0.6).Apoptotic hepatocytes were still pres-
ent at 81hrs. Apoptotic cells were sequestrated in the adjacent hepatocytes
and sinusoidal cells. Double stain (TUNEL and CD68/±SMA), revealed that
apoptotic bodies were phagocytosed by Kupffer cells or incorporated in stel-
late cells respectively. CONCLUSIONS: Liver-cell apoptosis contributes,
together with cell necrosis, to the development of liver injury after combined
administration of AA+CCl4. Prevention of these events may be important in
shortening the course of the acute hepatic injury and prevent the development
of chronic liver injury and fibrosis.
P041
5- year experience with surgical treatment of Budd-Chiari syndrome in a trans-
plantation centre
T Yaman,Y Yildiray, K Sukru and Z Murat
EGE University Medical School, HBP Surgical Unit, Izmir,Turkey
Budd-Chiari syndrome (BCS) is uncommon disorder characterized by hepatic
vein outflow obstruction leading to fibrosis and cirrhosis as early as 2-3 months
after presentation. The aim of this study was to evaluate the role of surgical
portal decompression in patients with BCS. From 1995 to 2000 we conducted
prospective studies of the treatment of 16 patients. Patients consisted of 8
females and 8 males. The average was 35. One patient presented child A, six
patients child B, nine patients child C class. Etiology of the BCS was postpar-
tum in 3 patients and for the remaining patients was idiopatic.All of the patients
were evaluated by color dopler ultrasound, angiogram and liver function tests.
In postoperative period, three patients died. One of them died as a result of
pneumonia , two patients died of hepatic failure. Mesocaval shunt was per-
formed in 12 patients, mesoatrial shunt was performed in 3 patients and prox-
imal splenorenal shunt was applied in one patient. All 13 survivors remained
free of ascites, almost all had normal liver function. All of the patients were
treated oral anticoagulan therapy postoperatively. Mean follow up 3 years.
Before the surgical treatment suprahepatic and infrahepatic vein pressures
were measured. So the stent was replaced before shunt in 2 patients and bal-
loon dilation was conducted in one patient.The key to long survival in BCS is
prompt diagnosis and treatment by portal decompression. Liver transplantation
should be preserved as a second choice of treatment because of the difficulty
of finding liver donor.
P042
Laparoscopic treatment of non-parasitic liver cysts
G Nuzzo, F Giuliante, F D’Acapito, M Vellone and M Murazio
Catholic University, General Surgery; Hepato-biliary Surgery Unit, Rome, Italy
Non-parasitic cysts of the liver are benign conditions with reported prevalence
<5 % in general population.These may be solitary, multiple or diffuse (policys-
tic liver disease, PLD) and are usually detected accidentally on ultrasound.
Symptoms (chronic abdominal pain, gastroduodenal obstruction, cough or jaun-
dice) may develop in 5-10% of patients and treatment may be come necessary.
Symptoms are usually related to rapid enlargement of the cyst, or to compli-
cations (sepsis, haemorrhage, rupture). Between October 1999 and September
2000, 6 patients (5 with multiple cysts, 1 with solitary cyst) underwent laparo-
scopic fenestration of cysts. Patients with PLD were not included in this study.
Median age was 63 years (range 57-75). 14 cysts were fenestrated; 6 cysts were
located in the right lobe and 8 in the left lobe. Diameters of cysts varied from
5 to 16 cm. We performed laparoscopic fenestration using a modified Lin’s
technique , involving wide cystic wall deroofing and cauterization of residual
wall. Mean duration of operation was 140 minutes (range 80-240). Histology of
excised walls confirmed diagnosis of congenital cysts.There was no morbidity
or mortality. Median hospital stay was 4.8 days (range 3-9). During a mean fol-
low up of 8.5 months (range 4-14) there has been no clinical evidence of recur-
rence. Laparoscopic fenestration, because of minimum surgical trauma, short
hospital stay, and low recurrence rate, should be considered as the gold stan-
dard for treatment of symptomatic non-parasitic liver cysts.
P043
Contribution to the treatment of non-parasitic cysts of the liver
J Pantoflicek1, M Ryska, J Rudiá and J Fronák
1Institute for Clinical and Experimental Medicine, Transplant Surgery
Department, Prague, Czech Republic
INTRODUCTION: Diagnostics of the liver cysts became very common with
the developement of imaging methods, but they are rarely symptomatic and
need surgical intervention. Every symptomatic liver cyst should be examined,
and preoperative diagnostic should evaluate the origin and localisation of the
cyst, to establish rationale and adequate method of treatment.RESULTS:During
the years 1998-2000 9 patients were presented for surgical treatment, with
liver cysts which were non suitable for conservative treatment.The main sign
was upper abdominal mass and abdominal pain. 3 patients had simple solitary
liver cyst, which were treated with laparoscopic pericystectomy .1 patient had
a large solitary cyst, which was indicated for laparoscopic procedure, but con-
version was necesary, because of large diameter of the cyst.1 right hepatecto-
my was performed for cystic cholangiosarcoma, and in 4 laparotomies with per-
icystectomies and marsupialisation of multiple cysts of liver parenchyma were
performed.The postoperative course of all patients was uneventfull , and they
were discharged between 3-7th postoperative day. During the 24 month of
repeated CT and US control 1 recidive of solitary cyst was observed.
DISCUSSION:Various treatments were proposed for nonparasitic liver cysts.
Conservative treatment consists of US guided puncture, and sclerosing of cyst.
Laparoscopic surgery is suitable for cases of certain origin, for complicated cyst
with uncertain origin we strongly advocate laparotomy.
P044
A new method for the experimental induction of secondary biliary cirrhosis in
Wistar rats
IFSF Boin1, GLJ Jorge1, CAF Escanhoela1, LS Leonardi1 and O Castro Silva Jr2
1FCM/State University of Campinas, Experimental Hepatology, Campinas, Brasil
2FMRP/University of SP, Experimental Hepatology, Ribeiráo Preto, Brasil
The aim of this study was to describe a method for the induction of experi-
mental secondary biliary fibrosis (SBF). Forty-seven Wistar rats were submitted
to hepatic duct obstruction (OB group) for thirty days without ligature, section
or cannulization causing interruption of biliary flow.This technique was carried
out by simple traction of the bile duct passing it through the xiphoid appendix.
Nine rats were submitted to a sham operation for bile duct stricture and seven
rats comprised the control group. Blood samples were collected for the meas-
urement of total bilirubin (TB), alkaline phosphatase (AP), alanine aminotrans-
ferase (ALT) and aspartate aminotransferase (AST). Liver fragments were
removed for morphological study.Thirty days after surgery TB,AP,ALT and AST
levels were significantly increased in the hepatic duct ligation group compared
to the sham operated group and the presence of SBF in the OB group was con-
firmed by morphological study of the liver.There was technical failure in 31.92%
cases.The survival was 100% at fifteen days and 82.97% at the end of the exper-
iment.We concluded that this simple surgical technique may be used to study
the consequence of bile duct obstruction which could be a reversible process
depending on the obstruction time. This technique can be carried out from
cholestasis to fibrosis.
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P045
Balloon catheter mediated isolated hypoxic hepatic perfusion (IHHP) in
patients: progress towards a percutaneous procedure in the Rotterdam pro-
gram
AWKS Marinelli, B van Etten, MGA van Ijken, JRM van der Sijp, EA de Bruijn and
AMM Eggermont
EMCR-Daniel, Oncological surgery, Rotterdam,The Netherlands
BACKGROUND: IHHP may be an attractive treatment of malignancy confined
to the liver.The classic surgical Isolated Hepatic Perfusion is a major, and non-
repeatable procedure with important morbidity that should be avoided in these
patients with a relatively poor prognosis.We have developed a minimally inva-
sive procedure that in principle is repeatable, as a more realistic treatment
option.We have published that balloon-catheter mediated IHHP can be carried
out in pigs without systemic leakage, in utilizing an intracaval double balloon
catheter collecting the venous outflow from the hepatic veins, an aorta-occlu-
sion balloon catheter for haemodynamic purposes and an occlusion inflow
catheter for the hepatic artery. CLINICAL PROGRAM: So far 15 patients with
irresectable colorectal or ocular melanoma liver metastases have been treated
in a Phase I-II program using Melphalan (1 mg/kg) in the perfusion system.We
started with the same double balloon catheter design as in the pigs.The hepat-
ic artery occlusion balloon catheter was introduced percutaneously, and both
the caval and aortic balloon catheters by surgical exposure of the common
femoral artery and vein. Continuous leakage monitoring was performed using
radio labeled albumen in the perfusion circuit.With the double balloon catheter
leakage was never well controlled. Therefore, new caval catheters were
designed.A three-balloon catheter causing total caval vein occlusion from above
the diaphragm to the renal veins was eventually developed. A portal vein
catheter was added for venous outflow of the liver. By including an expansion
bag in an one-pump pressure controlled perfusion circuit, a repeatable IHHP
procedure is achieved, with minimal personnel requirements, and excellent
leakage control resulting in a pharmacokinetic profile resembling leakage free
isolated limb perfusion with regional vs. systemic drug ratio’s of >100:1. The
next step in the program will be to develop a percutaneous cannulation of the
portal vein to turn the procedure in a fully percutaneous one.
P046
The effect of 2-acetylaminofluorene (2-AFF) administration on hepatic pathol-
ogy after simulataneous administration of allyl-alcohol (AA) and carbon tetra-
chloride (Cc14) 
E Felekouras1, A Tsamandas2, F Sigala1, S Salakou2, T Kourelis1, C Scopa2, D
Bonikos2, E Bastounis1, E Papalambros1 and G Michalopoulos3
1University of Athens Medical School, First Department of Surgery, Athens,
Greece
2University of Patras Medical School, Department of Pathology, Patras, Greece
3University of Pittsburgh Medical School, Department of Pathology, Pittsburgh,
PA, United States
AIM: Pre-treatment with 2-AAF for 7-days (2.5mg/day), protects from death
and diminishes parenchymal necrosis in rat livers after combined administration
of AA+CCl4 (Modern Pathology 13:187A, 2000). This study investigates
whether 2-AAF can inhibit liver-necrosis and prevent animal death after the
damaging molecular events, induced by AA+CCL4, have already occurred.
DESIGN: The study included 160 male Wistar rats assigned in 2-groups (80-
each). Rats received LD50-doses of AA (0.05ml/kg) and CCl4 (1.9ml/kg),
intraperitoneally. In rats of group-B a bolus dose of 2-AAF (5mg) was given
intraperitoneally, immediately (0hr)-8-16-24 and 36hr after AA+CCl4 injection.
Rats of both groups, that survived, were sacrificed at 48, 72, 81 and 153hrs.
Pathologic examination of liver tissue included H&E, immunohistochemistr y
(cytokeratinE1-HEPPAR-p53) and TUNEL-stain(apoptotic bodies). Pathology
results were expressed following computerized analysis. RESULTS: Liver sec-
tions from both groups showed periportal+pericentral necrosis peaking at
48hr.At each time point, parenchymal necrosis and transaminases values were
higher in group-A compared to group-B (2-AAF-group) (p<0.01 respectively).
In group-A total death rate was 80% but in group-B was 2%. Apoptotic bodies
were detected in hepatocytes and their numbers were higher in group-A
(AA+CCl4) compared to B(p<0.01 at every time point). Sections from group-
B(2-AAF-group) displayed positive immunostaining for oncogene p53; this was
not evident in group-A. CONCLUSIONS: 2-AAF administration, after injection
of AA+CCl4, protects from death and diminishes liver-cell necrosis. The signif-
icantly decreased hepatocytic apoptotic rate and increased p53-liver-cell
expression in the 2-AAF-model, suggest that 2-AAF may prevent the down-
stream effects of pre-existing liver damage by affecting the cell cycle and not
through modification of the chemicals.
P047
Regional therapy of activation of hepatic cirrhosis
T Pirtskhalava1, P Tarazov2, D Granov1 and I Rutkin1
1Research Institute of Roentgenology, Surgery, St Petersburg, Russia
2Research Institute of Roentgenology, Angio/Interventional, St Petersburg,
Russia
PURPOSE: Adequate transfusion therapy for patients with hepatic cirrhosis,
especially with activation and ascites, is limited. We tried to search for new
techniques to reach maximal concentration of drugs directly in the liver giving
small volumes of infusion. METHODS: 8 patients with hepatic cirrhosis of
Child-Pugh class B (6) and C (2) received 10 courses of regional therapy. Celiac
or hepatic artery was catheterized for 3-5 days.An optimal compound of the
infusion media was empirically determined comprising 100-150 ml 20-30% glu-
cose, 200 mg ascorbic acid, 400 mg inozin, 200 ml aminoacids with a branched
chain (Aminosteril-N-hepa) , 100 ml fresh frozen plasma and 2.1 ml hemeo-
pathic Heparcompositum. RESULTS: Within the given regional therapy the
index of cytolysis- alkalin phosphatase was twice re-duced on the average;
bilirubin and ALT was reduced at 45 and 48%, respectively.A positive balance of
the diuresis was 430 mL/day. By the end of the regional therapy, the circumfer-
ence of the abdomen has been reduced at 5.7 cm on the average with a stable
body weight.There was a regression of peripheral edemata and pastosity of the
anterior wall of the abdomen.All patients subjectively felt improvement of their
general state. CONCLUSION: Inclusion of regional therapy in the complex of
treatment procedures for cirrhotic pa-tients enables to reach a reduction of
activation within a short period and to decrease the duration of the patient’s
treatment.
P048
Sepsis: is there expression of BCL-2 and Bax genes in liver cells?
V Paizis5, E Messaris1, S Katsaragakis2, N Memos3, I Gomatos4, I Donta6 and G
Androulakis7
1University of Athens, Ippokration Hospital, Laboratory of Surgical Research,
Department of Propaedeutic Surgery, Old Psihiko, Greece
Our aim was to investigate the role of the expression of bcl-2 and Bax genes
in liver cells of septic rats. Sepsis was induced using the cecal ligation and punc-
ture model in 60 adult Wistar rats.The rats were sacrificed at 12, 24, 36, 48 and
60 hours after the induction of sepsis. A control group of 10 rats was used.
Brain tissue was obtained from each rat and the expression of Bax and Bcl-2
proteins was detected using the streptavidin-biotin method.The expression of
both BCL-2 and Bax proteins was found decreased in septic rats (58% and
46.8%, respectively) compared to the controls (90% for both proteins)
(p=0.02). Both genes were over expressed at the hyperdynamic phase of sep-
sis (12 hours) and the intensity of staining gradually decreased at 24, 36, 48 and
60 hours after the induction of sepsis (p=0.035). BCL-2 expression was found
consistently higher than that of Bax at each time point (p=0.001).We demon-
strate that the expression of both bcl-2 and Bax genes, that are regulators of
apoptosis, is decreased in sepsis. However, BCL-2 was found consistently over
expressed suggesting inhibition of apoptosis in liver cells in sepsis.
P049
Treatment of colorectal carcinoma with synchronous liver metastases (LM)
D Granov1,V Borovik1 and P Tarazov2
1Research Institute of Roentgenology, Surgery, St Petersburg, Russia
2Research Institute of Roentgenology, Angio/Interventional, St Petersburg,
Russia
PURPOSE:To assess results of treatment of patients with colorectal carcinoma
and synchronous LM. METHODS. Our retrospective study included 151 pts
with colorectal carcinoma complicated by synchronous LM. Treatment was
started with resection of the primary tumour; sumultaneous colorectal and
hepatic resection (atypical resection or bisegmentectomy) was performed in 12
cases with Gennari stage I LM. Metachronous hepatic resection (36 hepatec-
tomies and 3 extended hepatectomies) was done in 39 pts (2 with Gennari
stage I, 31 with stage II, and 6 with stage III). In 100 unresectable cases, cours-
es of angiographic regional treatment were performed: hepatic artery infusion
(HAI) with 5-FU in 35 pts, chemoembolization (HACE) with 30-100 mg
Doxorubicin-in-iodized oil plus Gelfoam in 65 pts. RESULTS.Mean survival after
sumultaneous, colorectal and hepatic resection was 24.1+6.9 mo. Mean survival
after metachronous resection of Gennari stage I, II, and  III LM was 26.1+6.3
mo, 24.3+ 7.2 mo, and 19.5+5.5 mo, respectively. Two patients died in early
postoperative period (mortality=4%). No complete response was achieved in
any of 100 pts after transcatheter treatment only. Partial response was seen in
8% and 30% of pts after HAI and HACE, respectively. Mean survival calculated
for pts who died was 7.8+3.1 mo. for HAI and 20.5+7.5 mo for HACE. CON-
CLUSION. According to our experience, survival after synchronous and
metachronous hepatic resections in pts with colorectal carcinoma and syn-
chronous LM (Gennari I) was compatible. Resection is indicated for Gennari
stages I-II while HACE for stage III LM.
P050
Cefepime use for the postoperative septic complications of liver surgery
(treatment and prevention)
A Severtsev, N Mironov, I Kositsyna, I Baginskaya and O Skalozub
Medical Centre for Russian Government, Russia
Surgery for patients with liver lesions (especially resections) is based on
immune decrease background. It is connected with advanced malignant
tumours, chronic liver disease, specific anti-tumour chemotherapy, the use of
liver-pump and cell-saver during surgery, etc.The result is the high risk of post-
operative septic complications.The aim of this study was to assess the postop-
erative septic complications during liver surgery and the use of cefepime as an
antibiotic that is effective (according to literature references) for patients with
immunity decrease. It was a retrospective clinical study (1994-2000) of the
records of patients (109) with liver resections.All postoperative complications
were calculated and analyzed.The main group (19 patients) received cefepime
2 g/day/iv for at least first 5 days after liver resection while the control group
(90 records) received other antibiotics (ampicillin + gentamycin - 61 patients,
cefotaxim - 20 patients, ceftriaxone - 5 patients, imipenem/cilastine - 4
patients). In severe cases cefepime dosage was increased up to 3 g/day/iv. In
postoperative period 26,32% patients in the main group and 65,56% patients in
control group had complications. The number of complications was 1,1 per
patient. Septic complications amounted to 15,79% in the main group and
27,78% of patients in the control group (p<0,05) . Most often septic complica-
tions were pulmonary, but the most serious were intraabdominal abscesses (all
positions were benefit for the main group, but NS). CONCLUSIONS: 1) Liver
operations have a lot of postoperative complications; 2) Septic postoperative
complications comprise 1/3 part of all complications; 3) Now cefepin is the
most acceptable antibiotic for prophylaxis and treatment of postoperative sep-
tic complications for patients with liver surgery.
P051
Surgical treatment of liver metastases
V Popov, R Gaydarsky,V Tassev, M Vassilev and T Frangov
Medical University, Department of Surgery, Sofia, Bulgaria
Metastatic tumours are one of the most usual causes for intervention on the
liver.The aim of our investigation was to evaluate the efficacy of surgical treat-
ment of liver metastases. For the period January 1990- December 2000, 165
surgical intervetions for liver metastases were performed in our department.
The patients were 85 males and 80 females ranging in age from 24 to 82 years.
In 111 patients the primary tumour was with colorectal localization, in 20
patients- stomach, in 18 patients- pancreas and in 16 patients-other localiza-
tions. Synchronous metastases were found in 88 patients and metachronous in
77.The metastases size in most of the cases was from 5-15 cm. In 33 % of the
patients the metastases were multiple. Six patients underwent a second resec-
tion for local recurrence.The surgical treatment was concidered radical when
the distance of the resection margins from the tumour was at least 0.5 cm and
no lymphnode mtastases werefound. The following surgical procedures were
performed: 9 left and 3 right lobectomies, 13 right and 7 left hemihepatec-
tomies, 33 segmentectomies, 32 atypic resections and 68 palliative interven-
tions in 37 of which a port-jet catheter was placed. Postoperative morbidity
and mortality rates were 10.7% and 4.8% respectively. Our results confirm the
efficacy of surgical treatment of liver metastases. Re-resections in patients with
local recurrence allow prolonged survival.
P052
Are liver resections justified for large hepatocellular carcinomas?
J Wang and S Ma
GuangZhou Railway Central Hospital, HPB Surgery, Guang Zhou, China
BACKGROUND AND AIM: Large tumour size is often consided a relative con-
traindication to hepatectomy for hepatocellular carcinoma (HCC) although few
studies have analysed outcome specifically for large tumours.This study had
evaluated the outcome of hepatectomy for HCC >13cm diameters.
METHODS: From Aug 1984 to Jan 1999,47 patients with large solitary HCC
(diameter > 13 cm) with good liver function underwent hepatectomy. Blood
transfusion was recorded. Postoperatively the amount of abdominal wound
drainage, period of hospitalization were observed.The complications and the
survival time were evaluated during follow-up. RESULTS: The postoperative
mortality was 2.67%.The complications rate was 24.34%, which was significantly
correlated with preoperative low serum albumin or elevated gamma globulin
and the volume of resected liver. The one-, three-and five-year survival rate
after the hepatectomy was 53.6%, 29.7%, and 15.4% respectively.
CONCLUSION: In the patients with large HCC, hepatectomy with adequate
resection margin (>1 cm) is still indicated for them.
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P053
Extended indications to liver resections with preoperative portal vein
embolization
G Nuzzo1, F Giuliante1, M Vellone1, F D’Acapito1 and B Barbaro2
1Catholic University, General Surgery, Hepato-biliary Surgery Unit, Rome, Italy
2Catholic University, Radiology, Rome, Italy
Liver tumours may be unresectable because of the small volume of future rem-
nant liver (FRL) after extended hepatectomies. Preoperative portal vein
embolization (PPVE) of portal branch of the portion of liver to be resected can
induce hypertrophy of FRL thus extending indications for resections.Aim of this
work was to determine retrospectively efficiency of this technique . Between
1996 and 1999, 12 patients (8 liver metastases, 4 hilar cholangiocarcinoma) with
initially unresectable tumours underwent right PPVE. Indication was volume of
FRL < 40% of whole functional liver (mean 29.5%) assessed by CT scan vol-
umetry.These patients represent 10.5% of patients resected for malignancy in
the same period (113 patients). PPVE was performed under ultrasound guid-
ance, through the controlateral left portal vein in 9 cases, and through the ipsi-
lateral right portal vein in 3. PPVE was performed in 8 cases with n-butyl-2-
cyanoacrylate and lipiodol (1:4) and in 4 with steel coils. Morbidity and mor-
tality after PPVE were nil. Induced hypertrophy was successful in 11 cases (91.6
%) with a mean increase by 35% of the initial size. Seven patients (58.3%) were
successfully resected 4-10 weeks after PPVE without postoperative liver failure.
Five patients (2 cholangiocarcinoma and 3 liver metastases), were found unre-
sectable at surgery. PPVE can increase resectability of liver tumours by reduc-
ing risk of postoperative liver failure, without morbidity related to the tech-
nique.
P054
Cavitron ultrasonic surical aspirator (cusa) for resection cirrhotic and normal
livers
AA Ashrafov and NJ Bayramov
Department of Surgical Diseases, Azerbaijan Medical University, Baku-
Azerbaijan
OBJECT: To evaluate the efficacy of the Cavitron Ultrasonic Surgical Aspirator
(CUSA) for resection of normal and fibrotic livers in comparison with the con-
ventional crushing technique . METHODS: This study has been performed with
89 patients, who underwent liver resection. 43 patients were operated by the
crushing technique whereas, 46 patients by the CUSA. In patients with both
normal and fibrotic livers the comparison between two techniques were made
by following blood loss, operation time, necrosis in the parenchyma, hepatic
function, complications and mortality rate. RESULTS: In patients with normal
liver (54 patients), the CUSA significantly decreased  in the comparison with
crushing technique blood loss ( from 1412±40 ml to 1090±37 ml in lobec-
tomies and from 545±37 ml to 275±29 ml in segmentectomies respectively),
operation time (from 219±11 min. to 124±10 min. in lobectomies and from
124±6 min to 82±5 min. in segmentectomies respectively), but differences in
ALT, AST, albumin, bilirubin levels were not statistically significant. In patients
with fibrotic livers the CUSA decreased blood loss (from 1750±51 ml to
1332±43 ml in lobectomies and from 735±32 ml to 412±29 ml in segmentec-
tomies), whereas differences in operation time,ALT,AST, albumin, bilirubin lev-
els between two techniques were not statistically significant. Complication and
mortality rates were 18.6% and 9.3% in the crushing technique group and
10.8% and 4.3% in the CUSA group respectively. CONCLUSION: Compared
with the crushing techniques, the CUSA decreased blood loss, complication and
mortality rates and did not increase necrosis of the liver parenchyma in
patients with both normal and cirrhotic livers. However in patients with liver
cirrhosis the CUSA did not decrease the operation time.
P055
Management of the hepatic adenoma
J Grondona1, R Bracco2 and M Dualde1
1Centro Medico Martinez y Omar, HPB Unit, Department of Surgery, San
Isidro,Argentina
2Clinica Privada Pueyrredon, HPB Unit, Department of Surgery, Mar del Plata,
Argentina
AIM:The widespread application of refined techniques of abdominal imaging has
immensely contributed to increased discovery of Hepatic Adenoma (HA).The
aim of this study is to present our experience in the management of the HA.
STATEMENTS OF FINDINGS: Between 1992 and 2000, 11 HA were treated
in our two Centres.The mean age was 37,6 % (29-48 ), 10 (90.9%) female and
1 (9.1%) male patients.The 90,9 % of the women had a previous history of oral
contraceptive agents (OCA) consumption. In most of the patients (63,6 %)
were discovered incidentally by imaging studies. One of the symptomatic
patients was referred to our Centre with active peritoneal bleeding due to the
rupture of HA caused by a percutaneous liver biopsy. 72,7 % were operated on
for uncertain diagnosis. Hepatic resections consisted of: 2 right lobectomies, 1
left lobectomy, 4 bisegmentectomies, 1 segmentectomy and 3 enucleations. No
operative mortality was observed.The morbidity rate was 36,4 %. KEY CON-
CLUSIONS: 1) The OCA consumption increases not only the possibility of
developing HA, but also the risk of associated complications. 2) The uncertain
diagnosis, the suspicion of malignant transformation and the increase in size of
the tumour, should decide the resective therapy. 3) The kind of resection should
be adequated to the size and the localization of the HA, and its relationships
with vascular structures. 4) When the percutaneous liver biopsy does not mod-
ify the therapeutic approach, it must be avoided due to the high incidence of
complications.
P056
Our experience with IOUS during hepatic resections - is it necessery?
Z Milosevic1, K Milosevic and D Zoricic
1Institute for Surgery, Clinical Centre Novi Sad, Clinic for abdominal and
Endocrine Surgery, Novi Sad,Yugoslavia,Argentina
OBJECTIVE: Evaluation of the tumour operability and extension of the liver
resection usually represent delicate problem for the surgeons and demand a
range of intraoperative procedures that could help in adequate decision. From
this range we choused intraoperative ultrasound (IOUS), as we concluded that
this procedure is fast and accurate method for inspection of the tumour size,
its contact with surrounding structures, vascular and billiary vessels, so after
IOUS examination we can determine the extension of the liver resection.
FINDINGS: During 2 year’s period (from 1998 to 2000), 65 liver resections
were performed for primary or metastatic liver tumours. IOUS was used in
every case. From 65 hepatic resections, 26 were done for primary tumours, and
39 formetastatic liver tumours. Hepatectomy (right or left) was done in 19
cases, mostly for primary tumours, extended right or left hepatectomy in 9
cases. For the rest, segmentectomy was done. Bisegmentectectomy was the
commonest procedure-in 18 cases; trisegmentectomy in 10, and 9 segmentec-
tomy (one segment). CONCLUSIONS: Employment of the IOUS in operability
estimation of the liver tumours, and after, during parenchyma dissection repre-
sent primary intraoperative procedure which makes liver resections shorter
and safer, with consecutive decrease of the early postoperative complications.
In our algorithm of the intraoperative procedures IOUS has the leading and inn
replaceable role.
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P057
Complete resection of the caudate lobe (CL) of the liver
G Nuzzo, F Giuliante, M Vellone and F Ardito
Catholic University, General Surgery, Hepato-biliary Surgery Unit, Rome, Italy
Complete CL resection is technically demanding because of dorsal and deep
localization, and close proximity to major liver vascular structures. Recent
improvements of anatomical knowledge of CL and of surgical techniques have
rendered CL resection safer. Between 1995 and 2000, 13 complete CL resec-
tions were performed on 6 men and 7 women (mean age 52 years; range 31-
72). Malignancy (8 hilar cholangiocarcinoma, 2 metastases) was the most fre-
quent indication (77%); the other 3 cases had hepatocellular adenoma, focal
nodular hyperplasia and intrahepatic lithiasis. In 12 cases (92%) CL resection
was associated with major hepatectomies (more frequently right hepatectomy).
In one patient complete isolated CL resection was performed: in this case ante-
rior transhepatic approach was used. Pedicle clamping was used in 6 cases, with
a mean duration of 54± 22 (range 8-75); in 3 of these patients total vascular
exclusion was necessary, with mean duration of caval clamping 35± 21 (range
8-58). Mean length of operation was 557± 88 (range 340-720) . Intraoperative
blood transfusions were needed in 8 cases (61.5 %), with 2.9± 2.1 units per
patients (range 1-8). Operative mortality was nil. Morbidity was 38.4% with 7
complications in 5 patients (2 liver failures, 4 biliary fistulae, 1 pleural effusion
requiring a thoracentesis). Complete CL resection, in specialized Units, is a safe
procedure without significant difference of operative risk compared to major
hepatic resections.
P058
Echogenicity of liver metastases is an independent prognostic factor after
potentially curative treatment
T Gruenberger, JL Jourdan, J Zhao, J King and DL Morris
St George Hospital, Surgery, Sydney,Australia
HYPOTHESIS: Intraoperative echogenic appearance of liver metastases from
colorectal cancer is a prognostic factor of outcome after curative treatment.
DESIGN: Retrospective analysis of prospectively collected data. SETTING:
Department of Surgery at a university hospital. PATIENTS: One hundred forty-
three consecutive patients with hepatic metastases from colorectal cancer who
underwent liver resection with curative intent between 1992 and 1998.
INTERVENTION: Curative treatment was achieved by liver resection alone,
liver resection plus edge cryotherapy, or liver resection plus cryotherapy to
lesions not amenable to further resection. In patients with more than 2 lesions,
a hepatic artery catheter was placed for regional chemotherapy. MAIN
OUTCOME MEASURES:The echogenic appearance of the liver metastases was
assessed by intraoperative ultrasound by a single person throughout the study
using a 5-MHz ultrasound probe.The findings were prospectively entered into
the database. Results: Fifty-four percent of patients had hyperechoic metas-
tases.This group had significantly longer overall (log rank, P<.001) and recur-
rence-free survival (log rank, P =.004) compared with patients who had hypoe-
choic metastases (36%). A significantly higher percentage of mucin-secreting
tumours were found in the hypoechoic patient group (P =.001). Dukes stage of
the primary tumour (P =.02), echogenicity of the liver secondaries (P =.04), and
diameter of the largest resected metastasis (P =.01) were independent prog-
nostic factors for recurrence-free survival in the Cox regression model.
CONCLUSION:These results support the hypothesis that echogenicity of liver
metastases from colorectal cancer is an independent prognostic factor of out-
come after curative resection.
P059
Anatomical resection of multiple liver segments as an alternative to conven-
tional major hepatectomy
D Cherqui, E Yachouchi, B Malassagne,A Laurent and PL Fagniez 
Hopital Henri Mondor, Surgery, Créteil, France
BACKGROUND: Anatomical resection of liver segments represents an alter-
native to extended hepatectomies avoiding unncessary sacrifice of functional
parenchyma.Advantages include prevention of postoperative liver failure, espe-
cially in patients with underlying liver disease and the opportunity to perform
repeat resections in case of recurrent disease. PATIENTS: Of 410 liver resec-
tions, 26 cases (6%) included 2 or more adjacent segments (bisegmentectomy
2-3 excluded).There were 11 central hepatectomies (segments 4,5, and 8 ±1),
2 central anterior (segments 4b and 5), 1 central posterior (segments 4a and
8), 7 right posterior (segments 6 and 7), 2 right superior (segments 7 and 8), 2
right inferior (segments 5 and 6), and 1 left anterior resection (segments 3 and
4b). Indications were malignant disease in 23 patients including 11 cirrhotics
and benign tumour in 2.Segmental delimitation: Selective devascularization or
clamping was used to create ischemic margins permitting identification of seg-
ments and sectors. Inraoperative ultrasound was used to identify the plane of
the middle and right hepatic veins and the plane of portal bifurcation.
Resections were performed anatomically by combining devascularization and
ultrasound. RESULTS:There was no mortality. Median transfusions were 1 unit
(range, 0-9), and 17 patients (68 %) were not transfused. Complications
occurred in 7 patients (18 %).Among 23 patients with malignant disease, intra-
hepatic recurrence occurred in 6 patients (26%).Three of these patients (50%)
underwent repeat hepatectomy. CONCLUSIONS:Anatomical resection of liver
segments is a safe and well-tolerated alternative to major liver resection that
allows parenchymal preservation and repeat liver resection.
P060
Rerepeated hepatectomies in colon cancer metastases to the liver
Z Biejat, P Bialek,A Szubert, M Uryszek and J Polanski 
Medical University of Warsaw, 3rd Department of Surgery,Warszawa, Poland
Authors present 3 cases of multiple repeated anatomical liver resections in rec-
curent colon cancer metastases. Patients were qualified to the hepatectomy
from 2 to 8 months after colonic primary sites procedures and chemotherapy
after CT volumetry, estimation of functional reserve of the liver parenchyma
(Arterial Ketone Body Ratio) and with excluded extrahepatic localisation of the
metastases with frozen section of lymph nodes of hepatoduodenal ligament and
underwent consecutive courses of ChTx after liver resection. MATERIALS
AND RESULTS: Patient BP age 49 underwent right hemihepatectomy 30 days
after colonic resection; hepatectomies repeated 8 and 13 months later; died 19
months after first hepatectomy with disseminated cancer. Patient MK age 67-
synchronic metastases; Left hemihepatectomy 8 weeks after colonic resection,
repeated hepatectomies 10 and 16 months later (the last with metastasectomy
from right lung). Died 24 months after first liver resection. Patient RM age 60
hepatectomized after repeated chemoembolisations of the left side synchro-
nous tumour (left hemihepatectomy). Repeated liver resections 10 and 21
months later (the last procedure via thoracotomy). During follow up he under-
went lung metastasectomy in another centre.He was still alive after 26 months.
CONCLUSIONS: In selected cases with proven exclusion of extrahepatic dis-
ease repeated hepatectomies may prolong survival and patients life quality in
metastases from colon cancer.
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P061
A comparison of standard and extended hepatic resections: indications, com-
plications and outcomes
C O’Suilleabhain, GD Stewart, PC Shrestha, EJ Currie, KK Madhavan, RW Parks
and OJ Garden
University of Edinburgh, Department of Clinical and Surgical Sciences
(Surgery), Edinburgh, United Kingdom
AIMS:This study compares and contrasts the demographics, indications, mor-
bidity, mortality and survival for standard and extended hepatic resections in a
major hepatobiliary centre.METHODS: Details of patients undergoing standard
and extended hepatic resections between October 1988 and September 2000
were reviewed. RESULTS: There were 185 standard and 54 extended hepatec-
tomies performed.The median age was 55 years (range 19-82 years) for the
standard group, and 61 years (range 24-78 years) for the extended group
(p=0.048). 63% of standard hepatic resections were performed for malignant
disease, compared with 85% of extended hepatectomies (p=0.002). Major peri-
operative morbidity occurred in 21% of standard hepatectomy patients and in
33% of patients undergoing extended resection. There were 8 postoperative
deaths, 4 (2%) following standard resections and 4 (7%) following extended
resections. Median postoperative stay was 11 days for the standard procedure
and 15 days for the extended operation (p<0.0001) . Using Kaplan-Meier point
estimation, the median predicted survival of patients with colorectal metastases
following standard resection was 66 months (CI=38-94) compared to 23
months (CI=13-33) for extended resections (p=0.0009 log rank test). CON-
CLUSIONS There were differences in the indications for performing a standard
or extended hepatectomy; the incidence of postoperative complications was
similar in the 2 groups of patients although postoperative hospital stay was sig-
nificantly longer following extended hepatic resection. Survival following
extended resection was significantly less than for patients undergoing standard
resection and may reflect more advanced pathology.
P062
Hepatic pedicle clamping (HPC) during liver resections (lr): a comparative study
G Nuzzo, F Giuliante, I Giovannini, M Vellone, M Di Mugno and Murazio
Catholic University, General Surgery, Hepato-biliary Surgery Unit, ROME, Italy
Decreasing operative bleeding extent of transfusions during LR, has become a
main criterion to evaluate operative results of hepatectomies. HPC is widely
used for this purpose.Aim of the study was to compare results of two groups
of resections performed with or without HPC. Data from 350 LR were ana-
lyzed. 190 resections were performed with HPC (146 continuous and 44 inter-
mittent HPC) (Group A).The average duration of ischemia was 40’±20’ (range
7-107). In 32 cases (16.8%) ischemia was prolonged for 60’ or more. 160 resec-
tions were performed without HPC (Group B). Major resections were 53% in
Group A (101 cases) and 35% in Group B (57 cases). Cirrhosis was present in
42 cases, 25 in Group A and 17 in Group B. Operative mortality was nil.
Postoperative mortality was 2.8%, morbidity 19.4%. Percentage of transfused
cases (30.5% vs 47.5%; p=0.07) and number of blood units per transfused case
(2.3±1.4 vs 4.1± 3.3; p<0.001) were lower in Group A vs Group B. Similar fig-
ures were found by considering only major resections. Postoperative blood
chemistries did not show important differences between the two groups, and
postoperative alterations were related more to extent and complexity of the
operation, than to length of HPC. HPC during LR is a safe and effective tech-
nique.This is demonstrated in a context where HPC is used continuously in
most cases, intermittently in cases with impaired liver function and for more
prolonged ischemia, and avoided in cases with limited bleeding, jaundice, simul-
taneous bowel anastomoses.
P063
Correlation between the socioeconomic profile and treatment compliance of
public health service liver transplant recipients
IFSF Boin, EY Udo and L Leonardi
FCM / State University of Campinas, Unit of Liver Transplantation, Campinas,
Brasil
Orthotopic liver transplants are the best option for treating various types of
terminal liver disease cases. The survival rates reported are around 85%, but
patients sometimes need hospitalization during the first two postoperative
years because of infection, rejection or change in medication and therefore
more effective immunosuppressive methods and fewer postoperative compli-
cations are important targets to be attained.The compliance of the family and
the patient regarding the treatment is absolutely necessary for a successful
transplant.The purpose of this study was to find the correlation between the
degree of compliance and the socioeconomic profile of the recipient. It was
observed that there was a direct relationship between marital status and satis-
factory compliance ,whereas family income and cultural background did not sig-
nificantly affect compliance . Regular follow-ups at the outpatient department
and compliance in relation to medication are also very important.
Postoperative complications did not affect the high regard the recipients had
for the surgical procedure.
P064
Development of autoimmune hepatitis following liver transplantation for pri-
mary biliary cirrhosis a role for HLA type?
AT Abraham1, SR Shah1, A Quaglia2, AK Burroughs3, D Patch3, BR Davidson1, K
Rolles1 and AP Dhillon2
1Royal Free & University College School of Medicine, HPB & Liver Transplant
Surgery, London, United Kingdom
2Royal Free & University College School of Medicine, Pathology, London,United
Kingdom
3Royal Free & University School of Medicine, Hepatology, London,Thailand
BACKGROUND: Patients transplanted for endstage primary biliary cirrhosis
(PBC) have been known to develop denovo autoimmune hepatitis (AIH) in the
post transplant liver.Class I restricted pathways may play a role and it has been
suggested that patients with partial or complete matches are at risk (Jones et
al, Hepatology 99). METHODS:Three patients with features of AIH were iden-
tified amongst those transplanted for PBC. Their donor and recipient HLA
types, as well as those of 20 patients transplanted for PBC who did not devel-
op AIH over a 6 year follow up, were compared. RESULTS:Two locus match
was seen in 11/20 controls vs 4/5 cases of AIH (P=0.61). One locus match was
seen in 18/20 controls and all AIH patients (P=0.99). Case1: DonorA2A9A24,
B7B16B39Bw6, DR1DQ1; RecipientA2A23, B44B60Bw4Bw6, DR7, 8, 53,
DQ2. Case2: DonorA1A3, B7B8Bw6, DR2, 15, 3, 17, 51, 52, DQ1, 6, 2;
RecipientA1A2B15B6235Bw6DR1 , 4, 53, DQ1, 5,3. Case3: DonorA1A29
B44B57DR7; RecipientA2A29, B44B60Bw4Bw6, DR44, w52, w53. Conclusions:
Partial class I matches were seen in all three AIH patients in this study, as well
as the two previously reported patients. However, similar matches were also
seen in 11/20 of the patients transplanted for PBC who did not develop AIH.
This suggests that the finding of partial or complete HLA matches in these
patients is a coincidental finding and is unlikely to be a predictor of risk of
developing denovo post transplant AIH, as has been suggested.
P065
Experimental orthotopic liver transplantation in hypercholesterolaemic rats
T Pantoflicek, M Ryska, K Lipar and R Poledne
Institute for clinical and experimental medicine,Transplant surgery department,
Prague 4, Czech Republic
BACKGROUND: Familial hypercholesterolaemia is an autosomal dominant
genetic disease, whose homozygous form affects 1 in 1.000.000 individuals in
normal population.The clinical manifestation of atherosclerosis quickly acceler-
ates in patients with homozygous form with the average life span about 20
years.The only effective treatment is liver transplantation.The aim of this study
was to demonstrate the effect of liver transplantation in hypercholesterolaemic
rats and to monitor the serum total cholesterol levels and LDL levels before
and after the transplantation. MATERIALS AND METHODS:We performed an
orthotopic liver transplantation (OLTx.) in 18 Prague hereditary hypercholes-
terolaemic rats (PHHCR), with normal livers of Wistar rats. The serum total
cholesterol and LDL concentration was measured in POD -1, POD 1, POD 3
and POD 5. The PHHC rats were fed with hypercholesterol diet whole the
time of the experiment. RESULTS:The mean plasma cholesterol level was 3.46
mmol/l +- 0.35 before transplantation and 2.26 +- 0.27 after orthotopic liver
transplantation in POD 1,3,5. The mean LDL level was 2.42 +- 0.29 before the
transplantation and 1.5 +- 0.42 day 5 (POD 5) after the transplantation. CON-
CLUSIONS:This study illustrates the effect of orthotopic liver transplantation
in hypercholesterolaemic rats, with significantly decreased serum total choles-
terol and LDL levels after the transplantation.
P066
Relationship between early graft function and biomarkers in preservation solu-
tion and effluent of human liver grafts
M Ryska1, F Belina1, M Kucera1, I Tilser2, I Smrckova1, D Mala1, M Holecek2, J
Vavrova3, L Pliskova3 and P Zivny3
1Institute for clinical and experimental medicine, Transplant surgery depart-
ment, Prague 4, Czech Republic
2Faculty of Pharmacy, Hradec Kralove, Czech Republic
3Teaching Hospital, Hradec Kralove, Czech Republic
BACKGROUND: The aim of this study was to determine whether ALT, AST,
LDH, GMT, CK activities, malondialdehyde (MDA) and free fatty acid  (FFA)
concentrations in various samples correlate with early graft function in clinica l
liver transplantation. METHOD: Samples were collected from: a) preservation
solution at the end of cold storage, b) systemic venous blood just before reper-
fusion, c) first 30 ml of caval effluent. Poor early graft function (PEGF) was
defined as peak AST > 1500 U/l and ALT > 1000 U/l during the first post-oper-
ative week. RESULTS: Effluent data according to early graft function: GEGF
(n=33)- 3.19 ALT, 5.40 AST, 10.2 LDH, 1.77 MDA, 1.02 FFA. PEGF (n=6) 7.56
ALT, 9.54 AST, 17.5 LDH, 3.71 MDA, 1.36 FFA. Relationship between first efflu-
ent biomarkers levels and graft function are analysed. Patients with PEGF had
significantly higher ALT, LDH and FFA levels in the effluent sample than those
with good early graft function (GEGF). Conclusions:ALT, LDH and FFA levels in
the first caval effluent predicted early graft function to some degree, but not
quite reliably. Other biomarkers are under evaluation.
P067
Methionine breath test to assess mithocondrial liver function after orthotopic
liver transplantation
B Nardo1, F Catena1, G Cavallari1, R Montalti1, G Angelini2, R Bellusci1, G Fuga1,
A Principe1,A Gasbarrini2 and A Cavallari1
1General Surgery, Department of Surgery and Transplantation, University of
Bologna, Bologna, Italy
2Internal Medicine, Department of  Internal Medicine, Catholic University of
Rome, Rome, Italy
BACKGROUND: Primary non-function (PNF) of the liver is a main cause of
organ failure following orthotopic liver transplantation (OLTx).An impairment
of hepatocytes mithocondrial function has been hypothesized in PNF, however
a reliable and easy to perform test of mithocondrial liver function is not yet
available. 13C-methionine breath test (13C-mBT) has been recently proposed
to evaluate the oxidative capacity of liver mitochondria. AIM: to perform 13C-
mBT in the early phase following OLTx. METHODS: 8 patients undergoing
OLTx for HCV-related cirrhosis were evaluated. 13C-mBT was performed
after 1, 3 and 5 days from OLTx. Breath samples were collect before and every
15 minutes for 3 hours after the ingestion of 2 mg/kg of body weight of 13C-
methionine (Isotec, USA). Results were expressed as cumulative percentage
dose of 13CO2 recovered (CPDR) at 120 and 180 minutes. 13CO2 enrich-
ment in breath was analyzed by isotope ratio/mass spectrometry. ALT, AST,
cholinesterase, bilirubin, alkaline phosphatase, fibrinogen, ammonia, antithrom-
bin III and prothrombin time were also assessed. RESULTS: PNF, which deter-
mined liver retransplantation after 7 days, was observed in one out of the 8
patients. Interestingly, when compared to all other patients, CPDR 120 and 180
of this patient was significantly lower after 1, 3 and 5 days from OLT.
Interestengly, at day 1 from OLTx, no differences in the other markers of liver
function assessment was observed between patients. CONCLUSIONS: 13C-
mBT, a safe and easy method to quantify hepatic mithocondrial function, could
represent a novel addictive tool to predict PNF following OLTx.
P068
Preoperative liver mass evaluation
O Tsiroulnikova,A Filine,A Semenkov and S Gautier 
National Research Centre of Surgery, Organ Transplantation, Moscow, Russia
Since the routine CT-scanning obtains adequate calculation only for the whole
liver or for its left lateral sector it cannot be used successfully to estimate lobes
or segments. Some formulas created for mathematical prediction of liver lobe
mass or volume also cannot obtain elective estimation of liver segment. The
study performed on 104 cadaveric livers to find out mass percent ratio of each
C. Couinaud’s segment showed the following correlation: SI - 1.6+/-0.2%, SII -
11.8+/-0.7%, SIII - 10.4+/-0.5%, SIV - 22.7+/-1.3%, SV - 15.1+/-0.6%, SVI - 12.3+/-
0.5%, SVII - 14.1+/-0.4%, SVIII - 12.0+/-0.4%. The revealed percentage can be
combined with any formula or other method of total liver mass calculation.
Segmental liver mass evaluation (SLME) was practically used in 21 cases of total
right or left lobe mass estimation for living related liver transplantation to pre-
dict the graft volume ratio. Using SLME we had withdrawn CT for liver volume
measurements since 1996.To establish the real volume or mass the graft was
weighed after harvesting.The difference between calculated and real volume of
fragment was 2.3 to 34.1 (mean 12.8+/-2.1) gm. SLME appears to be satisfac-
tory correct for living related liver grafts estimation. In the same time it gives
the possibility to avoid X-ray radiation during the traditional CT which is not
indifferent for the health of living donor.
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Randomized clinical study comparing University of Wisconsin and celsior solu-
tion in liver preservation for transplantation
B Nardo, F Catena, R Montalti, G Cavallari,A Di Naro,A Faenza, R Bellusci, G
Fuga,A Principe and A Cavallari
General Surgery, Department of Surgery and Transplantation University of
Bologna, Bologna, Italy
This study aimed to compare the effectiveness of University of Wisconsin solu-
tion (UW) and Celsior (CS) solution in the preservation of the liver. From Sept.
1998 to June 2000 we randomized 120 donors and performed 113 OLT. All
recipients were adults. Cold ischemic time was always < 13 hrs.The pts were
divided in: CS group (n=53 pts) and UW group (n=60 pts).A standard immuno-
suppressive therapy was used.There were not statistical differences in donor
and recipient characteristics. Cold and warm ischemia time were comparable
as well. 1st p.o. day bile production (mean ± SD) was 165 cc ±115 in UW group
vs 212 ± 123 in CS group. (p=n.s.). 3rd p.o. day bile production was 177.1 ± 95.7
in UW group vs 168.2 ± 94.0 in CS group. (p=n.s.). PT (%) levels were compa-
rable too. Intensive care unit p.o. stay was 6.4±11 days in UW group and
4.1±2.6 in CS group (p=n.s.). AST levels at 1, 3, 5, 7, 15 p.o. day in UW group
were respectively: 953±920.3; 399±735.5; 107±84.6; 66±36.6; 33±45.7.AST lev-
els at 1, 3, 5, 7, 15 p.o. day in CS group were respectively: 667±1246.9;
288±878.7; 75±137.0; 44±53.4; 29±27.4 (p=n.s.).ALT levels were comparable as
well.There were not differences in total bilirubin level in UW and CS groups.
There was also not statistical significance difference in graft or patient survival
between the groups at 3, 12 and 18 months. CS and UW are both effective in
cold storage of the liver for transplantation.
P070
Hybrid liver support: a novel approach for utilising explanted organs not suit-
able for transplantation
D Kardassis1, G Naumann1, IM Sauer1, N Obermayer1, D Horch1, E Trias2, C
Cabrer2, J Tost3, A Mas3,AR Muleller1, JC Gerlach1 and P Neuhaus1
1Virchow Clinic,Charità, Humboldt University, Department of General Surgery,
Berlin, Germany
2Hospital Clinic, University of Barcelona, Transplant Coordination Unit,
Barcelona, Spain
3Hospital Clinic, University of Barcelona, Liver Unit, Barcelona, Spain
INTRODUCTION: Despite shortage of donor organs, <23% of donor livers
are not transplanted due to steatosis, cirrhosis, traumatic injury, or other rea-
sons (Eurotransplant 2000). Isolated liver cells from these rejected organs
could be cultivated in bioreactors and used alternatively.The “Cell Module” of
the “Modular Extracorporeal Liver Support” (MELS) system is currently under
evaluation in order to receive information about its therapeutic safety.
METHODS:The liver cells from 20, out of 31 obtained, rejected organs were
enzymatically isolated, and were subsequently cultivated in a bioreactor with a
three-dimensional network of interwoven capillary membranes and integrated
oxygenation. Two patients suffering from acute liver failure (ALF) and one
patient suffering from acute-on-chronic liver failure (AoCLF) were treated.
RESULTS: Both patients with ALF were “bridged” to orthotopic liver trans-
plantation (OLT). Following primary graft non-function, one patient was
“bridged” again to re-OLT. The patient with AoCLF was treated during one
hepatic encephalopathy episode prior to OLT.The duration of therapy ranged
from 7 to 74 hours. No limiting adverse haemodynamic effects were observed.
The beneficial development of several biochemical parameters was recorded.
CONCLUSION: Isolated cells from explanted, but rejected livers can be culti-
vated and employed in hybrid liver support systems. The degree of organ
impairment is more likely the limiting factor for achieving a high-quality cell cul-
ture than donor age or cold preservation (ischaemic) time. Considering the
often unstable clinical status of patients suffering from ALF or AoCLF, the treat-
ment with the “Cell Module” of the MELS system was safe, allowing further
clinical applications.
P071
Effect of nutritional support procedure and prostaglandin infusion on preser-
vation injury in isolated rat fatty liver
B Nardo1, P Caraceni2, E Maiolini2, M Domenicali2, F Catena1, G Cavallari1, R
Montalti1, M Bernardi2 and A Cavallari1
1General Surgery, Department of Surgery and Transplantation University of
Bologna, Bologna, Italy
2Internal Medicine, Department of Medicine University of Bologna, Bologna,
Italy
INTRODUCTION: The sinusoidal damage and the impairment of hepatocyte
metabolism contribute to preservation injury in fatty liver intended for trans-
plantation. Thus, this study aimed to determine whether administration of
vasodilator substances and energetic substrates, alone or in combination, can
be an effective protective strategy. METHODS: Fatty livers induced by choline
deficiency were isolated by 18 h fasted Sprague-Dawley rats, preserved in UW
solution at 4 C for 18 h, and reperfused with oxygenated KHB solution at 37
C for 2 hrs.The experimental groups were: 1) no treatment; 2) supplementa-
tion with a 40% glucose oral solution in the 18 h prior explantation; 3) infusion
of alprostadil (1 ug/Kg/min) during liver reperfusion; 4) combined treatment.
RESULTS: The ALT release during reperfusion and the hepatocyte necrosis,
assessed at histology by the cell uptake of trypan blue, were significantly
decreased by glucose administration alone and, to a greater extent, by the com-
bined treatment as compared to controls.The reduction seen in livers treated
with alprostadil alone did not reach the statistical significance . Portal pressure
was significantly reduced by alprostadil infusion and, to a greater extent, by the
combined treatment. In contrast, glucose administration alone did not affect
portal pressure. Hepatic oxygen consumption increases when animals were
supplemented with glucose. CONCLUSIONS:These data indicate that a com-
bined treatment with a nutritional support, aiming to improve the energetic
metabolism of fatty hepatocytes, and the vasodilator alprostadil, aiming to ame-
liorate the sinusoidal perfusion, is able to reduce preservation injury in steatot-
ic liver.
P072
Living related right hepatic lobe transplantation: anatomical criteria for donor
selection
S Gautier, O Tsiroulnikova,A Filine, J Kamalov and A Semenkov
National Research Centre of Surgery, Organ Transplantation, Moscow, Russia
Living donor selection for liver transplantation must serve 2 main purposes: to
get an adequate liver graft which would meet the demands of recipient and sur-
geon and to estimate the degree of harm which the donor would be able to
overcome without morbidity. The importance of right criteria is more if the
right hepatic lobe is expected to be harvested. Up to the end of 2000 among
other transplant procedures 20 living related liver transplantations of the right
hepatic lobe had been performed.Total of 28 healthy relatives of patients were
investigated to find the best anatomical conditions for harvesting and grafting.
To find out the details of hepatic blood supply and outflow ultrasonography and
angiography were used. All variants of hepatic arterial configuration were
appropriate.The 4th segment was preferable to have at least 1 arterial branch
from the left hepatic artery. It allowed to ignore the branch from the right
artery if any and to get whole length of the right artery for more convenient
reconstruction in recipient. The portal vein branching was the main problem.
Only bifurcation with at least short trunk of the right portal branch was con-
sidered to be appropriate. It was important for adequate graft perfusion while
cooling and conservation.The right hepatic vein main orifice was only signifi-
cant. All other small veins from 8th segment to caval vein or to the middle
hepatic vein were ignored without any harm for graft.All grafts and recipients
survived. No complications in donors were observed.
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Liver recipients undergoing hepatic transplantation and subsequent retrans-
plantation: a comparison between clinical characteristics
JC Meneu-Diaz1, E Moreno-Gonzalez1, E Vicente-Lopez2, J Nuão2, C Loinaz1,V
Turrion2, C Romero1,Y Quijano2, P Lopez-Hervas2 and I Gonzalez-Pinto1
1University Hospital 12 De Octubre, Digestive Surgery and Abdominal Organs
Transplantation, Madrid, Spain
2University Hospital Ramon y Cajal,Transplant Unit, Madrid, Spain
INTRODUCTION: in order to get a rational strategy for organ distribution an
optimal patient management, we postulate it is mandatory not only understand
the pathophysiology of failing grafts but also to better recognized the baseline
clinical characteristics of the recipients shortly before receiving a second liver
allograft. Marterial and methods: between March 1986 and December 1997,
1061 patients underwent 1087 orthotopic liver transplantation at three
Hospitals in Madrid (122 retransplants). Results: mean follow up was 36 months
(range, 1-90), 40.6% of the recipients were alive and survival at 1, 3 and 5 years
was 62%, 53%, 46%. Almost 50% of the recipients were UNOS 1 before
retransplantation. In comparison to p-OLT (15% UNOS 1), it is clearly shown
that the retransplants have been performed in the sickest patients with more
adverse prognostic indicators (higher AST, bilirubin, creatinine serum levels,
higher Child-Pugh’s score, higher rate of ascitis and lower serum levels of albu-
min and prothrombin activity). Conclusions: liver retransplantation is accept-
able and significant differences in recipients baseline charateristics have an sug-
gest an impact on lower survival.
P074
Retrieval of the donor organ for orthotopic liver transplantation: an audit
AT Abraham, SR Shah,AK Agarwal, BR Davidson and K Rolles 
Royal Free & University College School of Medicine, Surgery, London, United
Kingdom
BACKGROUND: It has been suggested that harvesting of the liver should only
be performed by a consultant led retrieval team, as opposed to the current
United Kingdom trend of using senior surgical trainees, in order to minimise
the incidence of retrieval injuries and organ wastage.We carried out an audit
of the performance of trainee retrieval surgeons to determine whether such a
change in practice is warranted. METHODS:The incidence of retrieval injuries
was studied retrospectively in 196 consecutive livers retrieved by the seven
designated transplant centres in the UK, and transplanted at our institution
between may 1996 and April 1999. Data was retrieved from the detailed oper-
ation notes of the bench procedure as well as the donor procedure. Operative
difficulties at the time of implantation due to retrieval injury, as well as graft
outcome were noted. RESULTS: All grafts were usable. 83% were perfect
retrievals. Minor parenchymal damage was the commonest retrieval injury.
Major arterial injury was seen in 5%, but this made implantation difficult in only
2 patients.Thus 99% of the grafts retrieved were utilized without intraopera-
tive difficulty. The rate of primary non-function was 1%. CONCLUSIONS: All
grafts retrieved by senior surgical trainees across the UK were utilized. Ninety
nine percent of these grafts were transplanted without intraoperative technical
difficulty arising from the retrieval.
P075
Focal nodular hyperplasia (FNH): observation or surgery?
O Tsiroulnikova, J Kamalov, G Sheremet’eva, M Morozova and S Gautier 
National Research Centre of Surgery, Organ Transplantation, Moscow, Russia
Among several types of hepatocellular focal lesions such as hepatocellular car-
cinoma (HCC) and adenoma (HCA), cirrhotic regenerative adenoma the focal
nodular hyperplasia is considered to be benign and the indications for surgical
treatment are controversial. Since 1991 total of 342 patients were observed
with different focal diseases of the liver. FNH was found in 23 patients: 10 male
and 13 female in the age of 9 to 64 (mean 20.9+/-3.4) years old.The final diag-
nosis was obtained by estimation of duplex ultrasonic, laboratory and percuta-
neous biopsy data compared with morphological investigation of the tumour
postoperatively.The main features of FNH were the following: no complains, no
clinical or laboratory manifestation except cholestasis in 4 cases of huge FNH,
good arterial vascularization of the node itself and significant hypertrophy of
hepatic artery.The size of FNH was from 8 to 18 cm. in diameter with 3 to 6
C.Couinaud’s segments involved. Fifteen hemihepatectomies and 8 extended
hepatectomies had been performed with no complications or mortality and
with long survival without relapse. In 1 case of right extended hepatectomy
performed for gigantic HCA the small accessory tumour near the main one
appeared to be FNH. In other 2 male patients of 20 and 64 years old operated
for gigantic liver tumours FNH was found as the initial focal lesion that partial-
ly had been transformed into HCC. Since that initially benign FNH can be con-
sidered as the basis for HCA or HCC in future.Therefore active surgical treat-
ment is more preferable than observation.
P076
Large uninodular hepatocellular carcinomas mainly occur in the rigth lobe of
the liver and are not necessarily related to overt cirrhosis or viral infection.
M Zuckermann1, F Cetta1, A Mussia2, L Matera3, G Francini4, PP Correale4, G
Ercolani5 and A Mazziotti5
1University of Siena, Institute of Surgical Clinics, Siena, Italy
2University of Turin, Department of Pathology,Turin, Italy
3University of Turin, Department of Internal Medicine,Turin, Italy
4University of Siena, Institute of Radiology, Siena, Italy
5University of Bologna, 2nd Surgery, Bologna, Italy
Most of hepatocellular carcinomas (HCCs) are multiple and associated with
HBV-HCV infection and/or cirrhosis. Between 1994 and 1999, 49 patients (39M
and 10F) had preoperative diagnosis of single HCC >4cm not associated with
a preoperative diagnosis of cirrhosis, whereas 145 patients had HCCs (single
or multiple) associated with evident cirrhosis.All patients underwent complete
removal of their tumours.HCCs involved the right lobe in 44 of the 49 patients
of the former group (88.2%), but only in 66 of 104 patients of the latter group
who had segmental liver resection (63,4%) (p=0,001). In the former group
tumours were almost always capsulated and well differentiated and satellite
nodules were present in only 4 of the 49 patients. Only 19 of the 49 were pos-
itive for HBV-HCV infection vs 105 of 112 patients with evident cirrhosis, who
had this analysis (p<0,001). Ten of 49, but only one of 17 patients without por-
tal vein involvement, had recurrence 6 to 60 months after surgery. Large HCCs
without evident cirrhosis are seldom related to viral infection affect almost
always the right lobe, have an expansive growth pattern and usually show a
complete capsule, even when >8-10cm. It is suggested that: a) large uninodular
HCCs not associated with diffuse cirrhosis could be a different disease less
aggressive than multinodular HCCs, mainly associated with HCV infection; b)
growth factors normally present in the portal vein (Insulin, IGF2) and possibly
mainly draining into the right liver could play a role in the elective location of
these peculiar HCCs.
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Clinical relevance of disseminated tumour cells in blood of colorectal cancer
patients undergoing hepatic resection for metastasis is hampered by pre-oper-
ative chemotherapy
TJM Ruers1, FA Vlems1, 2, JHS Diepstra2, IMHA Cornelissen2, MJL Ligtenberg2,
CJA Punt3, JHJM van Krieken2,Th Wobbes1 and GNP van Muijen2
Depts. of Surgery 1, Pathology2, and Medical Oncology3, University Medical
Centre Nijmegen,The Netherlands
Hepatic resection improves the long-term prognosis of patients with colorec-
tal cancer metastasis isolated to the liver. However, even after resection still
tumour recurs in two third of the patients. This indicates that disseminated
tumour cells were present.We have studied the clinical relevance of dissemi-
nated tumour cell detection for improvement of patient selection.We evaluat-
ed pre-operative blood and bone marrow of 27 patients with colorectal can-
cer metastasis isolated to the liver for the presence of disseminated tumour
cells using RT-PCR for epidermal growth factor receptor (EGFR). Twelve
patients received pre-operative chemotherapy before resection. Follow-up
ranged from 4-23 months (mean 10,6) . In addition, we studied EGFR mRNA
expression in blood of healthy donors (n=11) and in blood and bone marrow
of non-cancer patients (n=11). All control samples were negative for EGFR
mRNA, whereas 47% of the patient blood and 88% of the patient bone mar-
row samples were positive.Analysis of all 27 patients according to the Kaplan-
Meier method showed that the presence of disseminated tumour cells in blood
and/or bone marrow could not predict disease free survival. Separate analysis
of patients with and without chemotherapy revealed that in the chemotherapy
group a reduced number of patients showed EGFR mRNA expression in blood
(25%) compared to the non-chemotherapy group (71%). However, EGFR
mRNA expression in bone marrow does not show this difference. In conclu-
sion, our results suggest that chemotherapy reduces the percentage of patients
with disseminated tumour cells in blood detected by EGFR RT-PCR and may
therefore interfere with the prognostic value of disseminated tumour cells.
P078
Transcatheter treatment of hepatocellular carcinoma (HCC)
P Tarazov2,A Granov1 and A Polikarpov1
1Research Institute of Roentgenology, Surgery, St Petersburg, Russia
2Research Institute of Roentgenology, Angio/Interventional, St Petersburg,
Russia
PURPOSE:To evaluate survival of pts with HCC after hepatic artery infusion
(HAI), mechanical occlusion (HAE), and transcatheter oily chemoembolization
(TOCE). MATERIALS AND METHODS: Between 1989 and 1999, 41 pts with
advanced unresectable HCC without clinically evident cirrhosis received tran-
scatheter treatment. Of them, 8 pts underwent HAI with 5-FU and/or
Doxorubicin. HAE using Gelfoam, Ivalon and/or steel coils was performed in 10
pts. In the remaining 23 cases, repeated TOCEs with 60-80 mg Doxorubicin in
10-20 ml Lipiodol plus Gelfoam was done. RESULTS:Two responses (25%) to
HAI included one partial tumour decrease and one stabilization, while 6 pts
showed tumour progression.The mean survival for HAI was 7.5+4.5 mo.After
HAE, the response rate was 30%, and the mean survival 8.9+6.0 mo (NS if com-
pared with HAI ). These indicators for TOCE were 87% and 27.0+13.6 mo,
respectively (P<0.01). CONCLUSION: TOCE with Doxorubicin is the most
effective transcatheter palliation for unresectable HCC without clinically evi-
dent cirrhosis.
P079
Earlier liver transplantation for metastatic neuroendocrine tumours?
T Lorf1, U Hanack1, K Däpkens1, B Sattler2 and B Ringe1
1Georg August Universität, Klinik für Transplantationschirurgie, Göttingen,
Germany
2Georg August Universität, Zentrum Pathologie, Göttingen, Germany
PURPOSE: Liver transplantation (LTx) for hepatic metastases of neuroen-
docrine tumours (NET) remains controversial due to frequent tumour recur-
rence. However, the indication for LTx is usually considered in case of failure of
conservative therapy with progress of symptoms. METHODS: Retrospectively,
we analyzed 12 patients (5 female, 7 male) regarding the relation between dura-
tion of disease, timing of surgical treatment and outcome. 4/12 patients had pri-
mary pancreatic tumours, 7/12 intestinal tumours and 1/12 a primary hepatic
NET. RESULTS: In 4/12 patients partial liver resection (LRx) were performed,
8/12 were listed for LTx, 5/8 were transplanted. 2/12 died on the waiting list
and one patient is currently waiting. 4/9 patients (group A) are free of tumour
recurrence (3 LTx, 1 LRx), 5/9 patients (group B) developed tumour recurrence
(2 LTx, 3 LRx).Mean (± SD) duration between diagnosis of liver metastases and
surgical treatment in group A was 6.41 (± 4.0) vs. 27.42 months (± 40.71) in
group B.After a mean follow up of 22 (±15) month 3 /4 patients in group A are
alive, one patient died from non tumour related course (sepsis). In group B 4/5
patients are alive with tumour progress. CONCLUSIONS: Early surgical treat-
ment seems to be necessary to get a chance for cure instead of palliation.
However, patients after LRx for hepatic metastases of NET are at risk for
tumour recurrence. LTx should already considered at time of detection of mul-
tifocal liver metastases and not if all other treatment methods are no longer
effective.
P080
Telomerase activity in human hepatocellular carcinoma: parallel correlation
with human telomerase reverse transcriptase (hTERT) mRNA isoform expres-
sion but not with cell cycle modulators or c-Myc expression
KL Shen1, CJ Chen2 and HJ Harn3
1Tri-Service General Hospital, Department of Surgery,Taipei,Taiwan
2National Defense Medical Centre, Graduate Institute of Medical Sciences,
Taipei,Taiwan
3Tri-Service General Hospital, Department of Pathology,Taipei,Taiwan
To explore the possible regulatory mechanisms of telomerase, we examined
the telomerase activity (TA), expression of human telomerase RNA (hTR),
human telomerae reverse transcriptase (hTERT) mRNA isoforms and cell cycle
modulators in human hepatocellular carcinoma (HCC) cell lines (J5, J7) and a
normal human immortalized hepatic epithelial cell line (Chang-liver). The cell
lines were chemically synchronized in either G1, G1/S, G2/M or M phases. TA
was measured by PCR-based telomerase repeat amplification protocol assay.
The hTR and hTERT mRNA levels were analyzed by reverse transcriptase-poly-
merase chain reaction.Western blotting and immunohistochemistry were used
to assay the cell cycle modulators.The TA of J5, J7 and Chang-liver cell lines
tested was highest in M phase.The expression level of hTERT mRNA associat-
ed with the highest TA detected in the M phase of HCC cell lines. Chang-liver
expressed markedly less TA and hTERT mRNA than J5 or J7. The elevated TA
and expression of hTERT mRNA in M phase of HCC cell lines did not signifi-
cantly correlate with that of the cell cycle modulators and c-Myc. The results
implicate that regulation of TA is related to hTERT mRNA isoform expression,
and that regulation is different between the cell immortalization and tumouri-
genesis. Keywords:Telomerase, hTERT, hepatocellular carcinoma, chemical syn-
chronization, isoforms
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Combined, hepatic artery and portal vein, chemoembolization, versus arterial
chemoembolization alone in colorectal cancer metastatic to the liver
P Tarazov1,A Polikarpov1, D Granov2 and V Borovik2
1 Research Institute of Roentgenology, Angio/Interventional, St Petersburg,
Russia
2 Research Institute of Roentgenology, Surgery, St Petersburg, Russia
PURPOSE:To evaluate results of combined, hepatic artery (HA) and portal vein
(PV) transcatheter oily chemoembolization (OCE) vs HA-TOCE alone in
patients with unresectable colorectal liver metastases. MATERIALS AND
METHODS: Between 1986 and 2000, 325 courses of OCE with 40-100 mg
Doxorubicin-in-Lipiodol and gelatin sponge were performed in 89 patients. Of
them, 45 patients (Group A) underwent ultrasound-guided PV-OCE with 30-60
mg Doxorubicin-in-Lipiodol (without sponge) in 2 weeks after HA-OCE, while
44 patients (Group B) received the same dose of Doxorubicin intravenously.
RESULTS: Response to treatment (partial tumour decrease plus stabilization )
was seen in 90% vs 66% in groups A and B.The mean survival for patients who
already died was 20.2+12.0 mo vs 11.2+4.4 mo, respectively; the 1-year survival
rates were 88% and 43% (P<0.01). CONCLUSION: Combined, HA+PV OCE is
more effective than HA-OCE alone for palliative treatment of unresectable col-
orectal liver metastases.
P082
Role of cell differentiation in post-operative recurrency of hepatocellular car-
cinoma
C-G Ker, K-S Chen, I-T Tseng, H-Y Chen, C-C Juan, H-Y Lo1, I-C Chai1, D-H
Shih2, I-I Shen2, C-L Chern3 and T-Z Liu3
Div. of HBP Surgery, Div. of Hepatology1, Dept. of Pathology2, and Dept. of
Medical Research3, Institute of Hepato-Gastroenterology, Yuan’s General
Hospital, Kaohsiung,Taiwan
INTRODUCTION: Using a group of hepatocellular carcinoma (HCC) cell lines
with varying degrees of differentiation (Diff) and surgical specimen were stud-
ied.We try to demonstrate expression of Matrix Metalloproteinase (MMP) and
recurrent time in HCC.METHODS:A) There were 83 specimens available from
103 surgical patients of HCC for studying the cancer cell differentiation and
their recurrent time. B),There were Hep G2, Hep 3B, Hep J5, Hep Mal, and SK-
Hep-1 cell lines for studying the MMP-2 and MMP-9 with the method of zymog-
raphy. RESULTS;A) From surgical specimen, the pathological findings for rating
the differnetiation with Edmondson classificaltion were performed.There were
15 cases(%), 42 cases(%) , 20 cases(%) and 6 cases(%) for Edmondson I,II,III, and
IV respectively. The tumour free was 40.0%, 40.4%, 15.0% and 16.7% after a
periode of 19.3, 27.2, 20.6, and 22.0 months for each group.The recurrent time
were 10.7, 9.47, 17.1,and 5.5 months as well respecitively.The residural median
survival times after the recurrency were 10.5, 13.7, 7.9, and 10.0 months for
each group. B) The SK-Hep-1 cell being rated as the most invasive express a
large amount of MMP-9, Similar Hep Mal cell also a poor-Diff cells , can express
an excessive amount of MMP-2 and lesser MMP-9.Conversely,Hep-G2 and –3B
cells, being classified as well-Diff cells express none or only minute amount of
MMP-9. CONCLUSION: Unuaually, the recurrent time was longer in the group
of Edmondson III because four of them (20%) accepted extended lobectomy
and six (30%) accepted right lobectomy. It is pertinent to prove the results still
good in moderate-Diff. if extended operation was performed where possible.
Diff. of HCC cell and extents of MMPs expression were found to be positively
correlated with the invasive proclivity.
P083
Liver function after surgery for liver tumours measured with 13c-aminopyrine
breath test - preliminary results
T Kruszyna, R Solecki,W Nowak and T Popiela
Ist Department of General and GI Surgery, Jagiellonian University, Kraków,
Poland
OBJECTIVE: Search continues for a single reliable test providing dynamic
assessment of liver function. 13-C aminopyrine breath test (ABT) is capable of
identifying the functional reserve of the liver and is useful in the study of kinet-
ics of liver metabolism in response to liver trauma. It is easy to perform and
thus may constitute an important element of diagnostic work-up preoperative-
ly and in follow-up. MATERIAL AND METHODS: A total of 15 patients sub-
jected for liver surgery (mean age 56 ±15,3 years) were followed up with ABT
after a mean of 8,7 postoperative days.A total of 7 hemihepatectomies (6 right,
1 left), 4 cryoablation procedures, 4 segmentectomies were performed.There
were 5 patients finally diagnosed with benign lesions, mean age 49 ± 11,7 years
and 10 patients with malignant lesions (metastatic lesions, liver infiltration by
extrahepatic neoplasms), mean age 60,1 ± 14 years. RESULTS: There was no
correlation of ABT results with the size or number of lesions. No correlation
between preoperative ABT results and benign/malignant origin of the lesion(s)
were observed.After the surgery the ABT results were consistently lower by a
mean of 21% at a mean of 8,7 postoperative days in the group of patients with
malignant lesions; no such tendency was observed in the benign lesions group.
A reduction by 40-60% could be observed if more than four segments of the
liver were ablated or resected. Neither preoperative nor postoperative results
of ABT correlated with the level of transaminases, total bilirubin or albumin.No
procedure or test-related morbidities were noted.CONCLUSIONS:According
to ABT results, approximately 20% reduction of the liver functional mass with-
in 1,3 postoperative week is a consistent finding in patients after liver surgery
for malignant lesions. The reduction of ABT value does nor correlate linearly
with the extent of liver surgery and rises abruptly when more than four seg-
ments are resected or ablated. Preoperative ABT may be a valuable prognostic
test in terms of postoperative liver recovery in patients with liver tumours
qualified for liver surgery.
P084
Cytoreductive liver surgery with CPT-11 use
A Severtsev, S Privezentsev and I Bakay
Medical Centre for Russian Government, Moscow, Russia
Cytoreductive surgery for the treatment of patients with malignant liver
tumour is the most modern and prospective part of liver surgery. Most of the
cases are patients with metastatic malignant tumours from colorectal cancer
origin. The important part of the scheme of cytoreductive treatment is the
regional intraarterial (a.hepatica) chemotherapy.The selection of chemothera-
peutic drug for these purposes is unclear. During last years the drug CPT-11
was successfully used for the systemic chemotherapy of colorectal cancer.The
aim of this study was to assess our experience of cytoreductive liver surgery
with the use of CPT-11 as the main chemotherapeutic agent. During the peri-
od 1996-2000 we treated 30 patients for advanced colorectal cancer with the
use of CPT-11.All of them had liver metastases, 10 patients had intraabdominal
(paraaortal) lymph nodes metastases, and 2 patients had lung metastases. All
patients had liver resections with maximal excision of tumour masses and
intraarterial port insertion. In case of abdominal lymph nodes metastases
patients had lymph node dissection and HIIC with mytomycin C or 5-FU.
Patients with lung metastases had no lung resections. During postoperative
course all patients were treated with CPT-11 150 mg/m? intraarterially (port,
a.hepatica) and 150 mg/m? i.v. All patients survived after surgery. Long term
results showed that all of them were alive for 3 months after surgery, 27 (90%)
for 6 months, 19 (63,33%) for 12 months, 8 (26,67%) for 24 months. 3 patients
were alive for more than 30 months (max 62 months): 1 with metastases recur-
rence and 2 were free of disease. All patients had conventional complications
of CPT-11 chemotherapy, but their severity was much less pronounced.
Conclusion: Our results show that CPT-11 could be selected as the treatment
of choice for the patients with advanced colorectal cancer during cytoreduc-
tive surgery.
P085
Laparoscopic surgery for liver tumour with cirrhosis
H-Y Chen, C-G Ker, I-T Tseng C-C Juan and H-W LO1
Department of HPB Surgery and 1 Hepatology, Yuan’s General Hospital,
Kaohsiung,TAIWAN
INTRODUCTION: For tumour ablation with laparoscopic technique , the
pathologic diagnosis and treatment decision were important with the aid of
laparoscopy especially for liver cancer with cirrhosis. PATIENTS AND METH-
ODS:A), for diagnosis: Fifteen patients were accepted laparoscopic examination
due to the liver tumours with cirrhosis. Under laproscopic quidance , biopsy
could be applied with the aid of laparoscopic ultrasound. Definite treatment can
be decided soon after the frozen pathology. B), for treatment:There were 56
patients underwent laparoscopic treatment for hepatocellular carcinoma by
laparoscopic microwave coagulonecrotic therapy (MCN) in 10, laparocopic
enucleation in 27 and laproscopic sub-segmentectomy in 19 patients. RESULTS:
A),The frozen pathological diagnosis revealed HCC in 8, NPC in 2, metastastic
adenocarcinoma in 2, and nodular hyperplasia in 3 cases. Laparoscopic tumour
ablation will be followed simultaneously. B), Those patients were treated with
these methods with mild morbidity and no mortality. Recurrent tumour was
found at the resection site in two of the enucleation group. CONCLUSION:
Laparoscopic examination could provide an accurate diagnosis. If it proved
malignancy, further procedures such as laparoscopic tumour ablation could be
performed without delay.
P086
Endothelin1, ET-A & ET-B receptor mRNA expression in human hepatocellular
cancer cell lines
AT Abraham, SR Shah, D Spalding,Y Sirivatanauksorn and BR Davidson 
Royal Free & University College School of Medicine, Surgery, London, United
Kingdom
AIM:To study the expression of endothelin1 (ET-1) and its endothelin A (ETa-
R) and endothelin B (ETb-R) receptors in human hepatocellular cancer (HCC)
cell lines. METHODS: Total mRNA was extracted from 6 human HCC lines
(C3A, Hep3B, hepG2, Huh7, PLC/PRF/5, SkHep1) by the guanidium-thiocyanate
method. cDNA was synthesized using AMV reverse transcriptase and amplified
using previously reported primers. Reverse transcription and polymerase chain
reaction (RT-PCR) products were run in 1.5% agarose gel and visualized by
ethidium bromide under UV illumination. RESULTS: Expected products for ET-
1 (462 bp) and ETa-R (367 bp) were seen in all 6 HCC lines studied(100%).ETb -
R mRNA was only demonstrated in 1/6 lines(16.6%) . CONCLUSION:
Endothelin and its receptors may play a role in the regulation of hepatocellular
carcinigenesis.We have demonstrated the expression of mRNA for ET-1 and
ETa-R for the first time in these human HCC cell lines.
P087
Complications of liver tumours surgery
W Nowak,T Popiela, J Kulig, J Skuciñski and G Mocny
Ist Department of General and GI Surgery, Jagiellonian Univeristy, 31501
Kraków, Kopernika 40 Str., Poland
The study aimed at evaluating the complications of liver tumours surgery.
Between 1985-2000, 130 patients (62 males, 69 females; mean age 59,4 yrs)
with liver tumours were subjected to surgery.The indications included metas-
tases to liver in 53 cases, liver tumours in 31, angiomas in 16, cysts in 20, and
other benign lesions in 10. Primary tumour foci giving metastases to liver were
localised in colon (46 patients), stomach (3), and in single cases in pancreas,
ovary, breast, appendix, respectively.A total of 24 extended right hemihepatec-
tomies (2 with criotherapy), 14 extended left hemihepatectomies, 13 right and
13 left hemihepatectomies (1 with criotherapy), 25 criotherapies, and laparo-
scopic cyst fenestrations were performed in the study group.After 95 resective
procedures, bile leaks occurred in 6 (6.3%) patients. They resolved sponta-
neously in 4, and in another 2 disappeared after endoscopic papillotomy of
Vater papilla to decompress bile ducts. Seven (7.3%) patients subjected to
extended resections due to malignant lesions died postoperatively.Direct cause
of death in 6 of them was haemorrhagic diathesis caused by insufficiency of
remaining parenchyma, and respiratory and circulatory failure in 1 case. No sig-
nificant complications were observed after criotherapy and liver cyst fenestra-
tion. In the patients subjected to criotherapy, drainage persisted for 7-20 days,
and temporary bile leaks (5-12 days) developed in 5 patients after fenestrations.
Liver surgery procedures are safe methods of treating liver tumours. Up to
date, the most frequent complication is insufficiency of the remaining parenchy-
ma manifested by haemorrhagic diathesis leading to death. For this reason, care-
ful examination of the liver parenchyma efficiency is necessary before taking
decision as to the type of surgery.
P088
Hepatocellular carcinoma (HCC): role of transcatheter arterial chemoem-
bolization (TACE) before liver resection (LR)
G Nuzzo, F Giuliante, I Giovannini, M Vellone and M Di Mugno
Catholic University, General Surgery, Hepato-biliary Surgery Unit, ROME, Italy
Effects of TACE on improving long term survival of patients with HCC treated
with LR is still controversial. We analysed and compared retrospectively the
results in patients with HCC treated only with LR and in those treated with
TACE (with carboplatinum and lipiodol) before LR. Sixty patients with HCC
underwent 62 LR between 1992 and 2000.Nine patients, all with cirrhotic liver,
underwent TACE before LR (7 minor and 2 major resections). There were 8
men and 1 female (mean age 58 years; range 37 - 69); mean size of tumour was
4.7 cm (range 1.8-11); mean interval between TACE and LR was 1.8 months
(range 1-4). The other 51 patients, 44 with cirrhosis and 7 with healthy liver,
underwent LR directly.There were 40 men and 11 female (mean age 62 years;
range 12-78).Twenty-three major resections (43.4%) and 30 minor resections
(56.6%) were performed (in 2 patients a second LR was performed after 31 and
63 months, respectively). Overall intraoperative mortality was nil; overall post-
operative mortality was 6.4% (4/62 resections): 4 patients (7.5%) in the LR
group, and 0 in TACE + LR group [p=NS].The overall 1-, 3-, and 5-years survival
rates did not differ significantly: 76%, 45% and 32% for patients only resected,
89%, 78% and 31% for patients who had preoperative TACE [p=NS]. In our lim-
ited experience with preoperative TACE, this technique did not improve signif-
icantly overall survival after liver resection for HCC.
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Glutathione s-transferase GSTM1 and GSTT1 polymorphisms: no influence of
the null genotypes in Sporadic colorectal carcinoma risk
IFSF Boin, H Nascimento, CSP Lima, CS Coy, LS Leonardi and FF Costa
FCM - State University of Campinas, Surgery / Hematology Centre, Campinas,
Brasil
Glutathione S-transferases (GST) modulate the effects of exposure to various
cytotoxic and genotoxic agents. Differences in carcinogen metabolism may
explain differences in cancer susceptibility. Both GST mu 1 (GSTM1) and theta
1 (GSTT1) genes have a null variant allele where the entire gene is absent.
Here, we tested whether null genotypes for GSTM1 and GSTT1 genes altered
the risk for sporadic colorectal carcinoma and liver metastasis. Genomic DNA
from 41 patients with sporadic colorectal carcinoma (22 male, 19 female; 62.0
+/-14.3 years) was analysed using polymerase chain reaction (multiplex-PCR)
from August 1999 to January 2001.The control group consisted of 204 con-
secutive blood donors (165 male, 39 female; mean age: 53.8 +/-3.1 years) from
the same university hospital in order to provide a representative group of the
general populations seeking medical assistence in this region. Frequencies of
GSTM1 (48.8%) and GSTT1 (14.6%) null genotypes in colorectal carcinoma
patients were similar to those observed in controls (46.1% and 12.2% respec-
tively). No differences in the null combined genotype frequencies were also
observed in colorectal carcinoma patients or metastasis and controls (12.2%
compared with 7.8%). Observation of a 1.11 (95% CI: 0.54 - 2.30) and 0.86-fold
(95% CI: 0.30-2.35) risk associated with GSTM1 and GSTT1 null genotypes,
respectively (p=0.88 and p 0.92) and a 1.63 - fold (95% CI: 0.49-5.16) risk asso-
ciated with the combined null genotype (p 0.88) suggests that the inherited
absence of this carcinogen detoxification pathway may not be a determinant of
sporadic colorectal carcinoma.
P090
Hepatocellular carcinoma occurrence 12 years after hepatoblastoma in the
same patient with familial adenomatous polyposis
F Cetta1, M Gori1, M Zuckermann1, G Montalto1, R Boldrini2 and C Bosmann2
1University of Siena, Institute of Surgical Clinics, Siena, Italy
2Bambin GesÃ? Hospital, Department of Pathology, Rome, Italy
Hepatoblastoma (HB) is an embryonic tumour, usually occurring before age 2.
It includes epithelial as well as mesenchymal components and it has been pos-
tulated that both might develop from the same pluripotent stem cell. Patients
with familial adenomatous polyposis (FAP) have a germ-line mutation in the
APC gene, mapped at 5p21, and show a markedly increased incidence of HB
(relative ratio >1: mil) and a slightly increased incidence of mature hepatocel-
lular carcinomas (HCCs) or other primary liver tumours. Recent study from
our institution on the relative prevalence of b -catenin gene alterations in HB in
different liver tumours showed b -catenin mutations in 67% of HBs, 19% of
HCC, whereas no mutations were found in cholangiocarcinomas.Nuclear over-
expression of b -catenin in all HBs and in both epithelial and mesenchymal HB
components outlines the crucial role of deregulated Wnt-b -catenin signaling
in malignant transformation of hepatic precursor cells. Here we report a FAP
female patient belonging to a kindred with a germ-line APC mutation at codon
1061, who had HB at age 2 and 12 years after right liver lobectomy plus
chemotherapy, developed mature HCC in liver remnant (segment IV). This is
the first FAP patient with both tumours at different ages. Findings in this patient
could be of interest for a better knowledge of the effects of the deregulated
APC-Wnt- b -catenin signaling in the liver tissue in various age periods (prena-
tal, childhood) and maybe show a different cooperation of the germ-line APC
mutations with other oncogenetic factors in different periods of life.
P091
The effect of lipopolysaccharide pretreatment in the prevention of bacterial
translocation in acute necrotizing pancreatitis
C Kucuk1, I Soyuer2,A Bedärlä1, S Gãkahmetoälu3, M Tellä3 and M Deneme1
1Erciyes University School of Medicine, General Surgery, Kayseri,Turkey
2Erciyes University School of Medicine, Pathology, Kayseri,Turkey
3Erciyes University School of Medicine, Microbiology, Kayseri,Turkey
This study was aimed to examine whether low dose LPS could affect bacterial
translocation (BT) in acute pancreatitis (AP). Rats were divided into three
groups, LPS, control and sham groups. AP was induced in LPS and control
groups by pressure injection of 5% taurocholate into the biliopancreatic duct
(1.5 mL/kg). LPS rats received LPS (50 mg/kg, ip); control and sham rats received
a similar volume of saline as placebo 24 hours before the induction of pancre-
atitis.At 24 hours postoperatively, blood was drawn from periphery and portal
ven for culture, serum AST,ALT, LDH, amylase, endotoxin and TNF-alpha deter-
minations. Specimens from MLNs, spleen, liver and cecum were harvested for
culture.There was no difference in serum AST,ALT, LDH and amylase levels and
the mean pancreatic histology score between LPS and control, respectively.All
these parameters were significiantly higher in the LPS and control groups com-
pared with sham group. Serum TNF-alpha and endotoxin level were higher in
control and LPS groups compared with sham group and were lower in the LPS
group compared with control group. Five of 7 LPS rats had BT to MLNs, com-
pared with 6 of 7 rats in control. Four of 7 LPS rats had BT to distant sites such
as spleen, liver, and/or blood, compared with 7 of 7 rats in control. Low dose
LPS treatment decreases bacterial spread to distant sites, increases serum TNF-
alpha and edotoxin levels but does not reduce serum amylase, AST,ALT, LDH
levels or ameliorate pancreatic damage in rats with AP.
P092
Possibilities of procalcitonin (PCT) test and laparoscopy in diagnosis and treat-
ment of acute pancreatitis
M Pavars,A Irmejs, U Maurins and J Gardovskis 
Medical Academy of Latvia, Department of surgery, Riga, Latvia, Sweden
INTRODUCTION: Aim of our study was to evaluate role of PCT test and
laparoscopy in diagnosis and treatment of severe acute pancreatitis. MATERI-
AL: 11/1998 - 11/2000 were treated 53 patients (30 male, 23 female,median age
42,5) with severe acute pancreatitis (27 - toxic pancreatitis, 26 - biliary pan-
creatitis).METHODS: For all 53 patients PCT tests were performed, totally 161
immunoluminimetric analysis. 28 patients were operated, 24 of them laparo-
scopically (4 - toxic pancreatitis, 20 - biliary pancreatitis). RESULTS: From 161
PCT tests in 106 cases (65.9%) results were normal, in 44 cases (27.3%) slight-
ly elevated, in 7 cases (4.5%) moderately elevated and in 4 cases (2.3%) highly
elevated. For all 14 patients with elevated PCT level presence of septic focus
was confirmed. Median hospitalization time in the group of operated patients
was 17 days, but in laparoscopically operated patients 11.1 days. In 4 cases
laparoscopic opening and drainage of lesser sac, 21 cases laparoscopic drainage
of abdominal cavity, 17 cases laparoscopic cholecystectomy, 6 cases laparo-
scopically assisted jejunostomy were performed. In laparoscopic group conver-
sion rate 5/24 (21%); complication rate 1/19 (5%); no mortality. Overall mor-
tality 2/53 (3,7%). CONCLUSIONS: 1) Level of procalcitonin strongly corre-
lates with the presence of septic foci. 2) Laparoscopy in treatment of severe
acute pancreatitis is technically possible, decreases operation trauma, improves
postoperative recovery and is good alternative to open procedure.
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Scheduled relaparotomies in the treatment of infected pancreatic necrosis
A Karamarkovic1, M Mitrovic, M Sukalo and V Djukic
1Universitu Centre for Emergency Surgery, Dpt. for Surgical infection and
Sepsis, Belgrade,Yugoslavia,Argentina
The diagnosis of infected pancreatic necrosis is an indication for surgical treat-
ment. Massive necrotic changes of pancreas with consecutive infection are irre-
versibile, and at the same time they are the source of both local and systemat-
ic septic complications accompaning the disease. Since it is impossible to inter-
rupt autodigestion process, necrossis and infection with flegmonous and
abscendens changes, within a single surgical procedure, scheduled reoperations
with temporary abdominal closure, has become practically unavoidable step in
surgical treatment of infected ANP. Placement of abdominal glider (ETZIP) and
planned relaparotomy every 24-48 hours enabled permanent control of infect-
ed and necrotic process, by daily lavage, debridement and evacuation of necrot-
ic and septic matherial. During the period from June 1996 to September 1999
the total number of 237 scheduled reoperations were performed, on 74
patients with confirmed diagnosis of infected necrotic pancreatitis.
Decompression gastrostomy and feeding jejunostomy was standard procedure
in 84%. Median value of APACHE II score was 19 points. Observed mortality
rate in the group treated by scheduled reoperations approach was 28%. In the
group of patients treated by single operation, mortality rate was 36%.
Temporary closure of the abdomen enables the permanent monitoring of
necrotic septic focus and prompt recongition and sanation of complications.
Feeding jejunostomy prevent bacterial translocation from the gut into the
necrotic pancreatis tissue, and support nutritive status. Immediate therapeuti-
cal results of the method and it’s associated mortality rate are encouraging
when compared to the group treated by single operation.
P094
Laparoscopic techniques in treatment of acute pancreatitis
VI Mamchich,VI Palamarchuk and AI Tarahonich 
Kiyv Medical Academy for Post-Graduate Education, Ukraine
The investigation is dedicated to laparoscopic techniques applying in treatment
of patients having serious forms of acute pancreatitis.The comprehensive treat-
ment 244 patient with the serious forms of acute pancreatitis is executed. 92
patients were treated conservatively, 87 patients were operated, in treatment
of 65 patients applied laparoscopie.The number of the women was insignificant
prevailed - 128 (52,46 %).The middle age of the patients was 50,55 years.The
cause of an acute pancreatitis were specified in 85,25 % of cases: biliary - 128
(52,46 %), alcoholic - 63 (25,82 %), trauma or operation - 17 cases (6,97 %).
Laparoscopie has the diagnostic and therapeutic objective: laparoscopie diag-
nostic - 14, supragastric pancreatoscopie - 6, infragastric pancreatoscopies - 43,
laparoscopic cryolysis - 18, laparoscopic hypothermia - 33, peritoneal dialysis -
31, external drainage of biliary system - 40, laparoscopic drainage of pseudo-
cyst- 6, ablation of necrsequestration – 6, conversation of laparoscopie in oper-
ation - in 18 cases. On the CT-data the pathological process was located direct-
ly under peritoneum in 31 patients, in their treatment peritoneal dialysis is
applied. The significant decrease of SAPS-valuation for 3 day of the dialysis (p
= 0,039) is marked in 21 patients. Laparoscopic cryolysis of pancreas necrosis
centres decrease significantly SAPS-valuation for all 18 patients. Lethal out-
comes in the group with laparoscopic treatment were in 7 patients with seri-
ous forms of acute pancreatitis, 4 of that had more then 6 Ransons criteria’s.
P095
Cytokine-dependent acute phase response in severe pancreatitis
A Perejaslov, S Chooklin and Y Detsyk
Medical University, Department of Surgery, Lviv, Ukraine, Russia
Interleukins (IL) 1 and 6 are the powerful proinflammatory cytokines play an
important role in pathophysiology of acute pancreatitis. IL-1 induces the syn-
thesis of I type acute phase proteins, such as CRP, while IL-6 induces the syn-
thesis of acute phase proteins II type, such as fibrinogen, a -antitrypsin (a -AT).
Due to this, the levels of IL-1ï¥¢, IL-6, CRP, fibrinogen and a -AT were studied
in 86 patients with acute pancreatitis, divided on two groups: 1st group of 48
with mild and 2nd group of 38 with severe pancreatitis. In patients with severe
acute pancreatitis, the significant increase of IL-1ï¥¢ (8.5±0.6 pg/ml), IL-6
(522.7±104.4 pg/ml) and a -AT (2.14±0.05 g/l) levels were noted after admis-
sion. CRP and fibrinogen was peaked on the third day (17.3±1.1 mg/dl and
5.39±0.25 g/l, accordingly). The decrease of IL-6 level with the simultaneous
lowering of a 1-AT level was observed on the third day. On the seventh day the
insignificant increase of IL-6 level (144.9±2.1 pg/ml) accompanied by increase of
a -AT level was noted. In patients with the mild pancreatitis, the initial level of
IL-1ï¥¢ (3.3±0.7 pg/ml) and IL-6 (119.6±1.8 pg/ml) was obviously lower, than in
patients with severe pancreatitis (p<0.05) .Accordingly, the levels of CRP, a -AT
and fibrinogen also were lower (8.24±0.35 mg/dl, 1.34±0.02 g/l and 4.06±0.21
g/l).At the subsequent days, the moderate increase of IL-6 and a -AT levels was
observed. Thus, the severe course of acute pancreatitis characterises by the
appearance of markers of systemic inflammatory response in blood.
P096
Evaluation of efficacy of endoscopic sphincterotomy on acute biliary pancreati-
tis
S Chooklin,V Fedoriv and A Perejaslov 
Medical University, Department of Surgery, Lviv, Ukraine, Russia
Choledocholithiasis is the main cause of the development of acute biliary pan-
creatitis.At the same time, the discussion of the role of the endoscopic retro-
grade sphincterotomy in the management of acute biliary pancreatitis still con-
tinued. For the comparative evaluation of the methods of the surgical manage-
ment, analyzed results of treatment of 74 patients (age ranged from 18 to 84
years) with acute biliary pancreatitis.All patients were divided on two groups:
1st - compiled 36 patients, in which endoscopic cholangiography and papil-
losphincterotomy was performed; 2nd - compiled 38 patients underwent con-
ventional laparotomy.According the Atlanta criterion (1992) the mild pancre-
atitis established in 25 patients of the first and 26 patients of the second group,
severe pancreatitis in 11 and 12 patients, accordingly. Endoscopic interventions
were applied during first 72 hours after admission, laparotomy during first
week. Did not observe complications after endoscopic sphincterotomy, obvi-
ously faster normalized the biochemical indices (total bilirubin, amylase, alkaline
phosphatase plasma levels), what is necessary for the subsequent laparoscopic
chelecystectomy. Only in three patients were observed complications after
laparoscopic chelecystectomy, at the same time in 13 patients the various com-
plications were noted after conventional management.Thus, the surgical man-
agement of acute biliary pancreatitis with early endoscopic sphincterotomy
with subsequent laparoscopic chelecystectomy is effective and safe.
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P097
Cytokine regulation in the serum of rabbits with bile acid-induced experimen-
tal acute pancreatitis (measured by western blotting and anti-human cytokine
antibodies)
M Osman1, G Gesser2, SL Jensen3 and CG Larsen2
1Dept.of HPB Surgery, National Liver Institute, University of Menoufiya, Egypt
2,3Depts. of Dermatology and Surgery,Aarhus University Hospital, University of
Aarhua, Denmark
Several cytokines have been implicated in the pathogenesis of severe acute pan-
creatitis (AP) and the development of its systemic complications. In most stud-
ies of AP, cytokine measurements are performed either by enzyme linked
immunoassay (ELISA) or polymerase chain reaction (PCR) for the mRNA lev-
els. AIM: By using the Western blotting (WB) technique we demonstrated the
pattern of 7 different human cytokines in the serum of rabbits after the induc-
tion of AP, compared with their pattern after pretreatment with an IL-10 ana-
logue (IT9302) or a monoclonal anti-IL-8 antibody (WS-4). METHODS:AP was
induced by the retrograde injection of 5% chenodeoxycholic acid in the pan-
creatic duct of rabbits followed by duct ligation. Control rabbits (n=10)
received physiologic saline and pretreated rabbits received IT9302 (n=10) or
WS-4 (n=8) 30 mins before the induction of AP.The following cytokines (IL-1b,
IL-2, IL-4, IL-8, TNF-a, IRAP, MCP1/MCAF) were studied for their regulation
during the early 12 hours by using WB technique . RESULTS:The inflammatory
cytokines IL-8, IL-1b, TNF-a, and MCP1/MCAF were induced during AP.
Pretreatment with IT9302 and WS-4 caused inhibition of these cytokines. In
contrast, IRAP (IL-1 receptor antagonist protein) was up-regulated after
IT9302, but not after WS-4. Similarly, the administration of WS-4 induced serum
levels of IL-4, which is known as an anti-inflammatory cytokine. Further, the 12-
hour survival was significantly better among rabbits pretreated with either
IT9302 or WS-4 than among controls. CONCLUSION:The serum IL-10 ana-
logue IT9302 and the mon-IL-8 antibody are able to modulate AP in a rabbit
model by down-regulating the pro-inflammatory cytokines (IL-1b, IL-8,TNF-a)
and by inducing the anti-inflammatory cytokines (IL-4 and IRAP) in the serum.
This immunomodulation may have beneficial effects on the outcome of severe
AP, concerning survival and development of systemic complications in this
model of AP.
P098
Significance of immune disturbances in acute pancreatitis
G Akhaladze1, E Galperin1, A Simonova2, T Dyuzheva1, K Dokuchaev1 and B
Aliev2
1Moscow Medical Sechenov Academy, Department of Liver Surgery, Moscow,
Russia
2Institute of Immunology, Moscow, Russia
OBJECTIVE: Definition of immune disturbances role in acute pancreatitis sep-
tic complications development . STATEMENT OF FINDINGS: Comparative
study of immune state was carried out in 30 acute pancreatitis (9 female and
21 male in age of 18-56 years) patients and 10 healthy donors.Absolute (thou-
sand) and percentile amount of leukocytes, lymphocytes, CD4+, NK, B-lym-
phocytes (by means of laser cytometry), spontaneous and stimulated chemilu-
minescence of polymorphnuclear neutroplils (PMN), IgA, IgM, IgI (Manchini
method) was evaluated in 3 groups of patients: toxaemic (10), retroperitoneal
phlegmona (11) and parapancreatic abscess (9). In toxaemic stage PMN aggres-
sive activity (stimulated chemiluminescence - 408.3±14.2 versus 200.5±42.0,
p<0.05 in donors and spontanous - 64.5±1.5 versus 40.2 ±2.2 in donors, p<
0.05) was accompanied with lymphopenia (14.3±1.2 versus 28.5±3.5 in donors,
p<0.05) that was considered as cell migration towards inflammation locus. In
patients with retroperitoneal phlegmona in comparison to those with para-
pancreatic abscess significantly increased CD4+ (983.8±58.6 versus
575.7±34.4,p<0.05) , IgA (396.6±11.5 versus 311.7±16.6, p<0.05) and PMN
spontanous chemiluminescence (72.4±1.3 versus 64.5±1.5 p<0.05) and
decreased B-lymphocyte (94.4±5.8 versus 147.8±17.8, p<0.05) and NK
(6.4±0.2 versus 14.3±1.5,p<0.05) amount. CONCLUSIONS: 1) in toxaemic
stage of acute pancreatitis are already displayed severe immune disorders; 2)
development of retroperitoneal phlegmona is associated with deeper immune
deficiency then abscess formation.
P099
Long-term risk of recurrent pancreatitis in patients with acute biliary pancre-
atitis treated by endoscopic sphincterotomy alone
I Virlos, GC Beattie and AK Siriwardena
Manchester Royal Infirmary, Department of Surgery, Manchester, United
Kingdom
OBJECTIVE: Cholecystectomy is accepted as definitive treatment for acute bil-
iary pancreatitis (AP) with endoscopic cholangiography plus sphincterotomy
(ERCP+ES) being reserved for patients with significant co-morbidity. The aim
of this study is to assess the long-term risk of recurrent AP in patients with an
index attack of biliary AP treated by ERCP+ES alone. METHODS: 203 patients
with a discharge diagnosis of biliary AP identified from Lothian Surgical Audit
database during November 1994 to August 1999 constitute the study popula-
tion. Biliary AP was defined on the basis of ultrasonographic demonstration of
gallstones, biochemical evidence of biliary obstruction, ERCP or operative find-
ings. 134 (66%) underwent cholecystectomy during or shortly after their index
admission. 41 (20%) were treated by ERCP without cholecystectomy with 18
of these undergoing ERCP alone and 23 ERCP+ES.The median age of the chole-
cystectomy group was 59 years (29-92) compared to a median of 72 (37-91)
years for the ERCP group [P<0.05 U-test]. 28 patients underwent no biliary
intervention (these patients either declined intervention or were transferred
elsewhere). Data are presented as median (interquartile range). RESULTS:
During a median follow-up of 36 (3-57) months, 3 (2%) of the cholecystecto-
my group were re-admitted with biliary problems: 2 with AP (1.5%) and 1 with
duct stones. 1 (6%) in the ERCP without ES and 2 (9%)of the ERCP+ES group
had recurrent AP. Overall, recurrent AP after ERCP occurred in 3 (7%)[P<0.05
vs cholecystectomy; U-test]. CONCLUSIONS: This study demonstrates that
after ERCP+ES there is an appreciable risk of recurrent biliary AP.
P100
Identification of aspects of the treatment of acute pancreatitis where there is
consistent divergence from current national guidelines
I Virlos, J Barnard and AK Siriwardena 
Manchester Royal Infirmary, Dept of Surgery, Manchester, United Kingdom
INTRODUCTION: Current national guidelines provide a framework for the
initial management of acute pancreatitis. Although several units have reported
comparisons of performance against these guidelines a national overview is
required to identify areas of consistent divergence from guideline standards.
METHODS:A search of MEDLINE (using the keywords acute pancreatitis; man-
agement; audit) yielded 1 audit. Examination of published abstracts from all
major national surgical gastroenterological meetings held in the United
Kingdom since publication of the guideline document yielded 3 further audits.
No audit was included more than once and audits were only included if a full-
published abstract was available. Data included at the time of presentation but
not available for analysis in the published abstract were also excluded. Data
from these audits compared to audit standards. Results: Four audits providing
pooled data on 445 patients were identified. Overall mortality from severe
acute pancreatitis was 11% (4-17%). Definite treatment of gallstone disease
within 4 weeks was performed in 49% (16-65%) [guideline recommendation
100%]. High Dependency or Intensive Care facilities were available in 52% (20-
100%) [recommendation 100%]. Urgent endoscopic cholangiography (ERC)
was available in 25% (12-41%) [recommendation 100%]. CONCLUSION:
Accepting that pooled data is not a substitute for a national overview, this study
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provides evidence of striking divergence from guidelines standards in the cur-
rent management of acute pancreatitis in the United Kingdom.The finding of
national variation in issues such as the availability of High dependency facilities
and access to operating theatres for 2index-admission cholecystectomy has
potential implications in the provision of services for patients with acute pan-
creatitis.
P101
Pancreatolithiasis: is resection procedure a treatment of choice?
B Kudra,T Popiela and M Sierzega
Jagiellonian University Krakow, Ist Department of General and GI Surgery,
Krakow, Poland
During the period between 1980 and 2000, 686 patients were treated for
chronic pancreatitis at Ist Department of General and GI Surgery. Five hundred
forty-one patients (79.9%)) received conservative therapy and 145 (21,1%)
underwent operative procedures.The indication for surgery in 21 (14,4%) cases
was pancreatolithiasis. Median age of the patients was 38 yrs, and males to
females ratio 2,6.The diagnosis was established on basis of plain abdominal radi-
ography, USG, ERCP and computer tomography. In 5 cases (23,8%) performed
imaging studies revealed presence of pancreatic pseudocyst. Abdominal pain
syndrome was present in 21 cases (100%), eight patients (38%) required high
doses of opiates. Endocrine insufficiency was present in 3 cases. Medium dura-
tion of symptoms was 5 years. Eleven patients underwent subtotal pancreatec-
tomy, total pancreatectomy was proceeded in 6 cases and one patient under-
went pancreatoduodenectomy (Whipple’s resection).The postoperative com-
plication ratio was 28%: pneumonia in 5 cases and intra-abdominal abscess in
one case. Insulin-dependent diabetes mellitus occurred in 7 patients (33%) in
the postoperative course. Complete relief of pain after resection procedure
was present in 18 cases (85,7%). In the remaining three cases (14,2%) significant
decrease of administered analgesic drugs was observed. Our studies indicate
that resection procedures are the treatment of choice in chronic pancreatitis
coexisting with formation of pancreatic duct stones, endocrine insufficiency and
intractable pain syndrome.
P102
Quality of life in chronic pancreatitis: results after duodenum-preserving resec-
tion of the head of the pancreas
J Fronek, M Ryska, F Belina and R Strnad
Institute for clinical and experimental medicine,Transplant surgery department,
Prague 4, Czech Republic
Selection of the type of the surgical procedure in chronic pancreatitis (CP) still
remains to be a subject of controversy:Whipple resection vs. duodenum-pre-
serving head resection. Studies on CP have focused predominantly on pain
measurement, morbidity and mortality. European organisation for Research and
Treatment of cancer (EORTC) quality of life questionnaire (QLQ) was reeval-
uated for patiets suffering from CP.Material:We performed a total of 113 pro-
cedures for CP (1998-2000) ; out this number 33 were duodenum-sparing pan-
creatic head resections according to Frey.The QLQ and the pain score were
assessed once before surgery and six months after surgery. Follow-up ques-
tionaire filled in 20 (66,6 %) patients, 10 (33,3 %) patients did not accept the
follow-up.After six months physical status and working ability was the same as
before surgery, emotional and social functioning , and global quality of life had
improved by 16,6, 5,7 and 24,6 %. Results:The pain score decreased by 60,3 %
(p 0.001).The EORTC quality of life questionnaire represents a valid measure
of quality of life in patients with CP. Conclusions: Our intra-operative results
are inferior to those reported by international centres, the quality of life and
the pain score are six months after surgery better than before surgery. Patients
are indicated for surgery late after all alternative therapeutic options have
failed.
P103
Distal pancreatic injuries from blunt abdominal trauma: early versus delayed
diagnosis and surgical management
A Issekutz,A Olah, G Pardavi, B Toth-Gombkoto, L Haulik and P Banga
Petz A.County Teaching Hospital, Surgery, Gyor, Hungary
Pancreatic trauma is relatively uncommon, but carries high morbidity and mor-
tality rates, especially when diagnosis is delayed or inappropriate surgery is
attempted. The clinical course and surgical management of 10 patients with
pancreatic transsection without (grade II according AAST score) and with main
pancreatic duct (MPD) injury (grade III) caused by blunt abdominal trauma
were analyzed in a university teaching hospital.Average age of the patients was
27,3 years. Five patients had isolated pancreatic trauma, other 5 had associated
intra- (2,4) or extraabdominal (0,8) injuries. Five patients were diagnosed and
operated within the first 24 hours. Four of them had complete transsection
with main pancreatic duct injury, in whom distal pancreatectomy with (1) and
without (1) splenectomy, distal pancreato-gastrostomy (1), and pylorus-pre-
serving pancreatoduodenectomy (PPPD) (1) were performed. In one case
(grade II) only external drainage was necessary. All the five patients were
alived. From the other five cases four patients were referred after initial treat-
ment elsewhere (underwent some kind of external drainage), and in one
patient the diagnosis of pancreatic injury was missed at initial operation in our
hospital. Three had undetected MPD injury, in two cases the parenchymal
lesions were underestimated or missed.All of them required subsequent resec-
tion (1), internal drainage due to fistula (2), or drainage of developed abscess
(2).Three of them had severe septic and pulmonary complications; one patient
with MPD injury was lost. Patients requiring delayed surgical intervention after
an unsuccessful period of observation or a subsequent operation due to unde-
tected MPD injury demonstrated higher pancreas-specific mortality and mor-
bidity rate and notably longer hospitalization.
P104
Three-dimensional sonography in the diagnosis of pancreatic pseudocysts
JR Ladny1, Z Puchalski1, J Polakow2 and M Kokoszko1
1Medical Academy of Bialystok, 1st Department of General Surgery, Bialystok,
Poland
2Medical Academy of Bialystok, Department of Radiology, Bialystok, Poland
At present a preliminary diagnostic method of the pancreatic pseudocysts is
two-dimensional sonography in majority of the hospitals. In our study we eval-
uated the usefulness of three-dimensional sonography in diagnosis of the pan-
creatic pseudocyst, especially its capability of visualizing anatomical features of
the wall and determining its reference to other anatomical structures. We
examined 52 patients diagnosed as having pancreatic pseudocysts on the basis
of clinical symptoms and two-dimensional ultrasonography findings. Then on
the basis of two- and three-dimensional scans results the decision to qualify
certain patients for the percutaneous fine-needle aspiration guided by ultra-
sonography was made. Next color Doppler was implemented in order to visu-
alize all blood vessels at the planned biopsy site.Three-dimensional sonography
was used to monitor the tip of the needle making its way to the pancreatic
pseudocyst and later inside the fluid 
collection. Pancreatic pseudocysts were diagnosed in all of the 52 cases.Three-
dimensional sonography was more precise in visualizing the shape and size than
two-dimensional ultrasound scans. In our investigation we have shown that
three-dimensional sonography can better visualize irregular shapes, local thick-
enings, calcifications of pseudocyst walls than classical, two-dimensional scans.
It did not failed when two-dimensional sonography was already of any help.We
strongly feel this technique when used on a routine basis ought to help us in
changing the inclusion criteria for guided biopsies and at the same time should
made the aspiration procedures much safer. This method can potentially
increase the specificity of ultrasonography in the diagnose of pancreatic
tumours.
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P105
Thoracoscopic splanchnicectomy for the relief of intractable upper abdominal
pain
IY Park1, KH Lee, GY Sung, MH Song, DS Lee,W Kim and JM Won 
1Catholic University of Korea, Surgery, Pucheon-City, Korea
Intractable abdominal pain is the most distressing feature of chronic pancreati-
tis. Many methods including powerful analgesics, celiac plexus block, surgical
splanchnicectomy are provided for the relief of the pain.Anatomical interrup-
tion of the major afferent pain nerve is indicated in severe refractory cases.
Recently, it appears that thoracoscopic splanchnicectomy may replace open
surgery and become the treatment of choice for the relief of pain. We per-
formed thoracoscopic splanchnicectomy in 5 patients (3 male, 2 female) for the
relief of pain due to chronic pancreatitis(2), pancreas cancer(2),stomach can-
cer(1). Under the double-lumen intubation, 10 mm thoracoscope was intro-
duced into the intercostal space and two 5 mm cannulars were introduced
under the direct thoracoscopic vision.The splanchnic nerves, at the level from
T5 to T11 thoracic symphathetic ganglia were resected. Mild subcutaneous
emphysema was developed temporarily but subsided. In chronic pancreatitis,
standard 10-point visual analogue scale (VAS) decrease from 10 to 0 and they
no longer required narcotics. In pancreas and stomach cancer patients, VAS
decreased and the need for narcotics was reduced, but pain was recurred.
Thoracoscpic splanchnicetomy may be safe and effective procedure for the
relief of intractable upper abdominal pain especially in chronic pancreatitis. But
we had only a few cases so further study will be needed.
P106
Conservative management of pancreatic pseudocysts: factors predicting suc-
cessful outcome in a long-term follow-up
M Sierzega, B Kädra and T Popiela
Jagiellonian University Krakow, Ist Department of General and GI Surgery,
Krakow, Poland
Introduction: Pancreatic pseudocysts are considered as a relatively common
complication resulting from pancreatitis. Recent data suggest that in some cases
conservative therapy may lead to successful resolution of pseudocyst.The aim
of this study was to assess the effectiveness of conservative management of
pancreatic pseudocysts and to identify the factors predicting successful out-
come. PATIENTS AND METHODS:We performed a retrospective analysis of
35 patients who underwent conservative therapy of pancreatic pseudocyst
from 1986 to 1999. Data on demographics, clinical presentation, pseudocyst
features, diagnostic evaluation and late outcome were obtained.The definition
of pancreatic pseudocyst formulated by Atlanta International Symposium was
applied retrospectively to US and CT findings. Successful therapy was defined
as pseudocyst resolution confirmed in control US; failure meant pseudocyst
requiring further therapy. RESULTS: Of 35 patients treated, conservative thera-
py was successful in 9 (25.7%) cases (group I) while 26 patients (74.3%)
required further interventions (group II). The mean age, sex and etiology of
pseudocyst did not differ between groups. Similarly neither pseudocyst location
nor features of pancreatic fibrosis found at ultrasonography had prognostic
value.The only factor predicting failure of performed therapy was pseudocyst
diameter, which was significantly higher in group II (8.0+/-4.6cm) compared to
group I (4.4+/-1.3cm); (p <0.05).The mean time of hospitalization and follow-
up were 15 days and 20.6 respectively months without differences between
both groups. CONCLUSIONS: Performed analysis suggests that conservative
therapy of pancreatic pseudocysts may by successful only in selected group of
patients with small lesions.
P107
Somatostatin vs. octreotide in the treatment of patients with gastrointestinal
and pancreatic fistulas
V Paizis1, D Milonaki2, P Antonakis3, S Katsaragakis4, I Gomatos5, MM
Konstadoulakis6 and G Androulakis7
1University of Athens, Ippokration Hospital, Laboratory of Surgical Research,
Aâ ™ Department of Propaedeutic Surgery, Old Psihiko, Greece
Gastrointestinal and pancreatic fistulas represent serious complications after
abdominal surgery and are associated with significant morbidity and mortali-
ty. The role of somatostatin and octreotide in their treatment is a matter of
debate while comparison of these two agents has not been reported until
now.This study was conducted in order to assess and compare the potential
clinical benefit from the administration of somatostatin and octreotide to
patients with gastrointestinal and pancreatic fistulas. Forty-eight patients with
gastrointestinal or pancreatic fistula were randomized, 16 receiving 6000
IU/day of somatostatin intravenously, 17 receiving 100µg tid of octreotide
subcu-taneously and 15 receiving only standard medical treatment (control
group).The fistula closure rate was 81% for the somatostatin group, 65% for
the octreotide and 27% in the controls. These differences were of statistical
significance (p=0.007). Overall mortality rate was less than 5% and statistically
significant differences in mortality between the three subgroups could not be
established.The administration of somatostatin or octreotide to patients with
gastrointestinal or pancre-atic fistula improved the closure rate in comparison
to standard medical treatment. No significant differences between the two
drugs were established.
P108
Hand assisted laparoscopic splenectomy (HALS) in cases of splenomegaly : pre-
liminary comparative analysis with conventional laparoscopic splenectomy
EM Targarona, C Balagué, G Cerdán, JJ Espert,AM Lacy, J Visa and M Trias
Service of Surgery, Hosp. S Pau. UAB, and Hosp Clinic Barcelona, Spain
Laparoscopic splenectomy (LS) is a well-accepted technique for cases with nor-
mal or slightly enlarged spleen. However, the difficulty of LS increases when the
spleen is enlarged because of the manipulation of a big organ into the abdomen.
Recently, some devices have designed to assist laparoscopic procedures with
the hand inserted in the abdomen, while the pneumoperitoneum is maintained.
This device permits to recover the tactile feeling and facilitate the mobilization
and dissection of the organ. Finally, the organ is recovered through the minila-
parotomy. OBJECTIVE:To compare the immediate results of conventional LS
and HALS in cases of splenomegaly. MATERIAL AND METHODS: Between
Feb-93 and January 2001, 179 LS were attempted in 2 surgical units in large
teaching hospitals. In 50 cases a clinical or radiological splenomegaly was
observed with a final spleen weight over 700 g. We compare the first 35
patients operated with conventional LS (Group I, LS) with the last consecutive
15 patients approached by HALS (Group II. HALS). We evaluated operative
time, conversion rate, morbidity and stay. RESULTS:
Group I. LE Group II. HALS p
N 35 15
Age (a) 58 (19–82) 62(44–76) ns
Op t (min) 177 (95–300) 131(85–270) .009
Conversion 20% 7% ns
Transfusion 40% 25% ns
Morbidity 35% 7% ns
Stay 6.3 (3–14) 3.6 (2–7) .05
Reoperation 1/35 (3%) 1/15 (7%) ns
Spleen weight 1425 (700–3400) 1324 (720-3100) ns
Mortality 0 0
CONCLUSION: Hand assisted laparoscopic surgery facilitates significantly the
surgical maneuvers during LS, while keeping the advantages of a purely laparo-
scopic approach.
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P109
Staging of pancreatic head cancer, comparison of UICC and JPN SC
R Strnad, M Ryska and J Fronek
Institute for clinical and experimental medicine,Transplant surgery department,
Prague, Czech Republic
Tumour staging should provide some guidance when selecting the therapeutic
strategy and suggest the prognosis of the disease.Two TNM classifications are
used, UICC and JPN SC. The aim of our study is to compare both methods.
Methods: 84 patients (40 men and 44 women), with mean age 63 years (35 -
82), were operated on for pancreatic head carcinoma.The evaluated group of
patients includes 25 patients (12 men and 13 women), who died after more
then 30 days after the operation. Each patient was classified.We compared sur-
vival rate in responsible groups. Results: UICC TNM classification patients allo-
cated into stage I survived on average 36 weeks, in stage III - 31 weeks, in stage
IVa - 32 weeks (there were allocated tree patients only) and in stage IVb - 17
weeks. Nobody was allocated into stage II. JPN SC patients allocated into stage
I survived on average 47 weeks, in stage II - 32 weeks, in stage III - 44 weeks
(there were allocated two patients only), in stage IVa - 26,8 weeks and in stage
IVb - 15 weeks. Conclusion:The numbers of patients allocated into individual
stages of disease did not allowed to arbitrate between the two classifications
for this time being.Considering the whole group of our patients who was oper-
ated on our department we expect more exact results in few moths.
P110
Comparative analysis of short and long-term survivors after curative resection
for invasive ductal adenocarcinoma of the pancreas
Y Takigawa, K Shimada,T Kosuge, J Yamamoto and S Yamasaki
National Cancer Centre Hospital, HBP surgery division,Tokyo, Japan
INTRODUCTION: The outcome of the surgical resection of Invasive ductal
adenocarcinoma of the pancreas is still dismal.We analyzed the clinicopatho-
logical features between the patients survived 3 years or more after resection
(long-time survivors) and patients who survived less than 3 years (short-time
survivors). PATIENTS AND METHODS: From 1980 to 1996, 118 patients were
resected with the diagnosis of invasive ductal adeocarcinoma of the pancreas.
93 patients obtained grossly curative resection and 25 underwent palliative
resection with grossly residual tumour.Among grossly curative patients, 32 sur-
vived over 3 years in June 1,1996, 61 died within 3 years during the same peri-
ods. Clinical, operative and pathological data were all retrospectively analyzed.
Statistical analysis was performed to evaluate the difference between the long-
term and sort-time survivors. RESULT: Grossly curative patients of all resected
118 patients were 93(78.8%) and actual 5-year survival rate was 28%. 61
patients (65%) survived less than 3 years and 32(35%)survived 3years or more,
including 20 5-year survivors. Univariate analysis of clinicopathological features
showed higher CA19-9, combined resection of PV, longer operation, more
transfused resection, tumour location, latent type, poorly differentiation, larger
size, nerve plexus invasion, paraaortic LN metastasis, histological margin posi-
tive are negative predictors for long-term survivors.Three factors prove inde-
pendently significant analysis and were associated with long-term survival;
absence of PV resection, negative LN metastasis, and negative surgical margin.
CONCLUSION:The patient who can obtain surgical resection with absence of
PV resection, negative LN metastasis, and negative surgical margin is good can-
didate for long-term survival.
P111
Diagnosis and treatment of pancreatic body and tail tumours
E Yettimis, E Costopanagiotou, N Varsamidakis,V Polymeropoulos, S Metrou, C
Katis, C Farantos,A Papas and E Kalokerinos
Athens General Hospital, 1st Surgical Department,Athens, Greece
Pancreatic tumours of its body and tail of the organ don’t have the presenta-
tion of pancreatic head tumours so they have certain difficulties in differentia-
tion the cancer from chronic pancreatitis. The last 5 years we treated 12
patients with a mean age of 64 yrs (8 men and 4 women).The main symptom
they suffer is pain in the back and lost of body weight (8-12 Kgr) the last 6
months. The thorough radiological examination with CT and MRI scan diag-
noses most of the patients. Pancreatography with ERCP is necessary in some
patients to confirm the diagnosis. From the tumour markers it was shown in
our pts that Ca 19-9 and CEA were most diagnostic as there combination was
accurate positive in 8 pts with cancer.We operated in all pts and a distal pan-
createctomy was undertaken. Frozen sections during the operation was posi-
tive in 8 pts. Postoperative mortality was 0% and morbidity 8,5%.The patholo-
gy examination of the specimen showed cancer in 9 pts while the other 3 pts
had chronic pancreatitis. In 4 pts the lymph nodes were infiltrated with carci-
noma while in a pt there were multiple small liver metastasis not diagnosed by
the CT scan. Conclusion: Preoperative diagnosis of pancreatic cancer of the
body and tail is not accurate to differentiate from chronic pancreatitis.The dis-
tal pancreatectomy is a safe procedure and relieves most of the patient from
the pain.
P113
Pancreatic cystic neoplasms. Is an aggressive surgical approach justified?
G Nuzzo1, G Clemente, F Cadeddu and F Ardito
Agostino Gemelli Medical School, Surgical Sciences, Rome, Italy
Malignant pancreatic cystic neoplasms have a better prognosis than adenocar-
cinoma. In the past, a deterrent to an aggressive surgical approach to these
tumours was the high incidence of morbidity and mortality associated with
pancreatic resection.A retrospective analysis of 20 cases of cystic neoplasms of
the pancreas observed at our Department between 1992 and 1999 was made
to assess clinical features and results of the surgical treatment.There were 20
patients (8 males and 12 females) with a mean age of 59 years (range 36-82).
Fifteen patients underwent surgery and a resection was possible in 13 of these.
Four Whipple’s procedures, 2 total pancreatectomies and 7 left pancreasec-
tomies (enlarged to stomach, colon and left lobe of the liver in 3 cases) were
performed. Histological examination showed a cystadenocarcinoma in 8 cases,
a serous cystadenoma in 4 cases and a mucinous cystadenoma in the remain-
der 3 cases.Morbidity was 33% (3 pancreatic fistulae and 2 cases of delayed gas-
tric emptying after Whipple’s procedures).There was one postoperative death
(6.6%) after leakage of pancreatico-jejunostomy following Whipple’s procedure.
Patients with benign disease are alive at 1-8 years after surgery. Mean survival
in patients with malignant disease was 18 months.These data suggest that an
aggressive approach to these neoplasms is justified in order to obtain a correct
histological diagnosis and to improve survival in patients with malignant disease.
Surgical excision of pancreatic cystic neoplasms should be recommended
whenever possible.
P114
Pancreas cancer
M Morisan, M Cernisevski, M Janic and D Kosanovic 
General Hospital Pancevo, Surgery, Pancevo, Greece
We would like to present the results we have achieved in surgical treatment of
pancreas cancer. In surgery ward of Pancevo General Hospital, 64 patients
affected by the pancreas cancer were surgically treated in the 1995 - 2000 peri-
od.The diagnosis had been made on the basis of laboratory analyses, UZ, CT,
NMR and ERCP, before the surgical operation was performed.The surgical pro-
cedures were different dependig on location of cancer, invasivenes and pres-
ence of distant metastases. METODS: 36 - bilo-digestive by-pass with G-E anas-
tomosis in the case of possible duodenum obstruction. 13 - exploratory laparo-
tomy in the case of disseminative malignant disease. 1 - distal pancreactetomia
with splenectomy. 14 - pancreatoduodenectomia cephalica (s. Whipple). We
performed, pylorus preserving pancreatoduodenectomia with a patient having
pancreas head cancer, which was well differentiated without local invasioness
and distant metastasis. Two patients died immediately after the operation in
postoperative period up to 30 days. In the case of other patients, there were
no complications. Conclusion.The pancreas cancer prognosis depends on the
disease condition as well as on the tumours biology.After a radical resection is
performed, a longer survival can be expected, especially in the case of those
tumours where there are no metastasis in the lymph glands and no invasion of
the blood vessels.
P115
Comparison between mucinous cystic tumour and intraductal papillary muci-
nous tumour of the pancreas
TJ Lim,WH Kim,TW Hwa and KJ Kang
Department of Surgery, Keimyung University School of Medicine
Intraductal mucin producing tumours have been reported with increasing fre-
quency and recognized as a distinct entity. They includes mucinous cystic
tumour (MCT) and intraductal papillary mucinous tumour (IPMT) that have dif-
ferent characteristics in age, gender, location and prognosis but sometimes
these two tumours are confused with each other.We report four cases of MCT
and three cases of IPMT of the pancreas treated at Department of Surgery,
Keimyung University, Dongsan Medical Centre from January 1997 to December
2000. All patients with MCT were female and those with IPMT were male.
Average ages of MCT and IPMT were 46.3 and 60 respectively. All MCT were
located in the body and tail but all IPMT were located in the head of the
pancreas. Communications between tumour and pancreatic duct were seen
in all cases of IPMT but only one out of four cases in MCT. Ovarian type of
stromal tissue was found in three cases out of four MCT but none in patients
with IPMT. CA19-9 was elevated only one in patients with IPMT.
Pancraticoduodenectomy was done in patients with IPMT and distal pancrea-
tectomy with splenectomy was performed in MCT cases. All patients with
MCT and IPMT are still alive.
P116
Preliminary results of gemcitabine-based multi-drug chemotherapy in non-
resectable pancreatic cancer
M Sierzega,T Popiela and B Kädra
Jagiellonian University Krakow, Ist Department of General and GI Surgery,
Krakow, Poland
INTRODUCTION: In spite of dynamic development of modern diagnostic and
therapeutic methods, long-term results of pancreatic cancer surgery are still
unsatisfying mainly due to very low resectability rate reaching 30% of cases.The
aim of this study was to evaluate the effectiveness of gemcitabine-based
polichemotherapy in non-resectable pancreatic cancer. PATIENTS AND
METHODS: We performed a prospective study of 28 patients with intraoper-
atively verified stage IVA and IVB pancreatic cancer (acc. to TNM/UICC 1997).
Beginning from the tenth day after surgery all patients received chemotherapy
as follows: gemcitabine (1000 mg/m2), leucovorin (200 mg/m2) and 5-
Fluorouracil (1000 mg/m2). Chemotherapy was administered once a week for
12 consecutive weeks. Response to therapy was assessed based on control US
and CT examinations and patients clinical status acc. to Karnofski scale.
RESULTS: Of 28 patients who underwent chemotherapy, 13 (46%) showed sta-
bilization of tumour mass in control examination. In the remaining 15 (54%)
cases progression of the disease was observed. Stabilization of patient’s clinical
status assessed acc. to Karnofski scale was found in 15 (54%) patients while 13
(46%) patients shoved deterioration. Chemotherapy-related side effects were
observed in 35% of cases and were mainly limited to transitory leucopoenia.
CONCLUSIONS: Obtained in our study preliminary results indicate that gem-
citabine-based multi-drug chemotherapy may result in some clinical benefits.
P117
Periampullary tumours: our two-year experience
C Aydin,A Koyuncu, M Erdem, S Gokgoz, M Turan and M Sen
Cumhuriyet University, General Surgery, Sivas,Turkey
Periampullary tumours include a group of malignant neoplasm arising at or near
the ampulla of Vater. In the vast majority, these tumours are adenocarcinoma
originating from the head of the pancreas, ampulla of Vater, distal common bile
duct, or duodenum. Primary symptom of these tumours is obstructive jaundice
and they require similar management. Forty-two patients who were operated
on for periampullary tumour between 1998-2000 in Cumhuriyet University
Medical Faculty Hospital, General Surgery Department are included in this
study, Patients medical records were evaluated retrospectivelly.30 (71.5 %)
patients were male and 12 (28.5 %) patients were female. Median age was 62.2
(31-83). Fourteen patients were accepted as unresectable in the operation and
palliative approaches were performed. Median survival was 4.5 month in those
patients.Twenty-eight patients were underwent radical operation, their diagno-
sis were pancreas carcinoma in 22, papilla of Vateri tumour in 5 and distal com-
mon bile duct tumour in 1 patient. Whipple operation was performed in 26
patients and 2 of them were pylorus-preserving pancreoticoduodenectomy. In
2 patients with ampulla of Vateri tumour local excision was done. Early post-
operative mortality and morbidity rates were %17 and %40 respectively. Mean
follow up time was 11 month. Local recurrence was occurred in one patient
with local excision 22 months later. One-year survival was %78. Five patients
with pancreas carcinoma have lost between 5 and18 months. It concluded that
pancreaticoduodenectomy for periampullary tumours are still going to be pre-
ferred choice both for cure and palliation.
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Results of complex treatment of patients with malignant jaundice
O Prokopchuk1,V Zemskov1,Y Nowicky2,A Potopalsky3 and S Zemskov1
1Kyiv Centre of Liver, Pancreas and Bile Ducts Surgery, Department of General
Surgery, Kyiv,Argentina
2Ukrainian Anticancer Institute,Vienna,Austria
3Institute of Molecular Biology and Genetics, Kyiv,Argentina
We analyzed the results of complex treatment of 31 patients with malignant
obstructive jaundice who were treated in our clinic from 1999 to December
2000. These patients in addition to standard treatment received Ukrain
(NSC631570), a drug with immunomodulating and antiblastic properties. 17
patients had pancreas cancer, 5 patients had gallbladder cancer, 6 had bile ducts
cancer.A level of bilirubin was from 67 to 493 mcmol/L.All patients were oper-
ated: hepatico-jejunostomy (n=15), choledocho-duodenostomy (n=7), the
external drainage of bile ducts (n=2), endobiliary drainage (n=2). In 3 patients
with gallbladder cancer cholecystectomy with regional lymphadenectomy was
performed, other 3 patients with gallbladder cancer underwent cholecystecto-
my with non typical liver resection. In 19 (61.3%) cases alcoholization of the
tumour was performed. Ukrain was injected intravenously in addition to stan-
dard treatment in dose of 10 mg, every day, N 5, in presurgical period. During
the operation patients obtained 10 mg of Ukrain. In postsurgical period patients
received 10 mg of Ukrain, every second day, N10.The efficacies of the therapy
were the quality of life, hemogram, immunogram, ultrasonography, survival rate.
Mean postoperative hospital day was from 7 to 27 days. The postoperative
complications were observed in 12.9% patients. Immune changes were revealed
in increase in T-lymphocyte and T-helper counts, normalization of the
helper/suppressor ratio. One-year survival was 54.8%. Our data showed that
Ukrain can improve the quality of life of patients with malignant jaundice and
prolong survival. Further prospective controlled studies are warranted.
P119
Malignant pancreatic tumours in children: three case reports
G Madern1, M van Dooren 1 and F Hakvoort-Cammel2
1Sophia Children’s Hospital, Department of Pediatric Surgery, Rotterdam,The
Netherlands
2Sophia Children’s Hospital,Department of Pediatric Oncology, Rotterdam,The
Netherlands
Malignant tumours of the pancreas are rare in children. Pancreaticoblastoma,
adenocarcinoma of duct cells, acinar cell carcinoma, solid cystic and solid pap-
illary carcinoma, and also pancreatic tumours with connective tissue, lymphatic
and islet cell origin have been described. Little information is available on appro-
priate management and outcome of these tumours. We reviewed pediatric
tumours in our institute focusing on type of tumour, treatment and follow-up.
Three patients with a pancreatic tumour were treated, over a 12-year period.
Cases of nesidioblastosis and (pseudo)cysts of the pancreas were excluded
from the analysis. First was a 15-year old boy, who presented with muscle pain
and general malaise and a palpable abdominal mass. Laparotomy revealed an
irresctible tumour of the pancreas, a biopsy showed an acinar cell carcinoma of
the pancreas with extension into the liver. He had been treated with
chemotherapy (Megace, Etoposide and Somatostatin). He developed lymphan-
gitis carcinomatosis and died of respiratory failure, fourth months after the
diagnosis. Second was 13-year old girl with a palpable mass of the upper
abdomen. Histologic investigation showed an island cell tumour of the pan-
creas. She underwent a pylorus-preserving Whipple-operation and radical exci-
sion was obtained. No complications were seen, eight years follow-up showed
no recurrence of disease, and there were no further complaints.Third patient
was a 9-year old girl, with jaundice and abdominal pain.A neoplasm of the pan-
creas was seen, histology revealed a carcinoid of the pancreas. She underwent
a pylorus-preserving Whipple-operation, with also radical excision. After 3
years she showed no signs of tumour recurrence, although an exocrine pan-
creas dysfunction was diagnosed, which was treated by oral suppletion of pan-
creatic enzymes. Eleven years follow-up showed no recurrence of disease. In
conclusion, malignant pediatric pancreatic tumours are rare, and vary in histo-
logic type and outcome.The pylorus-preserving Whipple-operation is quite fea-
sible in children with a tumour of the head of the pancreas. Long-term results
must be awaited.
P120
Regional chemotherapy (RCT) combined with radiation (RT) for inoperable
pancreatic cancer
DS Osinsky, OA Yugrinov, DF Gluzman, SP Osinsky and VA Chorny 
Department of Abdominal Oncology, Institute of Oncology,Academy of Medical
Sciences, Kiev, Ukraine
OBJECTIVE: to evaluate the efficacy of RCT combined with RT in the treat-
ment of patients with inoperable pancreatic cancer; to evaluate the detection
of tumour cells in bone marrow (BM) to correct the tumour staging and pre-
dict the disease outcome. METHODS: 29 patients were included in the trial.
RCT was performed by intra-arterial infusion of cytostatics through catheters
inserted angiographically into celiac axis (18 pts) or a. lienalis (11 pts) and left
in place for 4 consecutive days for each cycle.ADR (50-60mg/m2) and cis-DDP
(40-50mg/m2) were infused over 120 min for 4 consecutive days. RT was start-
ed 3 days later and given in 5 daily fractions (2.5 Gy) per week (total dose 30
Gy). Combined treatment was given in a median of three cycles. BM aspirates
were obtained from the sternum both of patients from above mentioned group
and patients with tumour staged as T
2-3
N
0-1
M
0-1
. The mononuclear¢s fraction
and smears of BM were analyzed by immunocytochemical technique (ICC)
using monoclonal antibodies directed against a pancytokeratin, p53 and CEA
(Ber-Ep4).RESULTS:Ten (34%) partial response, thirteen (45%) of stable disease
and six (21%) of progressive disease were observed. Median disease free sur-
vival was 11.3 months. Toxicity was generally mild to moderate: leucopenia
(8/29), nausea and vomiting (12/29) predominated.The side effects of catheter-
ization were not observed. Of all patients with M
0
, 35-40% of the patients were
presented with cytokeratin-positive (CK+) cells in BM.The finding of the CK+
cells in BM was not correlated with the expression of CEA and p53. The
patients with tumour cells in BM showed a shorter overall survival than those
without tumour cells. CONCLUSION: RCT with RT is feasible and well toler-
ated. This combined method improves the otcome of inoperable pancreatic
cancer. ICC detection of tumour cells in BM may assist both in clarifying of
tumour staging and modulating current therapy concepts by devising individual
treatment protocols as well as estimate the prognosis of patients.
P121
Extended right hepatic lobectomy with thrombectomy in a patient with hepa-
tocellular carcinoma and tumour thrombus in inferior vena cava
Y Yuzuzer1,Y Tokat1, M Dayangac1, M Zeytunlu1, F Yilmaz2 and O Tekesin3
1 Ege University Medical School, Hepatobiliary And Pancreatic Surgery, Izmir,
Turkey
2 Ege University Medical School, Pathology, Izmir,Turkey
3 Ege University Medical School, Gastroenterology, Izmir,Turkey
We report a case of hepatocellular carcinoma (HCC) and tumour thrombus in
inferior vena cava (IVC) treated by right hepatic lobectomy and thrombectomy.
A 64-year-old woman with post-hepatitis B cirrhosis was referred with abdom-
inal pain. Contrast-enhanced computed tomography (CT) scan demonstrated a
low-density tumour with an unclear margin extending to the right lobe of the
liver. CT scan also revealed tumour thrombus in the IVC at the level of the
tumoural mass. She was Child-Pugh class II and had an elevated level of alfa
fetoprotein (>400 ng/mL).The patient underwent extended right hepatic lobec-
tomy and total caudate lobectomy under selective vascular exclusion. IVC was
explored and thrombectomy was performed with concomitant resection of the
vein wall infiltrated with the tumour thrombus. Histological examination
revealed anaplastic carcinoma.The patients’ postoperative course was unevent-
ful, and she was discharged from hospital on the fifteenth postoperative day.
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Recently, in patients with HCC and tumour thrombus in vena cava, thrombec-
tomy performed with hepatic lobectomy has been proved to improve the sur-
vival significantly. Despite most surgeons deem HCC involving the IVC to be
unresectable , major hepatectomy with the resection of the IVC can be per-
formed safely, even in the cirrhotic patients.This aggressive surgical approach
may offer hope for patients with advanced HCC involving IVC.
P122
Improved survival and local control after IORT and postoperative radiothera-
py
S Alfieri1,A Di Giorgio1, F Rotondi1, P Caprino1,A Morganti2, N Cellini2 and GB
Doglietto1
1Digestive Surgical Unit-Clinica Chirurgica, Digestive Surgery, Rome, Italy
2Radiotherapy, Radiotherapy, Rome, Italy
In the present study the question whether intraoperative and adjunvant radio-
therapy may improve prognosis of these patients is addressed. From February
1985 to December 1995, 46 patients with an adenocarcinoma of the head of
pancreas underwent pancreatic resection. The last 26 patients received also
intraoperative radiotherapy (except 5 patients) and adjuvant external beam
radiation therapy. Demographic data, tumour characteristics, surgical proce-
dures as well as 5-year survival and local control of disease were analyzed ret-
rospectively.The morbidity rate was not increased by adjuvant radiation thera-
py: 43% in patients treated with surgery alone and 57% in patients treated with
surgery and radiotherapy, (p = 0.1); operative mortality was 8% and 9%, respec-
tively (p = 0.8). Overall 5-year survival and local control were 13% and 48.6%
respectively. Five-year survival was 5.5% +/-5.3% - median 10.8 months) in sur-
gery-alone group and 15.7% +/- 8.6% - median 14.3 months) in radiotherapy
group (p = 0.06); local control at 5-years was 29.8% +/- 16.9% and 58.4% +/-
19.9% (p < 0.01), respectively. Median metastasis-free survival was 8 and 9
months (p = 0.52), respectively. Multivariate analysis showed that adjuvant
radiotherapy was an independent prognostic factor for survival (p < 0.01) and
local control of the disease (p = 0.03).The present study supports the role of
radiotherapy combined with pancreatoduodenectomy for cancer of the pan-
creatic head because even if the improvement in overall survival is moderate,
it represents an effective form to improve the local control of tumour.
P123
Postoperative hernias following laparoscopic cholecystectomy: mechanism of
formation and possibilities of prevention: an animal and clinical study
G Mohamed1,Y Szaba2, E Brath2, L Hornok1, I Razsa1,A Oláh3, I Miko2, I Furka2
and J Kiss1
1Semmelweis University, Facutly of Health Sciences, Surgery, Budapest, Hungary
2Debrecen University, Medical and Health Science Centre, Dept. of Operative
techniques, Debrecen,
Hungary
3Petz Aladar Teaching Hospital, Surgery, Györ, Hungary
INTRODUCTION: It is supposed that the abscence of postoperative hernias is
one of the benefits of laparoscopic surgery (LS), though both the clinical and
animal studies confirm controversies.The aim of this study is to confirm that
postoperative hernias after LS are observed in animal experiments and do exist
in the clinical practise as well. MATERIALS AND METHODS: during 6o laparo-
scopic cholecystectomies (LC) performed in dogs second look laparoscopy
was performed to detect adhesion formation and postoperative hernias.Also
retrospective clinical study was made to detect the frequency of postoperative
hernias following LC-s. RESULTS: in 3 animals (5%)postoperative hernias were
observed as a result of insufficient desufflation of the abdominal cavity. In the
clinical work among 3000 LC-s performed this percent was 0.26%.All hernias
existed in the scar of the 10 mm trocars.The contents of all hernias was omen-
tum. In all operations abdominal wall retractors were used for the extraction
of the gall bladder. In all those cases only the skin incision was closed.
DISCUSSION: this animal and clinical study was devoted to draw the attention
to the fact that postoperative hernias may occur after LC when the desuffla-
tion of the abdominal cavity in not sufficiently performed and the enlarged inci-
sions are not perfectly colsed.This new phenomen can be impeded by the cor-
rect desufflation and closing of the incisions using the new armamentarium of
laparoscopic abdominal wall incision-closing instruments, which is demonstrat-
ed in this study.
P124
Progression of thermal necrosis 24 hours after radiofrequency ablation in
porcine livers
J Wiersinga,M Jansen, I Straatsburg, P Davids, J Klaase,D Gouma and T van Gulik
Academic Medical Centre, Surgical Laboratory, Dept. Surgery,Amsterdam,The
Netherlands
Radiofrequency ablation (RFA) is a novel treatment for unresectable hepatic
tumours. We aimed to investigate the possible progression of the thermal
lesion in time and to study the effect of RFA on the architecture and viability
of the liver parenchyma. Twelve healthy female pig livers were treated with RFA
(Radio Therapeutics) under general anesthesia. Six pigs were terminated direct-
ly after the procedure and six animals were kept alive for 24 hours. After
removal of the liver, biopsies were taken at 1, 2 and 3 cm from the rim of the
coagulated area, fixed in 4% formaldehyde and stained with H&E, or frozen and
stained for activity of NADH diaphorase (NADHd), a marker of mitochondri-
al viability, and 5-Nucleotidase (5-NT), a marker of plasma membrane integrity.
Compared to the viability directly post-RFA, a marked deterioration of the via-
bility (pericentral necrosis and loss of NADHd and 5-NT activity) was
observed after 24 hours up to 3 cm from the coagulated area.This area corre-
sponded with the site in which a temperature of 43ÂºC was measured during
RFA, suggesting hyperthermia-induced necrosis outside the target area of abla-
tion. CONCLUSION:Twenty-four hours after RFA, viability of liver parenchy-
ma surrounding the ablated area is decreased. For determination of the final
size of the ablated area the extent of secondary heat-induced necrosis in liver
parenchyma should be considered.
